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Multivariate Statistical Analysis In Single Cell Transcriptomics
Abstract
With technological advances in the last decade, single cell RNA sequencing (scRNAseq) has emerged as
an exciting weapon in the modern scientist’s arsenal to unravel cellular heterogeneity. The ability to
measure the transcriptome in each individual cell in any given tissue poses challenges galore, ranging
from purely taxonomical to methodological and computational. This thesis deals with the latter. Coping
with the hyper-diversity of cells requires fundamental conceptual advances in computational biology.
Chapter 1 sets the stage for the subsequent sections that follow, and provides a basic overview of the
single cell transcriptomics field, specifically focusing on the questions motivated by a molecular snapshot
of individual cells. In Chapter 2, we tackle the philosophical notion of similarity, and introduce a rankbased function on probability spaces that can be utilized to define cell-to-cell distance, and subsequently
cluster and identify niche cell groups. We demonstrate that this function is a valid kernel method, and can
thus find broad utility in kernel-based machine learning algorithms. In Chapter 3, we summarize a
framework for comparing a multivariate distribution across k groups, and thereafter describe scenarios
where this graph-based test allows us to compare the distribution of gene sets, corresponding to a
biological pathway or function, across a set of closely related cell types. We describe how, when paired
with scRNAseq data obtained from different T cell subtypes, this method allowed us to gauge new
biological insights regarding the T cell metabolic machinery. Chapters 4 and 5 dive further into a specific
pathway, the complement system. It is well known that the complement system shapes homeostasis in
immune-privileged organs such as the brain and the retina, and that intracellular complement also
regulates cellular metabolism. In Chapter 4, we describe analysis of scRNAseq data from the murine
retina, which insinuates at the presence of a local retinal complement system. And lastly in Chapter 5, we
describe a novel statistical method for detecting pathway- pathway synergy using scRNAseq data, based
on canonical correlations. We used this method to identify metabolic pathway candidates that might
potentially interact with the complement system, and subsequently affect metabolic reprogramming in T
cells.
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ABSTRACT

MULTIVARIATE STATISTICAL ANALYSIS IN SINGLE CELL
TRANSCRIPTOMICS
Divyansh Agarwal
Nancy R. Zhang
With technological advances in the last decade, single cell RNA sequencing
(scRNAseq) has emerged as an exciting weapon in the modern scientist’s arsenal
to unravel cellular heterogeneity. The ability to measure the transcriptome in each
individual cell in any given tissue poses challenges galore, ranging from purely
taxonomical to methodological and computational. This thesis deals with the latter.
Coping with the hyper-diversity of cells requires fundamental conceptual advances
in computational biology. Chapter 1 sets the stage for the subsequent sections that
follow, and provides a basic overview of the single cell transcriptomics field,
specifically focusing on the questions motivated by a molecular snapshot of
individual cells. In Chapter 2, we tackle the philosophical notion of similarity, and
introduce a rank-based function on probability spaces that can be utilized to define
cell-to-cell distance, and subsequently cluster and identify niche cell groups. We
demonstrate that this function is a valid kernel method, and can thus find broad
utility in kernel-based machine learning algorithms. In Chapter 3, we summarize a
framework for comparing a multivariate distribution across k groups, and thereafter
describe scenarios where this graph-based test allows us to compare the
distribution of gene sets, corresponding to a biological pathway or function, across
iv

a set of closely related cell types. We describe how, when paired with scRNAseq
data obtained from different T cell subtypes, this method allowed us to gauge new
biological insights regarding the T cell metabolic machinery. Chapters 4 and 5 dive
further into a specific pathway, the complement system. It is well known that the
complement system shapes homeostasis in immune-privileged organs such as the
brain and the retina, and that intracellular complement also regulates cellular
metabolism. In Chapter 4, we describe analysis of scRNAseq data from the murine
retina, which insinuates at the presence of a local retinal complement system. And
lastly in Chapter 5, we describe a novel statistical method for detecting pathwaypathway synergy using scRNAseq data, based on canonical correlations. We used
this method to identify metabolic pathway candidates that might potentially interact
with the complement system, and subsequently affect metabolic reprogramming
in T cells.
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CHAPTER 1: Single-Cell Transcriptomics: A Fertile Ground for
Biological Discovery and Statistical Innovation
Abstract
Karl Pearson called statistics “the grammar of science” in the context of how statistical
models can provide structure and meaning to physical or biological data (Pearson 1892).
Today’s biologists increasingly recognize that statistics is indispensable to their work,
and similarly, biology-driven problems continue to inspire statistical thinking. This
dissertation is born from a similar marriage between statistical ideas and biological
questions, and the latter are specifically motivated by new technological developments in
the field of single cell transcriptomics. In this chapter, we review the basic analyses in
single cell RNA sequencing, and the associated statistical issues that this technology
gives rise to. Every project described in this thesis is connected by a relatively new
domain in biology, one where instead of analyzing the average signals from many cells,
scientists can examine the properties of individual cells. Over the past decade, single
cell technologies have become immensely popular, making this an exciting time for
biological discovery, as well as theoretical developments in the field.

Quantifying the Transcriptome in an Individual Cell: Why is it
Momentous?
As multicellular organisms, each patch of tissue in our body is a heterogeneous
community of dissimilar cells. Comprehensively understanding a population requires
information about the multifaceted individuals that make up that population. Analogously,
capturing the heterogeneity of cellular activity in an organ or tissue necessitates
nuanced information about each cell’s unique transcriptome. Suppose you are tasked
with understanding how your city’s residents respond to a new tax policy. You survey
several thousand individuals from the city but only receive the aggregate opinion of the
population back. Although the average opinion might provide useful insights, were there
minority groups whose voices were missed? How does one estimate the diversity
captured in the survey, and does that estimate represent the population well? Do people
respond differently to the policy based on the ZIP code they live in? Until about a decade
ago, biologists interested in molecular cell biology were faced with similar questions.
Learning about the cell populations that constitute an organ required sequencing of a
large number of cells in a given tissue. As a result, it was nearly impossible to discern
how different cell populations arise, communicate with each other, or change over time
and in a particular disease. Moreover, if the dynamics of the cell populations of interest
are offset in time, or if cells of interest are in the minority, thereby having their behavior
masked by the majority, sequencing the whole tissue would fail to provide the desired
results (Di Carlo, Tse, and Gossett 2012).
A foundational purpose of biology is to understand living organisms. The basic unit of
structure, function and organization in all organisms is the cell. The instructions needed
to build and maintain cells are encoded in a long, double helix molecule called the DNA,
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and cells carry out these instructions by reading and transcribing DNA into RNA. The
RNA readouts for a given gene are called transcripts, and the collection of all gene
readouts, the transcriptome. Surveying the “average” transcriptome of cells in a given
tissue, also known as whole tissue or bulk sequencing, inspired prominent work at the
intersection of statistics and genomics. For example, new statistical frameworks allowed
biologists to (i) accurately estimate the technical variance associated with bulk
sequencing, (ii) identify differentially expressed genes between conditions, and (iii)
minimize false discovery by controlling for multiple hypothesis testing, among others.
Yet, while bulk transcriptomics allowed us to appreciate how a gene’s activity or
abundance might influence a cell’s function, the molecular aspects that underlie the
heterogeneity in gene expression, and by proxy in cellular function, remained elusive.
On the other hand, examining individual cells allows for the comprehensive cataloging of
the different cell types that constitute an organ, and providing an opportunity for
discovery of new subpopulations of cells previously hidden by bulk sequencing analyses.
Single cell RNA sequencing (scRNAseq) allows us to gain a deeper understanding of
what constitutes a specific cell type, how that type of cell normally functions, and how
might changes in gene activity reflect or contribute to disease. The multi-million dollar
global initiative, Human Cell Atlas, will soon “create comprehensive reference maps of
all human cells to give us a unique ID card for each cell type” (Regev et al. 2017). Given
the vasst amounts of high dimensional data being generated, there are exciting
opportunities for the collaboration of statistics and biology. One such collaboration
begins in the rather philosophical quest of defining a cell type. Canonical cell types
– think of muscle (myocyte), nerve (neuron) or fat (adipocyte) – were originally defined
by both the functions of the tissues in which they reside, and histological classification of
cells based on their morphology, often resulting from imaging of stained, non-functional
cells mounted on a microscopy slide. To define a cell type, let us revisit what a cell is.
On the one hand, it is a collection of “stuff”: mainly DNA, RNA and proteins. On the
other, a cell is a dynamic entity that operates in an ecological niche: in response to its
environment, it can adapt and modify. With single cell technologies, one can begin to
quantify both the fixed and dynamic states of single cells, and broaden the existing
catalogue of cell types. Are existing classifications appropriate, or should cell types be
defined to encompass the dynamic landscapes on which cells reside? This question,
which marks the beginning of a paradigm shift on how cell types should be defined by
the scientific community, is an open invitation for statistical ideas (Figure 1).
In fact, the crosstalk between technical advances and statistical methodologies in
biology is not new. With the advent of the microscope in the late 17th century, invisible
and previously unknown features of a cell became perceptible. For instance, the
microscopic structure of the brain revealed that the primary brain cells, called neurons,
are not physically connected to each other. This led Santiago Ramón y Cajal to
postulate that perhaps individual neurons organize themselves in an ensemble, and
transmit information to nearby cells through a small space, the synapse. This notion of a
statistical ensemble where nearest-neighbors interact resulted in rich developments in
spatial statistics, e.g., the evolution of Markov Random Fields. It became evident that not
only does new technology allow scientists to gallantly pin biology down, but that the
technical advances inspire conceptually new, interdisciplinary research. Fast forward to
today, and major statistical innovation continues to be driven by advances in molecular
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technology, which is naturally accompanied by a wealth of biomedical research
questions. As the 2002 Nobel Laureate Sydney Brenner mentioned in his speech:
“Progress in science depends on new techniques, new discoveries and new ideas,
probably in that order”. In the case of single cell technology, we are now in the phase of
new discoveries and new ideas.
Although analyzing the gene expression patterns of single cells provides a molecular
way to ascribe subtypes, there is considerable cell-to-cell variation in expression within a
single cell type. This variation can reflect stochastic gene expression and differences in
a cell’s microenvironment. Examining cells individually, in high dimensions and over
time, has shown that cellular properties are dynamic and may not follow rigid
hierarchies; they vary continuously as well as discretely ('What Is Your Conceptual
Definition of "Cell Type" in the Context of a Mature Organism?' 2017). These
observations have also led to the notion of a cell state, wherein the boundaries between
different cell types are blurred, and a cell can transition between states or have multiple
ID cards. Just as there is no singular, all-encompassing way of classifying people,
maybe there is none for cells. And as with people, history and context matters for cells.
How is a cell related to another cell and from where did it arise? What molecular events
or external stimuli influenced its transcriptome? What identity might a cell assume next in
light of its current environment and its history?

Figure 1. Common types of analyses with scRNA-seq data: (a) cell type identification
and detecting disease-associated cell populations, (b) differential expression analysis
and comparison of expression distributions across cell types, (c) analyses involving
gene-gene correlations, network reconstruction, and (d) trajectory inference.
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Existing, Frequently Studied Questions in scRNAseq
The concept of a cell type becomes particularly important if we think of them not just as
static molecular snapshots, but as histories unfolding in time. Each cell in the human
body has its origins in a single fertilized oocyte (female egg cell). Cells make decisions
as they divide along their developmental journey; some decisions are definitive, and
others more flexible with potential for reversal. scRNAseq captures the state a cell is in
depending on what decisions it has already made, which may or may not represent an
easily discernable, discrete category. For understanding both normal development and
disease, it is imperative to have a fundamental grasp of the cell-fate transitions that
occur in complex cellular ecosystems. Particularly in developmental biology, inferring
lineage relationships between cells has been a long-standing interest with the hopes of
mechanistically understanding the pathologies of development, for instance, in cancer.
Single cell transcriptomics naturally samples cells that are at different time points along a
developmental trajectory, and provides a high-resolution view of how gene expression
changes might occur over the course of development.

Trajectory Inference
Several approaches have been developed with the goal of deriving trajectories or
lineages using scRNA seq data. These methods seek to impose a temporal scale, or a
pseudotime metric that can tell us where each cell is in the time series. For instance, one
might try to infer a manifold that captures cell-to-cell relationships such that a graphical
path through the cells reflects gene expression changes over time. Dimension reduction
is a common first step in single cell data analytics. Building on this step, one way to
reconstruct trajectories from scRNAseq data is to infer the low-dimensional manifold
embedded in a high-dimensional space that captures the observed geometric
relationships among the cells. This modeling approach assumes that depending on
where cells fall on the projection, a set of gene expression changes would traverse a
graphical path (trajectory) in the high-dimensional space. Examples of method that rely
on this approach include Monocle (Qiu et al. 2017; Trapnell et al. 2014), TSCAN (Ji and
Ji 2016) and Wanderlust (Bendall et al. 2014), among others.
Understanding the dynamic changes in gene expression that occur over time is
challenging because techniques that enable temporal measurement of expression in
living cells can track only a limited number of genes. Moreover, techniques that broadly
measure the expression of all genes in a given cell end up destroying the cell, thereby
providing only a snapshot of expression. One way to overcome this problem is to utilize
the biological knowledge that freshly transcribed mRNA is immature, and in the process
of becoming mature, certain segments of the mRNA are cut out or spliced. When a gene
is turned on, we expect a relatively high proportion of immature transcripts to be present,
and when it is turned off, the mature mRNA transcripts will decay as the immature
transcripts also continue to decrease. If a gene’s expression is stable, for instance that
of the house-keeping genes which are necessary for a cell to function normally, we
expect that older transcripts will be continuously replaced with the new ones, and thus, a
small fraction of the mRNA to always be in the immature form. Hence, for a given gene
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in a cell, the ratio of unspliced mRNA to spliced mRNA can be exploited to deduce
expression dynamics. This method, RNA Velocity (La Manno et al. 2018),
has demonstrated that existing snapshots of gene expression can, indeed, provide bona
fide dynamic information. By predicting the mRNA levels for all genes concurrently, one
can predict future cells. In the gene expression space, the difference between observed
cells and future cells forms a vector field (Svensson and Pachter 2018), and these
vectors naturally lend themselves to biologically meaningful trajectory reconstruction. For
a detailed review and comparison of single cell trajectory methods, please refer to
(Saelens et al. 2019).

Identifying Cell Clusters and Associated Marker Genes
In addition to reconstructing trajectories, a primary goal of single cell transcriptomics has
long been to use the expression data to characterize the heterogeneity of cells within a
given tissue or organ. While there are now dozens of software that allow researchers to
explore the molecular diversity of cells, all methods initially group the cells by their
expression profiles and then compare expression values between groups. This step
– identifying groups of cells that are similar to each other, and subsequently finding the
genes that uniquely and faithfully mark these clusters/groups – represents another
avenue for statistical innovation. Assessing similarity between two objects is crucial not
only in the setting of scRNAseq, but in general for several bioinformatics algorithms. A
common problem is that similarity can appear by chance, particularly for low expressed
entities. This is especially relevant in single cell RNA-seq (scRNA-seq) data because
read counts are much lower compared to bulk RNA-seq. Virtually all clustering
algorithms that have been proposed for scRNA-seq data fundamentally rely on a metric
of association/similarity between individual cells. These measures have included
correlation-based metrics, geometric distances, as well as state-of-the-art kernel-based
clustering algorithms. Although in the next chapter we will discuss a novel way of
assessing cell-to-cell similarity, for a comprehensive comparison of existing measures,
we encourage the reader to see: (Kim et al. 2018; Skinnider, Squair, and Foster 2019).
Cell identity signals resulting from scRNAseq are highly robust because cell types are
low-dimensional and many genes encode identity (Crow and Gillis 2018), allowing
researchers to read out this property regardless of individual gene dropouts. Moreover,
the identification of marker genes via a differential expression (DE) analysis for cell types
is becoming increasingly convenient as new, publicly-available data is constantly being
generated and studies transparently report the genes they use to assign identity to cells.
In single cell data analysis, DE analysis is of particular significance because it
represents the hope of resolving a long-standing question posed by bulk transcriptomics
– Does the differential expression of a gene in whole tissues stem from gene expression
changes within a specific cell type, or from changes in cell type proportions across two
given conditions? The need to develop DE analysis methods for scRNAseq data also
arises from the fact that gene expression is not always unimodal across cells, and
compared to the bulk transcriptomics data, scRNAseq data is more noisy, especially for
lowly-expressed genes. Therefore, many DE methods proposed for single cell data
explicitly model gene expression through elaborate distributions to account for these
characteristics (Todorov and Saeys 2018). Data resulting from whole tissue sequencing
also tends to have smaller within-group variations, and hence, the corresponding DE
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methods are based on comparing the differences in mean gene expression. In contrast,
recent developments in single cell DE tools revolve around comparing two distributions,
for instance using nonparametric methods such as the Cramer-von Mises and the
Kolmogorov-Smirnov tests (Delmans and Hemberg 2016). Another approach, scDD
(Korthauer et al. 2016), considers different modality scenarios to compare the
distributions of gene expression values. The heterogeneity, multimodality, and sparsity
of scRNAseq data has motivated new statistical methods for DE analysis that utilize a
zero-inflated negative binomial (ZINB) model, two-part joint models or mixture modeling
frameworks. For example, MAST (Finak et al. 2015), and SCDE (Kharchenko,
Silberstein, and Scadden 2014) are both based on a hurdle model framework to account
for the zero counts and model the positive expression values; the former then also uses
logistic regression and linear regression to respectively identify DE genes for each part.
Lastly, methods to identify both the technical effects as well as the biological variation
between two groups of cells based on Bayesian models have also been proposed
(Wang and Nabavi 2018).
While examining DE, and even other aspects of cell-to-cell variability across conditions,
it is imperative to account for confounding factors such as heterogeneity in cell size, age
or proliferation state. The aforementioned internal parameters of a cell are commonly the
leading sources of inter-cellular variability, and precisely identifying such sources of
gene expression variance allow us to appropriately control the false discovery rate. To
grow and reproduce, all organisms rely on cells to duplicate their genetic material and
form daughter cells. This process, called the cell cycle, occurs in an oscillatory manner,
and an individual cell’s transcriptome depends on which phase of the cycle the cell is in
(Dolatabadi et al. 2017). Besides, not only do mRNA counts for most genes scale with
cell volume, but that the transcriptional burst size and frequency also change depending
on cell size and cell cycle (Padovan-Merhar et al. 2015). Therefore, estimating cell size,
cell cycle variables and other confounders to appropriately normalize the scRNAseq
data has also stimulated the development of statistical methods. Examples of these
methods include f-scLVM (Buettner et al. 2017) and scLVM (Buettner et al. 2015), which
seek to decompose the sources of variation in single cell data by employing a latent
factor model.

Data Denoising and Dropout Recovery
In general, single cell data provides researchers with a patchy picture of gene
expression. Recall that the most salient reason for noisy data is that most mRNA
molecules in each cell are lost during the sequencing steps. For a data scientist, this
means that the output data matrix is sparse, wherein the majority of the entries are
zeroes. To maximize each experiment’s value and extract all the relevant biological
information, it is desirable to “denoise” the data, i.e., recover any missing values that
would likely have been captured were all the sequencing steps perfect. While this may
seem like a case of missing data, it is important to note that denoising single cell data is
not a classical, statistical imputation problem. This is because of two reasons. First, the
more technical reason – in single cell transcriptomics experiments, the mRNA readouts
are sparse not only because of dropout events, but also because of other factors that
influence technical and biological variability. Not all zeros in scRNA-seq data represent
missing values because not every gene is expected to be expressed in every cell.
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Furthermore, many of the transcription factors that are lowly expressed in normal/healthy
cells are measured as a zero, and hence a value of zero might have contribution from
both technical as well as biological factors. The mechanism responsible for the
scRNAseq data we observe is undercounting; the data are not missing at random. The
second, more practical reason is that for single cell data, the goal of denoising is not
limited to filling in the missing zeroes. The concept of denoising applies to all data
entries, not just the missing/zero values, and is therefore more appropriate. In addition to
the mechanism for the scRNAseq data generation, empirical work has also
demonstrated the underlying noise model to be Poisson-alpha (Wang et al. 2018), which
allows one to denoise all the entries in the output data matrix, including genes both with
a value of zero as well as those with non-zero values.
Denoising single cell expression profiles is crucial to uncovering new biology, which is
highlighted by the enthusiasm for such methods in the field, and the work of scientists
who have successfully implemented denoising for data-driven discovery. Existing
methods aim to improve the signal-to-noise ratio of a cell’s expression profile, while
preserving biological expression heterogeneity. Methods such as kNN-smoothing,
scImpute, DrImpute and Markov Affinity-based Graph Imputation of Cells (MAGIC) (van
Dijk et al. 2018) construct a cell-cell affinity graph or identify the nearest neighbors of
each cell. Then, either by averaging the gene expression values for each k-nearest
neighbors, or by using a graphical diffusion technique, such as the Markov diffusion
operator, they aggregate data between cells to denoise gene expression values. Other
methods such as SAVER (Huang et al. 2018), netSmooth, and BISCUIT try to recover
“true” expression signals for a given gene using the expression of other genes.
Denoising based on gene–gene, or gene–network relationships is advantageous in that
methods relying on this approach can leverage existing, publicly available data for more
accurate predictions of gene expression. This idea is particularly enticing in light of
recent initiatives to have detailed cellular atlases for each anatomic organ in the mouse
(Tabula Muris et al. 2018; Han et al. 2018) and the human (Rozenblatt-Rosen et al.
2017). Recent methods that look to transfer information across scRNAseq datasets
include SAVER-X (Wang et al. 2019) and TRANSLATE (Badsha et al. 2018); both use
an autoencoder, a neural network that compresses the input into a latent-space
representation, and then reconstructs the output from this representation. Autoencoders
have gained traction as powerful models for unsupervised machine learning, and the
denoising methods utilizing this machinery seek to extract transferable gene expression
features across studies from different labs, generated by varying technologies, or
obtained from diverse species.
Although the paucity of gold-standard benchmarking scRNAseq datasets makes a headto-head comparison among the methods challenging, several studies have evaluated the
performance of the various denoising methods in a diverse testbed of simulations and
real datasets. Common metrics of performance evaluation have included a method’s
ability to: (i) recover gene-gene correlations, (ii) enhance the visualization of distinct cell
clusters, and (iii) improve downstream analyses. Examples of existing benchmarking
studies include scRNA-seq mixology (Tian et al. 2018), in which scRNAseq datasets
were generated from varying combination of a pre-determined mixture of cells from
distinct cancer cell lines. Comparison of twelve normalization and denoising methods on
these data showed substantial differences between methods in their ability to minimize
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bias (false signals). Another comparison of denoising methods on negative binomial
simulations and other publicly available data also stressed that most methods has a
tendency to introduce false positive gene-gene correlations between independently
drawn genes (Andrews and Hemberg 2018). Moreover, detection of differentially
expressed genes in denoised data also suffers from inconsistencies, depending on
which denoising approach is employed (Zhang and Zhang 2018). To biologists, it might
seem that data denoising is a bane given its systemic tendencies to bias the output data.
To statisticians, however, these problems are a boon for they provide a fertile ground to
develop new modeling frameworks.

Roadmap and Outline of Forthcoming Chapters
In this chapter, we sought to provide a gentle background on single cell transcriptomics
and some of the interesting computational methods it has already motivated. In the
remaining chapters in this thesis, we will delve deeper into the concept of cell-to-cell
similarity, and consider data proximity in a more general, probabilistic framework.
Accordingly, in Chapter 2 we describe a function on probability spaces that can be used
to cluster cells into similar/dissimilar groups. Being a Mercer kernel, this method has the
advantage of being useful in other kernel-based machine learning domains. An earlier
version of this work is available here: https://arxiv.org/abs/1808.02061
In Chapter 3, we discuss multivariate differential distribution testing, specifically in the
setting where multiple cell type groups are involved. This work is motivated by the desire
to understand changes in distribution of gene sets across multiple cell clusters. These
gene sets might correspond to a specific function or biochemical pathway, and therefore
can provide insights into how similar or dissimilar the biochemical machinery is across
different cell types. This work was done jointly with Drs. Bhaswar Bhattacharya and
Somabha Mukherjee at The Wharton School, and is available here:
https://arxiv.org/abs/1906.04776
In Chapter 4, we outline an analysis project which began with a set of simple questions:
does the eye, an immune-privileged organ, have its own innate immune defense? If so,
which cell types participate in producing the molecules that participate in innate
immunity? And by attempting to answer the first two questions, can we learn something
about how innate immunity is regulated in the retina? To begin exploring these, we
mapped the genes of an innate immune pathway, the complement system, across
individual murine retinal cells. We found evidence for a local complement system in the
immune-privileged retina, wherein the production of complement components was
distributed across the different retinal cell types.
Lastly, in Chapter 5, we delve deeper into understanding the role of complement, but
consider a different model system, the adaptive immune guardians of the human body –
T cells. Specifically, the complement pathway has been found to regulate lymphocytic
metabolic reprogramming. We performed scRNAseq on naïve and memory T cells at
rest, and at 12h and 24h post CD3+CD28 costimulation. We then developed a statistical
framework based on canonical correlation analysis and stratified permutation testing to
identify the metabolic pathways that might synergize with the complement system. We
discovered that this approach recapitulated previously known patterns of crosstalk
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between complement and pathways such as glycolysis and oxidative phosphorylation
among both CD4+ and CD8+ T cells.
Collectively this thesis describes a diverse spectrum of projects at the intersection of
computational biology, immunology, and statistics that are interwoven through single cell
transcriptomics. The seemingly broad scope of this dissertation is akin to the broad
research that has spawned from scRNAseq data -- allowing us to develop new
methodologies, generate interesting data-driven hypotheses, and gain new biological
insights.
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CHAPTER 2: A Rank-Based Kernel on Probability Spaces for Niche
Detection
Abstract
In data science, determining proximity between observations is critical to many
downstream analyses such as clustering, classification and prediction. However, when
the data’s underlying probability distribution is unclear, the function used to compute
similarity between data points is often arbitrarily chosen. Here, we present a novel
definition of proximity, Semblance, that uses the empirical distribution of a feature across
all observations to inform the similarity between each pair. The advantage of Semblance
lies in its distribution-free formulation and its ability to place greater emphasis on
proximity between observation pairs that fall at the outskirts of the data distribution, as
opposed to those that fall towards the center. We prove that Semblance is a valid
Mercer kernel, thus allowing its principled use in kernel-based learning algorithms.
Semblance can be applied to any data modality, and we demonstrate its consistently
improved performance against conventional methods through simulations and three real
case studies from diverse applications: cell-type classification in single-cell
transcriptomics, image reconstruction, and financial forecasting.

Background
In modern data analysis, the data are often first reduced to a proximity matrix
representing the pair-wise similarity between observations, which becomes the input to
downstream analyses such as clustering, classification, and prediction. This proximity
matrix is an information map as well as an information bottleneck. The former, because
all of the information available to a downstream analysis algorithm are represented in the
matrix, and the latter, because the matrix must transmit enough information about the
data for any downstream method to be able to do its task. In exploratory data analysis
settings, Euclidean distance or correlation-based metrics are popular ad hoc choices for
inferring proximity (Gavilan and Morente 2014; Schweizer and Sklar 1960; Wong and
Yao 1987), although more sophisticated, context-specific choices have been designed
for particular tasks (Genton 2002; Wang, Xing, and Schaid 2015).
During the last two decades, efficient kernel-based learning algorithms and their
Reproducing Kernel Hilbert Space (RKHS) interpretations have generated intense
renewed interest. Specifically, efforts have focused on the development of proximity
matrices that satisfy the Mercer condition, which would allow the detection of complex
nonlinear patterns in the data using well-understood linear algorithms (Hofmann,
Schölkopf, and Smola 2008; Shawe-Taylor and Cristianini 2004; Gisbrecht, Schulz, and
Hammer 2015). Such proximity matrices, called Mercer kernels, form the core of several
state-of-the-art machine learning systems. Constructing a similarity function or a
proximity matrix amounts to encoding our prior expectation about the possible patterns
we may be expected to learn in a given feature space, and thus, it is a critical step in
real-world data modeling (Saitoh 1988; Schaid 2010). Noise distributions in the real
world are often non-elliptical, with continuous and discrete features generally intermixed.
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Yet, in the initial stages of data analysis, when the underlying structure of the data’s
probability space is unclear, the choice of the similarity/distance metric is often arbitrary.
In exploratory data analysis, there is often little prior knowledge to guide the selection of
distance/similarity measures, much less the design of valid Mercer kernels. Thus, even
as kernel-based machine learning algorithms become sophisticated, due to the lack of
more informed options we often default to relying on Euclidean distance or Pearson
correlation during the exploratory stage of data analysis.
Here we present a general, off-the-shelf kernel function, Semblance, that uses the
empirical distribution of a feature across all observations to inform the proximity between
each pair. Semblance puts a premium on agreement in rare feature values, for discrete
features, and on proximity between points at the outskirts of the data distribution, for
continuous features. This allows Semblance to reveal structures in the data that are
obscured by current, commonly-used kernel measures. We first describe the intuitions
behind Semblance using a concrete example and subsequently prove that it is a valid
Mercer kernel, and thus can be used in any kernel-based learning algorithm (Minh,
Niyogi, and Yao 2006). Then, under simplified but transparent simulation experiments,
we systematically explore the types of patterns that we can expect to identify using
Semblance versus other common approaches such as Euclidean distance. Semblance
achieves higher sensitivity for niche features by adapting to the empirical data
distribution. Through examples from several fields – single-cell biology, image analysis,
and finance – we demonstrate how the Semblance kernel can be used.

Constructing the Rank-based Semblance Function
Suppose we begin with N nxG , the data matrix with n rows and G columns. Let each row
correspond to an object, and each column correspond to a feature measured for all
objects. We would like to construct a similarity kernel relating the objects. For ease of
notation, let X = (x1 ,…, xg ,…, xG ) and Y = ( y1 ,…, yg ,…, yG ) be two objects, i.e., two rows
in the matrix N nxG .
Consider a feature for which most objects record the value “1”, and only very few record
the value “0”. Now consider two objects, both of which record the rare value “0” for this
feature. Is this stronger evidence for similarity between these two objects, as opposed
to the scenario where both record the much more typical value “1”? Intuitively, it is much
more improbable for two independent objects to agree on a rare value than on a
common value, and thus, two objects agreeing on the rare values for many features
suggests that they may belong to a common niche group. Similarly, for a continuousvalued feature, proximity in terms of absolute distance between two independent draws
is much more unlikely at the tails of the distribution as compared to at its center. Thus,
for discrete features, we would like to reward agreement between objects on rare feature
values, and for continuous features, we would like to reward proximity between objects
in the tail of the empirical distribution. Furthermore, for robustness, it is desirable for the
similarity function to be nonparametric and invariant to monotone transformations of the
features. These are the considerations underlying the construction of Semblance.
More formally, for a given feature g, let Pg be its underlying probability distribution. Let
the observed values for this feature g in objects X and Y be xg and yg, respectively. In
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practice we don’t know Pg , but if we did, we could ask how likely are we, if we were to
redraw one of the two values (xg, yg), to obtain a distance that is equal to or smaller than
the actual observed distance, while preserving the order between the two. Let Z be the
redraw, then this could be expressed as the probability:

{

}

pg (xg , yg ) = pg ( yg , xg ) := Pg min(xg , yg ) ≤ Z ≤ max(xg , yg ) .

(0.1)

The above probability is a natural measure of the dissimilarity between any two values of
feature g, see Figure 2. A subtle but important detail is that the probability in (1.1)
includes both endpoints xg, yg, and therefore pg (xg, xg) = P {xg} > 0. This definition of
proximity is desirable because it naturally incorporates the information in the underlying
probability measure that generated the data. For example, as illustrated in Figure 1, in
the binary setting, it is much more rare for two observations to both be equal to 0 if 0 has
low probability, and thus the “reward” for xg = yg = 0 depends on the probability mass at
0. Similarly, in the continuous setting, the reward for proximity between xg and yg
depends on where the pair falls on the distribution. For the same linear distance
between xg and yg, their dissimilarity is higher when they both fall at the center of the
distribution than when they both fall at the tails.

Figure 2. Illustration of what pg(xg, yg) corresponds to in the case of a discrete
distribution or a continuous distribution. In this toy example, X and Y are two objects
with four features measured. Semblance computes an empirical distribution from the
data for each feature, and uses the information of where the observations fall on that
distribution to determine how similar they are to each other. Specifically, it emphasizes
relationships that are less likely to occur by chance and that lie at the tail ends of a
probability distribution. For example, X and Y are equal to 0 for both the first and second
feature, but these two features contribute different values to the kernel: “0” is more rare
for the second feature, and thus p2 (0, 0) is smaller than p1 (0, 0) and the second feature
contributes a higher value in the Semblance kernel. Similarly, even though the difference
between X and Y is 1 for both features 3 and 4, feature 4, where the values fall in the
tail, has lower pg(xg, yg) and thus contributes a higher value in the Semblance kernel
than feature 3.
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In practice, Pg is not known, but with a large enough sample size the empirical

! serves as a good approximation, leading to the plug-in empirical
distribution P
g

! for P in (0.1). This is reminiscent of
estimate p̂g (xg , yg ) , obtained by substituting P
g
g
empirical Bayes methods, where information is borrowed across all observed values to
inform our dissimilarity evaluation between any given pair. We define:

k g ( X ,Y ) = 1− p̂g (xg , yg )
n

1
= ∑ [1− I(min(xg , yg ) ≤ N ig ≤ max(xg , yg ))],
n i=1
the empirical probability of falling strictly outside the interval [xg, yg]. The indicator I
returns 1 if min(xg , yg ) ≤ N ig ≤ max(xg , yg ) , and 0 otherwise.
Suppose feature g is continuous, and hence each observed value is unique, and let rX, rY
be the ranks of 𝑥' , 𝑦' among all observed values of this feature across the n objects.
Then, 𝑘' can be expressed simply as a function of the ranks:

1
k g ( X ,Y ) = (| rX − rY | +1).
n
However, for discrete features, the computation of kg(X, Y) is more complicated due to
ties. Nevertheless, computing kg(X, Y) in general is easy and fast. An example algorithm
is provided in Methods section at the end of this chapter.
We now define the Semblance function as:

K( X ,Y ) =

1 G
∑ k ( X ,Y )wg ,
G g=1 g

(0.2)

where 𝑤' corresponds to the relative weight or importance of each feature. When there
is reliable domain knowledge to prioritize features, these should be used to construct the
weights. When no a priori information is available, a weight that reflects the shape of the
feature distribution can be used, for example the Gini coefficient for positive-valued
features, or a robust approximation to the negentropy for real-valued features. In our
experiments, we have found that considering all features to be equally important (wg =1)
gives decent results in most cases.
Since p̂g (xg , xg ) ≤ p̂g (xg , yg ) if xg ≠ yg , it follows that

K( X , X ) ≥ K( X ,Y ) ∀ X ≠ Y.

Thus, when applied to any data matrix N, this function outputs a symmetric n x n matrix
whose rows and columns are maximized at the diagonal.
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Semblance is a valid Mercer kernel
Since K(X, Y) is just the mean of kg(X, Y) across g, we start by considering
K g = {K g (i, j) = k g (N ig , N jg ) : 1 ≤ i, j ≤ n} ,
the matrix derived only from observations of feature g. First assume that the objects
have been permuted such that {N ig : i = 1,…,n} are monotone nondecreasing. Define:

! (Z < N ) and b = P
! (Z > N ),
ai = P
ig
i
jg

(0.3)

suppressing the notational dependence of ai and bi on g, for simplicity. Based on (0.1),
for i ≤ j,
(0.4)
K g i, j = ai + bi

( )

By our monotone nondecreasing assumption, ai ≤ ai+1 and bi ≥ bi+1 . Thus, Kg has the
decomposition:

⎡
⎢
⎢
⎢
Kg = ⎢
⎢
⎢
⎢
⎣

a1
a1
!
!
a1

a1 ⎤ ⎡
⎥ ⎢
a2 ... a2 ⎥ ⎢
⎥ ⎢
"
! ⎥+⎢
" ! ⎥ ⎢
⎥ ⎢
a2 ... an ⎥ ⎢
⎦ ⎣
a1

...

b1

b2

b2

b2

b3

b3

!
bn

bn

... bn ⎤
⎥
... bn ⎥
⎥
... bn ⎥ = M + N.
" ! ⎥⎥
... bn ⎥
⎦

Remark: The matrices M and N have a symmetric and analogous structure. The leftupper hook comprising the first row and column of M has all entries a1, the second hook
has all entries a2 and so on, until the nth hook which is simply the entry an. Similarly, the
right-lower hook of N comprising the last row and column has all entries bn, all the way
up to the solo entry b1 in the first row and column.
Proposition 1: M is a nonnegative-definite (NND) matrix
The Proof is by induction. For the base case, consider the 2 x 2 matrix

⎡ a a ⎤
1
1
!
⎥
M=⎢
⎢ a1 a2 ⎥
⎣
⎦
!
! is NND. The induction
By construction ai+1 ≥ ai , therefore det( M ) ≥ 0 , and hence M
hypothesis is that all m x m matrices, M , with the structure
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⎡
⎢
⎢
⎢
⎢
⎢
⎢
⎢
⎣

a2

a2

...

a2

a3

...

a2

a3

...

a3

"
...

!
a2

a2 ⎤
⎥
a3 ⎥
⎥
a4 ⎥ where a2 ≤ a3 ≤ ... ≤ am ,
! ⎥⎥
am ⎥
⎦

(0.5)

are NND. Now, to prove that the same is true for m x m matrices, we can write such
matrices in the form

⎡ a
⎢ 1
⎢⎣ U T

U ⎤
⎥,
(0.6)
M ⎥⎦
where U represents the vector ( a1a1a1 !) and M is a matrix that satisfies the induction
hypothesis. Using the Schur complement condition for the nonnegative definiteness of a
symmetric matrix (Liu and Huang 2010), we can show that M − U T a1−1U is NND:

⎛ a ⎞
1
⎜
⎟ 1
T −1
M − U a1 U = M − ⎜ a1 ! ⎟ ( a1a1a1 ")
⎜
⎟ a1
a
⎝ 1 ⎠
⎡ a a ...
⎢ 1 1
⎢ a a ...
= M −⎢ 1 1
"
⎢ !
⎢ a1 a1 ...
⎣
⎡ a −a a −a
2
1
⎢ 2 1
⎢ a2 − a1 a3 − a1
⎢
=⎢
!
"
⎢
!
⎢
⎢ a2 − a1 a3 − a1
⎣

a1 ⎤
⎥
a1 ⎥
⎥
! ⎥
a1 ⎥
⎦
... a2 − a1 ⎤
⎥
... a3 − a1 ⎥
⎥
!
⎥
⎥
"
!
⎥
... an − a1 ⎥
⎦

This resultant matrix is of a form that satisfies (0.5) and thus, by the induction
hypothesis, is NND. Therefore the matrix (0.6) is also NND.
Since N mirrors the properties of M by construction, we have by Proposition 1 that N is
also an NND matrix. For NND matrices, it is also true that: (i) the sum of NND matrices is
NND, and (ii) applying the same permutation to the rows and columns of an NND matrix
preserves the NND structure (see proofs in the methods). Based on these facts, together
with Proposition 1, the kernel matrix K (sum of all Kg’s) is NND. The matrix K computed
on any data matrix by the Semblance function defined in (0.2) is NND, and thus
Semblance is a valid Mercer kernel. As a result, the Representer theorem allows
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effective implementation of nonlinear mappings through inner products represented by
our kernel function (Hofmann, Schölkopf, and Smola 2008; Minh, Niyogi, and Yao 2006).
We review the theory governing the existence of an RKHS and a feature space for
Semblance in the supplementary material.

Algorithm to implement the Semblance kernel

R package implementation
Semblance is an open-source R package available on CRAN (https://cran.rproject.org/web/packages/Semblance/), and is compatible with existing kernel method
libraries such as kernlab (Karatzoglou et al. 2004). In our R package, we implemented
the kernel method in the ranksem function, which takes an input Nng matrix (of g feature
measurements for n objects), and returns an n x n similarity matrix.

Semblance is conceptually different from rank-based similarity measures
Since, in the case where all features are continuous, Semblance can be simplified to a
function on ranks, we first clarify how it differs from existing rank-based similarity
measures: Spearman’s Rho (r) and Kendall’s Tau (t). By construction, Semblance is
fundamentally different from these existing measures in two ways. First, while r and t
are based on ranks computed by ordering the values within each object (the rows of
matrix N), Semblance is computed using ranks determined by ordering the values within
each feature (the columns of matrix N). Thus, the Semblance kernel can be expected to
produce values that differ substantially from these two measures. Second, Semblance
treats ties differently from simple rank-based methods, such that ties shared by many
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objects diminish the proximity between those objects. This treatment of ties, for discrete
data, makes Semblance more sensitive for niche subgroups in the data. Therefore,
Semblance is better understood through the lens of empirical Bayes, where, for each
feature, the empirical distribution across all objects informs our evaluation of the
similarity between each pair of objects.

Simulations
Simulations allow us to compare the effectiveness of similarity/distance measures under
simplified but interpretable settings. We used simulations to compare Semblance against
Euclidean distance, Pearson correlation, and Spearman correlation in their ability to
separate two groups in an unsupervised setting. We simulated from a two group model,
where multivariate objects either came from group 1, with probability q < 0.5, or from
group 2, with probability 1−q. Let each object contain m features, drawn independently,
with a proportion p Î (0, 1) of the features being informative. The informative features
have distribution PI,1 in group 1 and PI,2 in group 2. The rest of the features are noninformative, and have the same distribution PNI across both groups. We consider both
continuous and discrete distributions for the features. In the continuous case, the
features are generated from:
PNI = N (0,1), PI ,1 = N ( µσ 2 ,σ 1 ), PI ,2 = N (0,σ 2 ).
(0.7)
In the discrete case, the features are generated from:

PNI = PI ,2 = Bernoulli(r0 ), PI ,1 = Bernoulli(r1 ).

(0.8)

Of course, whether a feature is informative or not, and whether an object is from group 1
or group 2, is not used when computing the similarity/distance matrix.
As shown in Figure 2A, in each simulation run, we generated n objects with the first n1 =
qn coming from group 1 and the next n2 = (1 − q)n coming from group 2. Our goal is to
detect the existence of the minority group 1 and assign objects to the appropriate group.
Similarities (Semblance, Pearson, Spearman) and distances (Euclidean) are computed
on this data, each producing an n x n matrix, which we will call S. Let:

S11 =

1
1
1
Sij , S22 =
Sij , S12 =
∑
∑
∑ S.
n1 1≤i< j≤n1
n2 n1<i< j≤n
n1n2 1≤i≤n1< j≤n2 ij

Then S11 is the mean similarity/distance between objects in group 1, S22 is the mean
similarity/distance between objects in group 2, and S12 is the mean similarity/distance
across groups. To quantify the signal in S, we let T1 = (S11 − S12 ) / se1 ,T2 = (S22 − S12 ) / se 2 ,
where se1, se2 are standard errors of the differences in the numerators. Hence, large
positive values of T1, T2 imply that downstream algorithms based on S will be able to
separate the two groups well.
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Figure 3. Simulations exploring the effectiveness of similarity/distance measures.
(A) Set-up for one simulation run. (B) T1 (top) and T2 (bottom) values for each
similarity/distance metric, for varying values of s1 Î [0.1, 1] (horizontal axis) and s2 Î
[0.1, 1] (vertical axis). (C) T1 (top) and T2 (bottom) values for each similarity/distance
metric, for varying values of r1 Î [0.1, 1] (horizontal axis) and q Î [0.1, 1] (vertical axis).
Figure 3B shows the T1 and T2 values for an example set of simulations where
n=m=100, the proportion of informative features is 10%, the rare subpopulation
proportion is 10%, and every feature is normal following (0.7) with μ = 2 and s1, s2
varying from 0.1 to 1. Heatmaps in the top row show the values of T1 and those in the
bottom row show the values of T2 for each of the four similarity/distance measures. We
see that Semblance improves upon Euclidean distance, Pearson, and Spearman,
attaining large values for T1 and T2 across a broad range of parameters, especially when
s2 is small. Figure 3C shows another set of simulations, with the same n, m and p
values as Figure 3B, but under the model (0.8) with r2 = 0.5, r1 varying from 0.01 to 0.2,
and q varying from 0.05 to 0.5. We see that in this case, there is no signal in T2 for all of
the measures except Semblance, and in fact, both Pearson and Spearman correlation
fail to separate the two groups for much of the parameter range. In contrast, Semblance
gives large values for both T1 and T2 for a large portion of the explored parameter
region.
We explored varying combinations of p, q, s1 and s2 in the normal setting, and p, q, r0
and r1 in the Bernoulli setting. Summarizing these systematic experiments in
representative heatmaps (Fig. 4), we found that Semblance has robust performance
across different distributions and distribution parameters (s1, s2 , r1, r2) as long as the
proportion of informative features is not too small. Semblance is better than the other
metrics especially in differentiating small tight subpopulations, i.e., niche groups.
Unweighted Semblance (wg =1 in (1.2)) retains less information and should not be used
when informative features are extremely rare (p®0) but the separation between clusters
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is extremely large (p®0, μ®¥). This lack of sensitivity for rare features, however, can be
remedied by the use of distribution-informative weights wg.

Figure 4. Simulation results over parameter sweeps. For each 2 by 4 group of
heatmaps, the top row shows T1 and the bottom row shows T2 for each similarity/distance
metric, computed as described in the text. Simulation parameters are varied along the
rows and columns of the heatmaps. (A) Normal model, p = {0.1, 0.2, . . . , 0.9} for horizontal
axis, and q Î {0.05, 0.1, . . . , 0.5} for vertical axis. (B) Normal model, q Î {0.05, 0.1, . . . ,
0.5} for horizontal axis and s2 Î {0.1, 0.2, . . . , 1.5} for vertical axis. (C) Normal model, p
= {0.1, 0.2, . . . , 0.9} for horizontal axis and s2 Î {0.1, 0.2, . . . , 1.5} for vertical axis. (D)
Binomial model, p = {0.1, 0.2, . . . , 0.9} for horizontal axis, and q Î {0.05, 0.1, . . . , 0.5}
for vertical axis.

In its explicit construction, Semblance is shift and scale invariant, however, this
robustness comes at a trade-off of being insensitive to the shape of the distribution. We
compared the performance of a Semblance metric that does not put explicit weights on
the features (wg =1) with a modified metric where features are weighed based on the
shape of the distribution (wg ≠1 in (1.2)). We used as weights the negentropy, a robust
approximation of kurtosis and nongaussianity that is invariant for invertible linear
transformations of data (Cios et al. 2007), in our simulations described above, and found
that negentropy-weighting further enhances the information captured by Semblance (Fig.
5A-C). For positive-valued data, we recommend the use of Gini coefficient for weights.
The Gini index is a robust measure of dispersion (Moskowitz et al. 2008). It ranges from
0 to 1, wherein a value of 0 means that values of the feature is distributed perfectly
uniformly across the objects, and a value close to 1 means that there is high dispersion
of values.
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Figure 5. Comparison of a naturally weighted Semblance metric with one wherein
features are weighed by a context-dependent measure. In all heatmaps (A–C) and
(E–F), we computed T1 (top heatmap) and T2 (bottom heatmap) values as described in
the results for varying values of the model parameters. (A–C) For the simulation setup
and results summarized in Fig. 3, when the features are weighed by an approximation of
the negentropy, the benefit of Semblance is further enhanced. (D) Simulation set-up
when the data is strictly positive. We simulated a data matrix, analogous to Fig. 2, where
the features are drawn from the gamma distribution as summarized in the figure. A
weight with appropriate properties for positive-valued data which captures the shape of
the distribution is the Gini index. Similar to the gaussian-negentropy scenario, we find
that weighing features by the Gini coefficient when the data are simulated from the
gamma instead, leads to a clear increase in the performance of Semblance. The
simulation parameters in all the heatmaps are varied along the rows and columns as
displayed in the figure.
When the data are simulated from gamma distributions (Fig. 5D), we found that Giniweighting provides a robust and sensitive method of feature selection. Compared to an
unweighted Semblance, the Gini-weighted statistic carries more signal, especially when
the fraction of informative features is small (Fig. 5E–G). Collectively, our simulations
demonstrate that Semblance can perform well in a totally unsupervised fashion;
nonetheless when prior knowledge about the data distribution is available, Semblance
can also incorporate that to weigh features and augment its performance.
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Semblance kernel-tSNE in niche cell population detection
In the setting of single-cell RNA sequencing (scRNA-seq), the data is in the form of a
matrix with each row representing a cell, and each column representing a gene. For cell
c and gene g, Ncg is a count matrix measuring a gene’s RNA expression level in the
given cell. A first step in the analysis of such data is often visualization via a t-distributed
Stochastic Neighbor Embedding (tSNE)-type dimension reduction. Most studies
arbitrarily use the Euclidean distance or the Radial Basis Function (RBF) in this step,
although methods based on more sophisticated kernel choices that rely on strong prior
assumptions have been proposed (Wang et al. 2017). Starting from the low-dimension
embedding, a primary goal in many single-cell studies is to classify cells into distinct celltypes and identify previously unknown cell subpopulations. This is a challenging analysis
due to many factors: (i) Expression levels are not comparable across genes, lowly
expressed cell type markers may be swamped by highly expressed housekeeping
genes; (ii) gene expression at the single cell level is often bursty and thus cannot be
approximated by the normal distribution; (iii) one is often interested in detecting rare
niche subpopulations for which current methods have low power. These considerations
motivated us to use the Semblance kernel to compute a cell-to-cell similarity metric,
which can be used as input to tSNE, PCA, and other kernel-based algorithms. Most
methods used for cell-type identification based on scRNA-seq limit their consideration to
highly variable genes, thereby using only a subset of the features. Instead, Semblance
can be computed over all features, ensuring that information from all informative genes
is retained.
Consider the Retinal Horizontal Cell (RHC), a unique cell-type that recently came to
limelight due to its notable morphological plasticity, and its role as the possible precursor
for retinoblastoma (Poche and Reese 2009). RHCs have a special level of complexity
wherein they can undergo migration, mitosis and differentiation at late developmental
stages. They are traditionally divided into H1 axon-bearing and H2-H4 axon-less
subtypes, although the latter are largely absent in the rod-dominated retina of most
mammals (Boije et al. 2016). The axon-bearing and axon-less RHC subtypes are
generated during retinal development from progenitors that are susceptible to a
transition in metabolic activity. For example, Follistatin, an anabolic agent that alters
protein synthesis and the inherent metabolic architecture in tissues, increases RHC
proliferation (Edqvist et al. 2008). RHC subtypes also exhibit temporally distinguishable
periods of migration, likely affected by their cellular metabolic state. These distinctive
features are controlled by a niche set of genes, and thus RHCs provide a nonpareil
setting to test Semblance. We employed unweighted Semblance on an scRNA-seq
dataset of 710 Lhx1+ RHCs from healthy P14 mice (Macosko et al. 2015), and sought to
answer the question: how similar are RHCs to each other? When we use Euclidean
distance for tSNE analysis, only one RHC cluster could be identified (Fig. 6A), as
opposed to two subsets of RHCs identified using kernel-tSNE (Fig. 6B).
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Figure 6. A unique RHC cluster is identified by Semblance kernel-tNSE. Each black
dot in (A-C) represents a single cell. Euclidean distance tSNE identifies a single RHC
cluster (A) as opposed to two sub-populations identified by Semblance. Comparing the
kernel’s performance when features are naturally weighted on skewness (B) versus
when they are weighted based on Gini coefficient (C) points a geometric, trajectory-like
structure in the data. The top 5 pathways found to be enriched in the rare cellular
subtype are shown (D), and GO Analysis suggested that the smaller RHC cluster has
unique metabolic response properties (E). We also found evidence that these metabolic
properties might lead to increased proliferation as suggested by increased expression of
cell-cycle genes by the cells in the red/rare cluster (F). For DE analysis, BenjaminiHochberg–corrected P-values are noted underneath each cyclin gene; the color codes
blue and red correspond to the major and rare RHC clusters, respectively.
Moreover, since the Gini coefficient is a robust measure of gene expression dispersion
in single cell transcriptomics experiments (Wang et al. 2018), we wondered how the
unweighted Semblance-tSNE (wg =1 in eq. 1.2) would compare against a Semblance
measure where features are Gini-weighted. Although both kernel-tSNE projections
successfully separated the second/rare RHC cluster, weighing genes by their Gini
coefficient also suggested an underlying geometry, pointing to a plausible trajectory (Fig.
6C). We then sought further biological interpretation of these results and discovered that
the cells in the second, smaller cluster − comprising 12% of the total RHC population −
identified by Semblance exhibit differential expression of pathways that affect
metabolism (Fig. 6D). We explicated our results by testing for enriched Gene Ontology
(GO) functional categories using REVIGO (Supek et al. 2011), and uncovered a niche
RHC population that has unique metabolic response properties (Fig. 6E). Gini-weighting
showed that this niche RHC cohort, which has an upregulated metabolic state, resides at
one end of a trajectory, suggesting that this trajectory may be related to proliferation. In
other words, the niche RHC cohort could be a group of proliferating horizontal cells,
compared with the more mature RHCs that constitute the larger cell cluster. To examine
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this, we tested for differential expression (DE) of cell-cycle associated genes, which are
common markers of proliferation (Whitfield et al. 2006), between the two groups using
Model-based Analysis of Single-cell Transcriptomics (MAST) (Finak et al. 2015). We
found evidence for DE of genes associated with increased proliferation ability (Fig. 6F) in
support of our hypothesis. Thus, without any domain knowledge, exploratory analysis
using Semblance successfully uncovered meaningful biological signals from this data.

Semblance kernel PCA is efficient at image reconstruction and
compression
Kernel Principal Component Analysis (kPCA), the nonlinear version of PCA, exploits the
structure of high-dimensional features, and can be used for data denoising, compression
and reconstruction (Romney et al. 2000; Scholkopf, Smola, and Muller 1999). This task,
however, is nontrivial because the kPCA output resides in some high-dimensional
feature space, and does not necessarily have pre-images in the input space (Mika et al.
1999). kPCA, particularly using the Gaussian kernel defined by 𝑘(𝑥, 𝑦) =
exp (−‖𝑥 − 𝑦‖6 /2𝜎 6 ), has been used extensively to improve active shape models
(ASMs), reconstruct pre-images and recreate compressed shapes due to its ability to
recognize more nuanced features in real-world pictures (Lu and Yang 2014). Nonlinear
data recreation based on kPCA rests on the principle that using a small set of some f
kPCA features provides an f−dimensional re-parametrization of the data that better
captures its inherent complexity (Kung 2014). Since Semblance is nonparametric and
empirically driven, emphasizing rare or niche feature values in data, we surmised that it
would be useful as a nonlinear image reconstruction method. We discovered that
Semblance kPCA can indeed be used to reconstruct real-world images with remarkably
good performance (Fig. 7A and B). Upon adding uniform noise to an image, we found
that Semblance kPCA can de-noise images, and compares favorably against linear PCA
and Gaussian kPCA (Fig. 7C and D).
We further evaluated the performance of kPCA on pictures obtained from The Yale Face
Database (http://cvc.cs.yale.edu/cvc/projects/yalefaces/yalefaces.html) and the
Bioconductor package EBImage (Pau et al. 2010), and found that Semblance can give a
good re-encoding of the data when it lies along a nonlinear manifold, as is often the case
with images. In each experiment, we computed the projections of the given image data
onto the first f components and then sought to reconstruct the image as precisely as
possible. We found that Semblance kPCA performed better than linear PCA and
Gaussian kPCA when using a comparable number of components (Fig. 8). This
encouraging observation is supported by the intuitions underlying the construction of
Semblance. Linear PCA encapsulates the coarse data structure as well as the noise
(Schmidt, Santelli, and Kozerke 2016). In contrast, Gaussian kPCA, similar to a knearest neighbor method, recreates the connection between data points that are close to
each other in the original feature space (Weinberger, Sha, and Saul 2004). On the other
hand, Semblance apprehends data points that are proximal in the feature space under
the metric determined by the empirical data distribution, and therefore performs better
when informative and non-informative features in an image are not on the same scale.
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Figure 7. kPCA using the Semblance kernel provides a useful method for image
reconstruction and denoising. Two example open-source images: Philadelphia skyline
(A), and Daffodil flowers (B) are shown here. Semblance kPCA was able to effectively
recover and compress when compared with linear PCA or Gaussian kPCA. These
images were corrupted with added uniform noise: (C) and (D), respectively. The
recovered image output using linear PCA, Gaussian kPCA and Semblance kPCA is
displayed. Comparing the same number of features (and even 2.5x as many features for
Gaussian kPCA), Semblance performs favorably. More examples are given in the figure
below. Photo Credits: Mo Huang (The Wharton School) and the EB Image Package.
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Figure 8. kPCA using the Semblance kernel is able to efficiently compress and
denoise images. Demonstrated examples are from the Yale Face Database (A), and
the EBImage package in R (B-C). Panel B demonstrates an example of a microscopic
image. Subpanels 1 in (B-C) show the results on the original images, whereas
subpanels 2 display the results on corrupted images with added uniform noise. Photo
Credits: EB Image (10.182129/B9.bioc.EBImage) and Yale Facebook Database B
(http://vision.ucsd.edu/~iskwak/ExtYaleDatabase/ExtYaleB.html)
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Semblance performs comparably with domain-specific kernel SVMs in
stock market forecasting
In finance and business analytics, although predictions of market volatility are inherently
challenging, support vectors machines (SVMs) using Gaussian and Laplacian kernels
have been found to efficiently model stock market prices, partly because training these
kernel SVMs (kSMVs) allows convex optimization with a linear constraint, resulting in a
stable and unique global minimum (Upadhyay et al. 2016; Cao and Tay 2003).
Semblance is a context-free kernel, and therefore one might be tempted to rely on
existing kernels that explicitly incorporate domain-specific information. To examine
Semblance in the setting of financial forecasting, we compared the performance of
Semblance against eight other kernel functions. We used the Center for Research in
Security Prices (CRSP) Database (http://www.crsp.com/products/researchproducts/crspziman-real-estate-database), which combines stock price and returns data
with financial indices and company-specific information on all real estate investment
trusts (REITs) that have traded on the three primary exchanges: NASDAQ, NYSE and
NYSE MKT. We focused our analysis on the 5,419 REITs that were actively trading
between January 1, 2016 and December 31, 2017, and obtained a list of financial
indices and company-specific indicators for each REIT (Table 1).

Table 1. List of technical indicators recorded for each observation/REIT by the
CRSP Real Estate Database
Financial Indicator
Rate of return on REIT stock
Ordinary Dividends
Capitalization
VW Return Index
Used Price

REIT Type
Property Type
Stock Exchange

Description
Total Return based on Used Prices and Used Dates and the
CRSP distribution history. This is the variable to be classified
by the SVM as positive or negative
Company's profits that get passed on to the shareholders
Market value of a company’s outstanding shares
A value-weighted (VW) stock market index whose
components are weighted according to capitalization, and
each stock in an index fund is not given the same importance.
Combination of various good and soft prices used in an index
according to index methodology rules. To be in an index, the
security must be a valid security and have a good price, as
well as an observed or soft price.
Description of whether the investment trust is of type
mortgage, equity, or hybrid
Description of whether the property type is residential,
industrial, retail, healthcare or lodging/resorts.
Description of whether the securities were traded at NASDAQ,
NY Stock Exchange (NYSE) or NYSE MKT.
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We determined which REITs had a net positive rate of return on their stock, and then
classified the companies based on whether they had a positive or negative rate of return.
We then used kernel SVM (kSVM) to determine how accurately the model was able to
predict the REIT category. We randomly split the data into training and test subsets in a
3:1 ratio, and compared the generalization ability of each kSVM classifier using 10-fold
cross validation. Consistent with previous research in this area (Fan and Palaniswami
2000; Hu, Zhu, and Tse 2013), we observed that the Gaussian and Laplacian kernels
performed better than linear, spline and hyperbolic tangent kernels likely because the
former two kernels are homogenous and have good approximation capabilities to model
financial fluctuations. Nonetheless, Semblance was more accurate at REIT classification
than most other kernel choices (Table 2), and performed comparably to other popularly
used context-specific kernels.

Table 2. Test accuracy in forecasting whether the Rate of Return for an REIT would
be positive or negative using SVMs for a range of kernel choices

Choice of Kernel
Laplacian
Radial Basis “Gaussian”
Semblance
Linear
Bessel
Polynomial
ANOVA
Hyperbolic tangent
Spline

Training
Accuracy
74.4
68.7
68.0
67.7
67.5
66.9
60.9
56.4
54.1

Testing
Accuracy
67.7
67.3
65.8
64.9
66.6
68.9
56.3
55.0
53.7

Discussion
We have presented Semblance, a new similarity kernel for the analysis of multivariate
data. Semblance relies on the simple intuition that the empirically observed distribution
for each feature should be used to reward a premium to proximity among objects in lowprobability regions of the feature space. In this way, Semblance is sensitive for detecting
niche features in the data. We have shown that Semblance is a valid Mercer kernel and
thus can be used in a principled way in kernel-based learning algorithms. From a
computational point-of-view, Semblance enables the extraction of features of the data’s
empirical distribution at low computational cost. It naturally relies only on ranked feature
values, and thus is extremely robust. We evaluated Semblance and compared it to some
commonly-used similarity measures through simulations and diverse real-world
examples, demonstrating scenarios where Semblance can improve downstream
analysis.
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Kernelized learning methods have been tremendously useful in a wide variety of
applications and disciplines, particularly because of their ability to map data in complex,
nonlinear spaces (Scholkopf, Smola, and Muller 1999; Kung 2014; Hofmann, Schölkopf,
and Smola 2008). Most commonly, kernels have been used to compare and classify
objects, for instance in clustering algorithms (Shawe-Taylor and Cristianini 2004);
however, Mercer kernels have another important interpretation in that they reflect
similarities between sets of local features in the data. Semblance exploits this latter
concept by defining a general-purpose similarity measure on probability spaces, even
when no explicit correspondence between the data might appear obvious or intuitive.
Satisfying the Mercer condition ensures that Semblance will guarantee unique global
optimal solutions for downstream learning algorithms (Schölkopf, Burges, and Smola
1999). Semblance operates in a high-dimensional, implicit feature space and can be
applied to any data domain. We anticipate that it will also find utility in “multiple kernel
learning” approaches, wherein multiple kernels are often combined to learn from a
heterogeneous data source.

Materials and Methods
Proofs concerning nonnegative definite matrices
Lemma 1: The sum of NND matrices is NND.
Proof: Let K g (1) and K g ( 2) be two NND matrices, such that

∀z ∈! n :

z T K g (1) z and z T K g (2) z > 0 ⇒ z T K g (1) z + z T K g (2) z > 0
Using the distributive law of matrix multiplication:

(

)

0 < z T K g (1) z + z T K g (2) z = z T K g (1) + K g (2) z

(

)

(

)

⇒ z T K g (1) + K g (2) z > 0∴ K g (1) + K g (2) ≻ 0.
Lemma 2: Permuting the observations of an NND matrix preserves the NND structure.
Proof: Let π be the permutation matrix such that it has exactly one entry in each row and
in each column equal to 1, and all other entries are 0. For any permutation matrix, π–1 =
πT and thus:

ππ T = π T π = I
For any given NND matrix, K, π K π T is also NND. Clearly, π K π
as:

wT (π K π T )w = (π T w)T K(π T w) ∀w ≠ 0

T

is also symmetric

since K is NND

Furthermore, every NND matrix can be factored as K=ATA, where A is the Cholesky
factor of K. The Cholesky factorization of NND matrices is numerically stable – a
principal permutation of the rows and columns does not numerically destabilize the
factorization (Stepanov 2002). This leads to the result that symmetrically permuting the
rows and columns of an NND matrix yields another NND matrix.
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Data and materials availability:
All data needed to evaluate the conclusions in the paper are described in the paper
and/or are publicly available on open-access repositories. Any additional computer
codes related to this chapter may be requested from the authors. The scRNA-seq data
were generated using the Drop-seq platform, and are publicly accessible via the NCBI
Gene Expression Omnibus (Accession: GSE63473). An explanatory blog on kPCA for
image recovery is available here: http://www.di.fc.ul.pt/~jpn/r/pca/pca.html. The data on
Real Estate Investment Trusts (REITs) is curated by the Center for Research in Security
Prices (CRSP), and is accessible at: http://www.crsp.com/products/researchproducts/crspziman-real-estate-database
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CHAPTER 3: A Framework for Examining Changes in Pathway
Distributions Across Single Cells
Abstract
In this chapter, we will briefly describe a novel nonparametric graphical test based on
optimal matching for assessing the equality of multiple unknown multivariate probability
distributions. This method pools the data from the different classes or groups to create a
graph based on the minimum non-bipartite matching, and then utilizes the number of
edges connecting data points from different classes to examine the closeness between
the distributions. The mathematical details and rationale underlying this test are
described here: https://arxiv.org/abs/1906.04776, where we show that this test is exactly
distribution-free and universally consistent. In scenarios where this test suggests
distributional differences across classes, we also identify which class or group
contributes to this overall difference by examining the pairwise statistic among each pair
of classes. Further, we apply this method is applied to single cell transcriptomics data
obtained from the peripheral blood, cancer tissue, and tumor-adjacent normal tissue of
human subjects with hepatocellular carcinoma and non-small-cell lung cancer. Our
method, implemented in the R package multicross, unveils patterns in how biochemical
metabolic pathways are altered across immune cells in a cancer setting, depending on
the tissue location.
This work, done jointly with colleagues at Wharton Statistics (Prof. Bhaswar Bhattacharya
and Somabha Mukherjee), at the time of submission of this thesis is under review at
Journal of the American Statistical Association.

Nonparametric Testing of Multivariate Distributions
Comparison of two distributions is a statistical problem of immense historical interest.
Specifically, in the setting of univariate data, several distribution-free, nonparametric and
two-sample tests, such as the Kolmogorov-Smirnov maximum deviation test (Stephens
1992), the Wald-Wolfowitz runs test (Wald and Wolfowitz 1940), and the Mann-Whitney
rank-sum test (Mann and Whitney 1947) are commonly used and widely celebrated.
Efforts to generalize these methods to higher dimensions go back to Weiss (Weiss
1960) and Bickel (Bickel 1969). Subsequently, Friedman and Rafsky (Friedman and
Rafsky 1979) proposed the first computationally efficient 2-sample test, which applies to
high-dimensional data. The Friedman-Rafsky test, which can be viewed as a
generalization of the univariate runs test, computes the Euclidean minimal spanning tree
(MST) of the pooled sample, and rejects the null hypothesis (𝐻: ; no difference between
the distributions) if the number of edges with endpoints in different samples is small.
Variants of this test based on nearest-neighbor graphs were considered by Henze and
Schilling (Henze 1988; Schilling 1986). More recently, Chen and Friedman (Chen and
Friedman 2017) suggested novel modifications of this method for high-dimensional and
object data. Despite the utility of these methods in high-dimensional problems, none of
these tests are distribution-free, and as a result, their applicability is remains limited and
dictated by the underlying assumptions on the data structure.

30

A breakthrough in this direction was made relatively recently by Rosenbaum
(Rosenbaum 2005), who proposed the crossmatch test, a multivariate two-sample test
based on the minimum non-bipartite matching of the pooled sample. This test is exactly
distribution-free in finite samples and computationally efficient. In fact, the crossmatch
test statistic can be computed in time which is polynomial in both the number of samples
and the dimension of the data, making it attractive for high-dimensional applications.
This test has also found many interesting applications in causal inference, especially in
assessing balance between covariates in a treatment group and a matched control
group (McHugh, Berez, and Small 2013; Heller et al. 2010; Heller, Rosenbaum, and
Small 2010).
In this chapter, we are specifically interested in the multivariate, K-sample problem,
which can be described as follows:
Given K multivariate probability distributions 𝐹= , 𝐹6 , … , 𝐹? , the null hypothesis is 𝐻: : 𝐹= =
⋯ = 𝐹? ,
and the corresponding alternative hypothesis is 𝐻: : 𝐹B ≠ 𝐹D , for some 1 ≤ 𝑠 ≤ 𝑡 ≤ 𝐾.
This classical problem in statistical inference has been extensively studied in the
parametric regime, where the distributions often have low-dimensional functional forms.
However, the parametric methods perform poorly for mis-specified models and for highdimensional problems, which necessitates the development of nonparametric methods
that do not make distributional assumptions on the data. Motivated by this need, we
developed a nonparametric test for the K-sample problem which is exactly distributionfree, allowing the method to be readily applicable in a wide range of problems.
Although K-sample generalizations of the runs test (Mood 1940), and Mann-Whitney test
(Kruskal 1952) have been described, these have been shown to be not powerful enough
across a wide range of alternatives in arbitrary dimensions. Even though the highdimensional multisample problem manifests itself in various modern applications,
methodological progress to address this problem remain limited. A nearest-neighbor
based test for testing the equality of multiple distributions with categorical components
was considered in (Nettleton and Banerjee 2001). Recently, the direct generalization of
the Friedman-Rafsky test has also been described (Petrie 2016). However, these tests
tend to lose power with increasing dimension and/or the number of classes. The latter is
especially important for multisample multivariate tests to be useful in conjunction with
single cell data. For example, scRNAseq profiles the expression of tens of thousands of
genes across thousands of cells, and the cells might belong to different subtypes, where
the K cell types are characterized based on some functional or morphological
parameter. In this setting, determining whether the expression of a set of genes,
corresponding to a particular biochemical pathway or function, belong to the same or
different distribution across the K groups can yield insights into cellular processes and
the underlying biological system.
Using optimal matching and the concept of crossmatch as the basis, we propose a new
graph-based multisample test based. To compute the test statistic, we construct the
minimum non-bipartite matching of the pooled sample, compute the 𝐾 × 𝐾 matrix of
cross-counts (the (𝑠, 𝑡)DK element of this matrix is the number of edges in the matching
from sample/class s to sample t). The cross-counts – centered by their means,
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conditional on the pooled sample and scaled appropriately – converge in distribution to a
multivariate normal distribution under general alternatives
(https://arxiv.org/abs/1906.04776). Furthermore, our experiments demonstrate that the
proposed method outperforms other relevant parametric and non-parametric tests in a
diverse set of simulation settings.
Lastly, we demonstrate the broad potential of our method by utilizing it to investigate
whether the activities of biological pathways across K closely-related cell types are
conserved. Single cell data is sparse count data with many zeros, so it is difficult to
transform it to conform to normal distribution assumptions. Moreover, gene expression
has complex correlation structure and thus any parametric model would require many
nuisance parameters. Therefore, this method, being nonparametric and distribution free,
is especially fitting. The proposed test, hereafter referred to as Multisample Crossmatch
(MCM), allows us to comparison the distribution of gene sets (as a proxy for examining
biochemical pathways) across cell populations using scRNA-seq data. MCM
successfully recapitulates known biology by detecting differential distribution of
metabolic pathways which are known to be disparate across T cell subtypes. We also
discovered pathways such as purine metabolism that differed across T cell subtypes,
irrespective of whether the sequenced cells were obtained from blood, liver cancer
tissue, lung cancer tissue, or tumor-adjacent normal tissue. Moreover, we ascertain that
our method can be used to narrow down gene sets that are differentially distributed
across cell types, thereby facilitating its use in single cell clustering and visualization
algorithms.

MCM: A novel multisample test based on optimal matching
Assume that for every 𝑠 ∈ [𝐾] ≔ {1,2, … , 𝐾}, we are given 𝑁B i.i.d. observations 𝑿(B) ≔
(B)
(B)
{𝑋= , … , 𝑋UV } from the distribution 𝐹B . Let’s begin with the formal definition of a minimum
non-bipartite matching. For simplicity, assume that the total number of samples 𝑁 =
∑?
BY= 𝑁B ≔ 2𝐼 is even (otherwise, we can add or delete a sample point to make it even).
Given a finite 𝑆 ⊂ ℝ] and a symmetric distance matrix 𝐷 ≔ (𝑑(𝑎, 𝑏))bcd ∈ e , a non-bipartite
matching of S is a partition of the elements of S into 𝐼 = 𝑁f2 non-overlapping sets of size
2 each:
𝑆 = 𝑆= ⋃ … ⋃ 𝑆h , where |𝑆b | = 2 and 𝑆b ⋂𝑆d = ∅, for 1 ≤ 𝑎 ≠ 𝑏 ≤ 𝐼.
The weight of a non-bipartite matching is the sum of the distances between the 𝐼 matched
pairs. A minimum non-bipartite matching of S is a matching which has the minimum weight
over all matchings of S.
The minimum non-bipartite matching graph ℊ(𝑆) =
(𝑉nℊ(𝑆)o, 𝐸(ℊ(𝑆))) is the graph with vertex set 𝑉nℊ(𝑆)o = 𝑆 and edge set 𝐸nℊ(𝑆)o =
{𝑆= , … , 𝑆h }, consisting of the 𝐼 disjoint pairs.
The 2-sample crossmatch (CM) test rejects the null hypothesis for small values of:
Us

Ux

𝑅6,U ≔ r r 𝟏 {n𝑋t (=) , 𝑋v (6) o ∈ 𝐸(ℊ(𝜘))},
tY= vY=
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where 𝜘: = {𝑿(=) , 𝑿(6) } is the pooled sample. Note that the statistic 𝑅6,U counts the
number of matched edges in the pooled sample with one end point in sample 1 and the
other endpoint in sample 2 (the cross-matches), which is expected to be small when the
two distributions are different.
Next, we describe how this CM statistic can be generalized for K samples, based on the
minimum non-bipartite matching of the pooled sample. In this case, denoting the pooled
sample by 𝜘: = {𝑿(=) , … , 𝑿(?) }, we define, for 1 ≤ 𝑠 ≠ 𝑡 ≤ 𝐾, the (𝑠, 𝑡)-cross count as the
number of matched edges in the pooled sample with one endpoint in sample s and the
other end-point in sample t, which is denoted by:
UV

Uz

𝑎BD nℊ(𝜘)o ∶= r r 𝟏 {n𝑋t (B) , 𝑋v (D) o ∈ 𝐸(ℊ(𝜘))} .
tY= vY=

Similarly, for each 𝑠 ∈ [𝐾], we also define the (𝑠, 𝑠)-pure count as the number of
matched edges in the pooled sample with both endpoints in sample s. The matrix of
cross/pure counts 𝑨U nℊ(𝜘)o = 𝑎BD nℊ(𝜘)o =|B,D|? will be referred to as the count matrix
(hereafter, we drop the dependence on ℊ(𝜘) for ease of notation). Figure 9 shows an
example of the cross/pure counts for a sample of 100 points in 3-dimensions with 4
classes.

Figure 9. Illustration of a minimum non-bipartite matching for 100 points in three
dimensions with K=4 classes, and the different cross/pure counts.
The joint distribution of the elements of the count matrix is exactly distribution-free under
the null. Therefore, we can construct distribution-free tests by considering real-valued
functions of the cross-matrix. MCM rejects the null hypothesis for small values of the
statistic:
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𝑅?,U ≔

r

𝑎BD (ℊ(𝜘))

=|B|D|?

This direct generalization of the 2-sample cross-match statistic (recall 𝑅6,U ) counts the
total number of cross edges in the matching constructed using the pooled sample.
There are many natural multivariate alternatives where the MCM test described above
performs poorly, especially when the dimension, or the number of groups being
considered is large. For example, the MCM test can be further modified by taking into
account the correlations within the dataset. To incorporate the covariance, we propose a
new test statistic based on the Mahalanobis distance of the observed cross-counts,
which rejects the null for large values of:
•
𝑆 ≔ n𝐴 − 𝔼•€ 𝐴o 𝐶𝑜𝑣•…=
n𝐴on𝐴 − 𝔼•€ 𝐴o,
€
‡

where 𝐴: = (𝑎BD ) =|B†D|? ∈ ℝn x o denotes the vector of cross-counts.
𝑆 is distribution free under H0, and exact expressions for the entries of 𝔼•€ 𝐴 and
𝐶𝑜𝑣•€ (𝐴) can be computed from a given dataset. Instead of using the exact null
distribution of 𝑆 its weak limit, the chi-squared distribution with n?6o degrees of freedom
can be used for computing the test cut-off. Since 𝑆 is a measure of distance between
𝔼•€ 𝐴 and 𝐴, the null hypothesis is rejected when 𝑆 is “sufficiently large”, i.e. exceeds
the cut-off. Note that adjusting by the sample covariance matrix brings the cross-counts
in the same scale, which makes 𝑆?,U a more appropriate measure of the centrality of the
empirical cross-counts.

Null Distribution of the Test Statistic
The efforts of Dr. Bhaswar Bhattacharya and Somabha Mukherjee were critical in
developing the underlying theoretical foundations of this test, the details of which are
described in the following pre-print: https://arxiv.org/pdf/1906.04776.pdf.
Below, we outline the theorems that demonstrate that the joint distribution of the
elements of the count matrix is distribution-free under the null, that is, it does not depend
on the unknown distribution 𝐹= = ⋯ = 𝐹? .
‡

Theorem: Let 𝐴: = (𝑎BD ) =|B†D|? ∈ ℝn x o as defined above. Then:
ℙ n𝐴U = 𝒃|𝜘o =

=
‹
Š‹ ,…,‹
Œ
s

‡

.

6 ∑sŽV•zŽ‡ dVz h!
∏sŽV•zŽ‡ dVz !

, for 𝒃 = ((𝑏BD ))=|B,D|? ∈ ℬ,

where ℬ is the set of all symmetric K × K matrices 𝒃 = ((𝑏BD )) with non-negative integer
entries, satisfying 2𝑏BB + ∑BcD 𝑏BD = 𝑁B , ∀ 𝑠 ∈ [𝐾]. As a consequence, the statistics 𝑅?,U
and 𝑆?,U defined above, are distribution-free under H0.
Sketch of the Proof:
Note that the distribution of the cross-count matrix is supported on the set ℬ defined
above. Given 𝒃 ∈ ℬ and the pooled sample 𝜘, there are
6 ∑sŽV•zŽ‡ dVz h!
∏sŽV•zŽ‡ dVz !
(?)

ways of forming the classes 𝑿(=) , … , 𝑿

such that 𝑎BD = 𝑏BD ∀ 𝑠, 𝑡 ∈ [𝐾].
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This comes from first assigning the 𝐼 matched pairs such that there are 𝑏BD pairs
h!
corresponding to the (𝑠, 𝑡)-counts, for 1 ≤ 𝑠, 𝑡 ≤ 𝐾 in ∏
Ways, and then for each
d !
sŽV•zŽ‡ Vz

of the 𝑏BD cross-matched pairs, assigning either one of the end points s or t in 2dVz ways.
(=)

(=)

(?)

(?)

Since the random vector (𝑿= , … , 𝑿Us , … , 𝑿= , … , 𝑿U‡ ) is exchangeable under H0, each
…=
U
Œ .
,…,U
s
‡

of these classifications has probability ŠU

Note that ℙ n𝐴U = 𝒃|𝜘o = ℙ n𝐴U = 𝒃o, and therefore the statistics R “,” and S“,” , which
are functions of 𝐴U , are distribution-free under H0.
Furthermore, to compute the mean vector 𝔼•€ 𝐴, we have:
𝑁B (𝑁B − 1)
⎧
,
𝑤ℎ𝑒𝑛 𝑠 = 𝑡
2(𝑁 − 1)
𝔼•€ (𝑎BD ) =
⎨ 𝑁B 𝑁D
𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
⎩ 𝑁 − 1,
Next, we apply the MCM test with the Mahalanobis modification described above to
single cell transcriptomics data obtained from the peripheral blood, cancer tissue and
tumor-adjacent normal tissue of human subjects with hepatocellular carcinoma and nonsmall-cell lung cancer. Our goal is to investigate how biochemical metabolic pathways
change across immune cells in a cancer environment, depending on the location of the
tissue. We begin with a short background on biological pathways and the single cell
RNA sequencing data.

Case Study: How do metabolic pathway distributions change across
closely-related T cell subtypes in the setting of an oncologic phenotype?
Every tissue in the human body comprises of numerous different cell types, and each
cell in turn contains tens of thousands of genes. The function of a tissue or an organ is
rarely driven by a single unique gene, and analogously, complex disorders of organ
dysfunction affect multiple genes. Therefore, to understand complex diseases, a
systems biology approach examines sets or functional modules of related genes, called
biological pathways. Because diseases such as cancer result from different
combinations of perturbed gene activities, grouping genes into functional sets can often
provide deeper insights into the underlying biological system. Indeed, the activity of
certain pathways, particularly those that regulate cellular metabolism, has been found to
be a strong predictor of complex phenotypes and response to treatment, both at the
level of cells as well as that of individual patients (Salavert et al. 2016; Fey et al. 2015).
A biological pathway can be defined as a collection of molecules that coordinate to
perform a specific action or change in the cell. This change could involve production of a
new molecule, movement, growth or a physical transformation, or even cell death. While
the activity of a particular pathway can be understood qualitatively based on the
phenotypic changes in a cell, its quantitative estimation relies on the relative proportion
of RNA molecules produced. The use of gene expression as a proxy for activity rests on
the notion that the amount of mRNA molecules produced represent the economic
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resources of the cell (Lynch and Marinov 2015). Despite an understanding of how
individual molecules in a biological pathway orchestrate a particular cellular function, it
remains unclear whether the distribution of certain gene modules, and by proxy the
corresponding pathway activities, are shared across cell types (Peregrin-Alvarez,
Sanford, and Parkinson 2009). It has recently been shown that vastly different cell types
contain similar ratios of metabolic enzymes, and tightly control the amounts of
specialized proteins produced (Lalanne et al. 2018), highlighting previously
unappreciated similarities among cell types. Nonetheless, the extent to which the
distribution of relative mRNA molecules for genes in a given pathway might be
consistent across different cell types remains elusive. Are there certain pathways which
maintain a similar activity across cell types? This question is of fundamental significance
because if true, it suggests a widespread design principle of cell biology.
With the advent of single cell RNA sequencing, it is now possible to study distinct but
closely related cell populations and examine the aforementioned question. scRNAseq
allows us to measure gene expression information from tens of thousands of individual
cells, unraveling the cellular heterogeneity of a tissue in unprecedented detail. The
resulting data can be thought of as a 𝑐 × 𝑔 matrix,
𝜂 = ((𝜂bd ))=|b|¡,=|d|¢ , where c corresponds to the number of cells, and g refers to the
number of genes, and each entry 𝜂bd corresponds to the number of RNA molecules
detected for a given gene a in some cell b. The high-dimensional, multisample
(corresponding to multiple cell-types) nature of a typical scRNAseq experiment makes
this a fitting application of the multi-sample crossmatch test.

Data Overview and Study Setup
We apply our method on scRNAseq data generated from purified T cell populations
found in three tissue locations: (a) peripheral blood (hereafter referred to as blood), (b)
tumor-infiltrating immune cells (hereafter referred to as tumor), and (c) normal tissue
adjacent to the tumor from the same organ (hereafter referred to as Adj. normal). We
examined the following two datasets, where T cells extracted from each location were
assigned a particular subtype based on flow cytometry and expression of known
canonical cell surface proteins:
(i) Non-Small-Cell Lung Cancer (NSCLC (Guo et al. 2018)) dataset: Here, the T cell
subtypes found at each location were: CD8+ Cytotoxic, CD4+ Naive, CD4+ Regulatory T
cells (Treg), and CD4+ Naive Helper.
(ii) Hepatocellular Carcinoma (HCC (Zheng et al. 2017)) dataset: Here, the T cell
subtypes profiled were: CD8+ Cytotoxic, CD4+ Naive, and CD4+ Tregs.
Both the datasets used are open access, and available in the Gene Expression Omnibus
(GEO). The raw sequencing data for T cells for the Hepatocellular Carcinoma dataset
can be obtained from the GEO entry GSE98638 and the European Genome-phenome
Archive database entry EGAS00001002072. The single cell sequencing data
corresponding to the Non-Small-Cell Lung cancer case study can be found at
GSE99254 and EGAS00001002430.
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Recall that single cell data is extremely sparse count data with complex correlation
structure. Nonetheless, the two datasets are comparable in terms of the sequencing
protocol used, data generation, and the technical quality of the data (Table 3). In both
the datasets we used deep sequencing was performed, ensuring our ability to detect
genes with low expression. The summary of the number of cells sequenced for each cell
type is provided in Table 4 below.

Table 3. Summary characteristics of the two scRNAseq datasets: Non-Small-Cell
Lung Cancer (NSCLC) and Hepatocellular Carcinoma (HCC). For scRNAseq it has
been shown that with half a million reads per cell, most genes expressed can be
detected, and that one million reads are sufficient to estimate the mean and variance of
gene expression (Rizzetto et al. 2017).
NSCLC
1,040,000
2,859
12,210

Mean reads per cell
Median genes per cell
Total number of T cells profiled

HCC
1,100,000
2,702
4,794

Table 4. The number of cells sequenced for various T cell subtypes in each of the
two cancer settings. These correspond to the sample sizes of the different groups in
the K-sample hypothesis testing problem. (Adj. Normal denotes tumor-adjacent normal
tissue from the same organ, Treg stands for regulatory T cell, and CD abbreviates cluster
of differentiation or classification determinant, a protocol used for immunophenotyping
cells.)
Non-small cell lung cancer (k=4 groups)
Tissue Type
Adj. Normal (2115 cells)

CD8+
Cytotoxic
934

CD4+
Naïve
655

CD4+
Treg
288

CD4+
Helper
238

Tumor (5835 cells)

2182

1591

1170

892

Blood (4260 cells)

1323

1254

1011

672

Hepatocellular carcinoma (k=3 groups)
Adj. Normal (997 cells)

412

406

179

Tumor (2170 cells)

563

515

549

Blood (1627 cells)

777

606

787

The metabolic state of T cells is implicated in diseases such as cancer, wherein the
tumor microenvironment enforces dysfunctional T cell metabolism, thereby negatively
affecting their anticancer functionality (Bantug et al. 2018). Thus, for each of the two
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cancer datasets and in the three tissue locations described above (namely, Adj. Normal,
Tumor and Blood), we examine whether the distribution of gene sets that correspond to
biological metabolic pathways are consistent across T cell subtypes (therefore, the
number of different T cell subtypes corresponds to the number of classes k. We
specifically focus on 86 metabolic pathways described in the Kyoto Encyclopedia of
Genes and Genomes (KEGG (Kanehisa et al. 2017)). We obtained a list of genes
corresponding to each pathway, and subsequently ascribed genes into 86 subsets, each
subset corresponding to a metabolic pathway. Then, for each one of the 3 different
tissue locations and for each one of the 86 pathways, we tested the null hypothesis that
the multivariate distribution of the genes belonging to that particular pathway is alike
across the k different T cell subtypes (recall that k=4 in the NSCLC dataset, and k=3 in
the HCC dataset). In each of the cases the corresponding sample sizes for the k groups
are given in the rows of Table . The number of genes in a given metabolic pathway
ranged approximately between 30 and 110. To account for multiple-hypothesis testing,
the resulting p-values are adjusted using the Benjamini-Hochberg (BH) correction
procedure (Benjamini and Hochberg 1995).
This study design allowed us to understand which metabolic pathways change in
distribution across distinct, but closely-related, T cell subtypes. In particular, assessing
the distribution of gene sets that belong to a particular metabolic pathway across the T
cell subtypes allows us to address the following questions: (1) Which pathways have a
similar distribution across T cell subtypes in a given tissue? (2) Are there pathways that
have a stable and comparable distribution across T cell subtypes in a normal/healthy
tissue, but a heterogenous or perturbed distribution in a tumor? (3) For pathways that
have a disparate distribution across the T cell subtypes, which subtypes show the most
distinct distribution?

Comparing Pathway Distributions Based on Tissue Location
The following is the outcome of the BH-corrected MCM tests for assessing metabolic
pathway distributions across the different T cell subtypes in the two datasets:
- In the NSCLC dataset, we found that of the 86 pathways examined, our test did not
reject the null hypothesis for merely 35 pathways in the tumor tissue, compared to 56
and 74 pathways in the blood and adj. normal tissues, respectively.
- In HCC dataset, the set of pathways for which we failed to reject the null were
remarkably alike to that for NSCLC. Specifically, 41, 63 and 76 metabolic pathways
were undistinguishable across T cell subtypes in the tumor, blood and adj. normal
tissues, respectively.
The fact that majority of the metabolic pathways do not show evidence for dissimilar
distribution across cell types based on our test indicates that the T cell subtypes might
be more similar than previously appreciated in terms of how they regulate their basic
metabolic machinery. Further, for each pair of tissue location, we computed the overlap
in the pathways for which the null hypothesis was accepted or rejected. As expected, we
found that the concordance between the results was substantially higher for blood and
adj. normal, than either of these tissues had with the tumor tissue (this is seen from the
off-diagonal values in the tables in Figure 10).
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Figure 10. A set of 𝟐 × 𝟐 tables showing how many of the 86 hypothesis
(corresponding to the pathways) were accepted/rejected for each of 3 pairs of
tissue locations. Here, 0 corresponds to pathways whose distribution are either
similar/stable (null hypothesis accepted), and 1 for pathways whose distributions are
perturbed/heterogenous (null hypothesis rejected), across the T cell subtypes in two
types of solid organ malignancies.
Interestingly, we found that 8 metabolic pathways were differentially distributed across
the T cell subtypes in each tissue examined in NSCLC whereas 5 pathways exhibited
this pattern in the HCC dataset (Figure 11). The purine metabolism pathway was a
common pathway shared by both datasets which showed evidence for heterogenous
distribution among the T cell subtypes in every tissue. This discovery suggests that
purine metabolism is fundamentally different even among the closely related T cell
subtypes. In order to find out which T cell subtype contributed most to this difference for
the metabolic pathways that emerged as being heterogeneously distributed in all tissues,
we employed a class selection procedure. To select a single class, we looked at all the
pairwise comparisons where the null was rejected, and then identified the class that was
common across all the cases of rejection (Figure 11c-d).
We found that CD4+ Tregs were the strongest contributors as to why a pathway, such as
purine metabolism, was detected as being differentially distributed. It is important to note
that, purine metabolism regulates the balance of proinflammatory and
immunosuppressive molecules produced by T cells, and the activation of the purinergic
receptor P2X7 has been shown to inhibit the immunosuppressive functions specifically in
Tregs (Schenk et al. 2011). Thus, the fact that our test discovered purine metabolism as
being differentially distributed across T cell subtypes in both studies, and specifically in
Tregs, showcases its ability to unearth meaningful biological phenomena.
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Figure 11. Venn diagrams showing the overlap among the metabolic pathways that
demonstrated evidence for differential and similar distributions across the T cell
subtypes in NSCLC (a) and HCC (b), respectively. For the pathways that were
heterogenous among the T cell classes across all 3 tissue types, we used the class
selection procedure to identify which T cell subtype had the most disparate distribution
(c), (d). Differential distribution for the purine metabolism pathway, driven largely by Tregs,
was observed in both NSCLC and HCC.

Differentially Distributed Pathways as Biological and Algorithmic
Features
In the NSCLC dataset, we found that 51 pathways showed evidence for differential
distribution across the tumor-infiltrating T cell subtypes, whereas 45 pathways exhibited
this pattern in the tumor-infiltrating T cells in the HCC dataset. We observed that if a
metabolic pathway demonstrated an intra-T cell-type heterogenous distribution in blood
and adj. normal, that heterogeneity was preserved in the tumor tissue (in the first and
third Venn diagrams in Figure , the intersection of the green adj. normal) and the blue
circles (blood) is completely contained in the orange circle corresponding to tumor). In
other words, rejecting the null for a particular pathway for T cells in the adj. normal and
blood tissues was useful in prognosticating that pathway's behavior in the tumorinfiltrating T cells. On the other hand, we found that certain pathways that demonstrated
a dissimilar distribution across T cell subtypes in the tumor and adj. normal tissues
showed evidence for homogenous distribution in blood (the intersection of the green and
orange circles minus the blue circle in the first and third Venn diagrams in Figure 11).
Specifically, this pattern was true for 2 pathways (sphingolipid metabolism and
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glycophospholipid synthesis) in the NSCLC dataset, and for 3 pathways (phenylalanine
metabolism, oxidative phosphorylation and O-glycan biosynthesis) in the HCC dataset.
This difference can be attributed, at least partially, to the organ-specific function of these
pathways. For instance, ceramide, a central molecule in the sphingolipid metabolism,
regulates endothelial permeability and airway smooth muscle function in the lungs (Uhlig
and Gulbins 2008), and increased sphingolipid metabolism is a hallmark of lung cancer
(Ogretmen 2018). Similarly, phenylalanine hydroxylase, the main enzyme in the
phenylalanine metabolism pathway is active exclusively in the liver (Matthews 2007),
and otherwise inactive in the blood. Hence, in light of the organ-specific roles of these
pathways, it is rather reassuring that our test appropriately rejects the null hypothesis
and captures their heterogenous distribution among the T cell subtypes based on the
tissue location.
Clustering and cell type identification are crucial steps in single cell data analysis.
scRNAseq analysis pipelines often first identify highly variable genes in the dataset, and
subsequently use those genes as an input to the t-distributed stochastic neighbor
embedding (tSNE) algorithm. Even with this approach, however, single cell analysis
pipelines typically fail to resolve the different T cell populations, and rarely identify the
different immune cell subtypes in any reliable or discrete fashion. We wondered whether
in practice, one might be able to utilize our test to identify differentially distributed
pathways and then use this information to improve the tSNE-based clustering approach.
To investigate whether the pathways that emerge as being differentially distributed can
serve as meaningful features in identifying cell types, we focused on the pathways that
were consistently identified as being differentially distributed across the T cells in all
three tissue types in NSCLC. To our surprise, we found that using the subset of genes
corresponding to the pathways that our analysis identified as being heterogeneously
distributed improves the clustering results (Figure 12(a)). Moreover, the clustering
results converge with, and act as an indirect validation for our class selection approach
because the latter identified CD4+ Tregs as the cell type with the dissimilar distribution for
metabolic pathways such as IP3 metabolism, purine metabolism, and arginine and
proline metabolism. When we used the genes comprising these pathways as the input to
tSNE, we observed that indeed the CD4+ Tregs became more easily visually
distinguishable compared to using the genes in other pathways which had a similar
distribution across the T cell subtypes (Figure 12(b)).
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Figure 12. Results of the tSNE analysis performed using a specific pathway to
cluster the 4 different tumor-infiltrating T cell subtypes in NSCLC: (a) pathways that
were identified as differentially distributed successfully manage to segregate CD4+ Tregs
as predicted by our class selection procedure, whereas (b) pathways that were identified
as being similar across the T cell subtypes produce a more patchy clustering wherein
the subtypes are visually indistinguishable. All tSNE plots were generated with perplexity
= 30.
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Conclusion
Overall, we present the application of a novel graph-based nonparametric test for
comparing multiple multivariate distributions. Using optimal matching as the basis, we
demonstrate that our test, in addition to other multisample generalizations of
Rosenbaum's crossmatch test (Rosenbaum 2005), is distribution-free, computationally
efficient, and consistent for general alternatives, making it particularly attractive for
modern high-dimensional statistical applications. We also obtain a joint central limit
theorem for the entire matrix of cross-counts, and, hence, derive a distributional limit
theorem for the test statistics, under general alternatives. Our numerical experiments
demonstrate that the proposed method outperforms other non-parametric graph-based
multisample methods as well as commonly used parametric tests, in a variety of
simulation settings as shown here: https://arxiv.org/abs/1906.04776.
Lastly, we showcase the utility of this test in the field of single cell transcriptomics where
we used our test to address an important question in signal transduction and cell
biology. Our multisample procedure uncovered revealing patterns about how closelyrelated, key immune cells in the body (namely, T cell subtypes), might alter their
metabolic machinery in solid organ malignancies, particularly depending on the tissue
location. We envision that this test and the underlying theoretical intuitions described in
this work will find broad applicability in future research that examines hypothesis testing
in the multisample, multivariate framework. Furthermore, our test opens up new
paradigms of investigation for practitioners to assess its properties and its feasibility in
being adapted to other algorithms, as we have demonstrated here through its usage as
a pre-processing step in tSNE-based data visualization.
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CHAPTER 4: Cell-type Specific Complement Expression in the
Murine Retina Based on Single Cell Analysis
Abstract
Complement dysregulation is a feature of many retinal diseases, yet its mechanistic
understanding at the cellular level is limited. Due to this knowledge gap about which
retinal cells express complement, we performed single cell RNA sequencing on 92,000
mouse retinal cells and validated our results in five major purified retinal cell types. We
found evidence for distributed cell type-specific complement expression across 11 cell
types. Notably, Müller cells were found to be the highest contributor of complement
activators c1s, c3 and cfb. RPE mainly expressed cfh, whereas cfi and cfp transcripts
were most abundant in neurons. Aging enhanced c1s, cfb, cfp and cfi expression while
cfh expression decreased. Similarly, transient retinal ischemia induced complement
expression in microglia, Müller cells, and RPE. In summary, we report a unique
complement expression signature for murine retinal cell types that indicates a wellorchestrated regulation of the complement system in the local retinal microenvironment.
In light of my understanding of the conversations that occurred between my thesis
committee and the other investigators involved (investigators at Penn who are working
with researchers in Germany) during Oct-Nov 2018, this chapter is an almost verbatim,
unembellished copy of the manuscript shared by the Penn investigators and submitted to
Cell Reports in Spring 2019.
Update: On Oct 11, 2019, we were notified of the paper’s acceptance by Cell Reports.

Background
Single nucleotide polymorphisms in complement genes are associated with a number of
retinal diseases including glaucoma (Scheetz et al., 2013), age-related macular
degeneration (AMD) (Weber et al., 2014) and diabetic retinopathy (Yang et al., 2016;
Wang et al., 2013). The immune-privileged retina is under regular immune surveillance
by myeloid-derived cells and proteins of the complement system. Although systemic
complement is known to perform homeostatic functions that include modulating
opsonization for phagocytosis, formation of membrane attack complexes (MACs) and
recruitment of immune cells (Merle et al., 2015), the local regulation of complement
within the cellular architecture of the neurosensory retina is poorly understood. Current
evidence suggests that complement components are locally expressed in the retinal
pigment epithelium (RPE) (Schäfer et al., 2017; Luo et al., 2011; Anderson et al., 2010;
Tian et al., 2015; Li et al., 2014; Rutar et al., 2012) and microglia (Rutar et al., 2012).
Activation of these components is independent of the systemic complement produced in
hepatocytes and distributed via the bloodstream.
Upregulation of complement expression, subsequent protein deposition and MAC
formation have been demonstrated in the aging (Chen et al., 2010; Ma et al., 2013;
Chen et al., 2008) and diseased retina (Crabb, 2014; Sudharsan et al., 2017; Radu et
al., 2011; Zhang et al., 2002; Kuehn et al., 2008). In fact, complement components
present in extracellular deposits (termed “drusen”) are considered a hallmark of AMD
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(Crabb, 2014). Consequently, it is tempting to speculate that a source for complement
activation during aging could be the retina/ RPE itself, as animal studies have shown
increased retinal expression of c1q, c3, c4 and cfb in older mice (Ma et al., 2013; Chen
et al., 2010). Such a local retinal complement system may help facilitate a rapid
response to microbial invasion and disposal of damaged cells despite an intact bloodretina barrier. Complement upregulation has also been observed in retinitis pigmentosa
(Sudharsan et al., 2017), Stargardt disease (Radu et al., 2011), and conditions
associated with transient ischemic tissue damage, viz. diabetic retinopathy (Zhang et al.,
2002) and glaucoma (Andreeva et al., 2014; Kuehn et al., 2008; Kim et al., 2013).
Despite a clear indication for a fundamental role of the complement system in the retina,
it remains unknown which retinal cell populations shape complement homeostasis in the
healthy, aging and diseased retina.
The retina consists of more than 40 different cell types, which cooperate to capture,
process, and transmit visual signals to the brain (Macosko et al., 2015; Tian et al., 2015;
Rheaume et al., 2018; Shekhar et al., 2016). Our understanding of healthy and diseased
retina and its supporting tissues like the RPE and choriocapillaris has grown in light of
advances in microscopy (Tian et al., 2015; Pinelli et al., 2016). Yet, most transcriptomic
studies have focused on the whole retina or RPE, obscuring information about which
specific retinal cells transcribe the RNA (Pinelli et al., 2016; Tian et al., 2015). Dropletbased scRNAseq has identified the molecular differences between retinal ganglion cells
(Rheaume et al., 2018), bipolar cells (Shekhar et al., 2016) and Müller cells (Roesch et
al., 2008), however, these studies provided little insight into how the major retinal cell
types shape the overall retinal transcriptome.
Here, we profiled complement expression at the single cell level in the eleven major
retinal cell types of the mouse and further validated these results in enriched Müller
cells, vascular cells, microglia, neurons and RPE cells. We observed a characteristic
contribution of complement transcripts from distinct retinal cell populations. Our data
suggests that cfh is the major complement inhibitor in the mouse retina as retinal stress
consistently downregulates cfh expression. Moreover, cell type-specific changes in
complement expression differed in aging and acute retinal degeneration induced by
transient ischemia, implying a stress-dependent and cell type-specific modulation of
retinal complement homeostasis.

Transcriptomic analyses reveal complement component expression
across multiple cell types
Retinal cells, 92,000 total, were isolated from six male healthy C57BL/6J mice and
separated for scRNAseq (Macosko et al., 2015; Shekhar et al., 2016). Following
sequencing, the data were analyzed using 30 principal components as input to the tdistributed stochastic neighbor embedding (t-SNE) method for dimension reduction and
data visualization (Fig. 13). Cells were classified into 11 major types based on
established markers (Table 5), and the proportion of cell types identified in this study
was comparable to other scRNAseq studies of the retina (Table 6). We then mapped the
expression of complement genes across all 11 cell types, and observed a distributed
expression of complement components across various resident cells in the retina (Fig.
14).
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Table 5. Marker genes used to identify the major cell classes in the retina along
with their cell type-specific expression parameters:
(i) % of cells with non-zero expression, and
(ii) mean expression (based on UMIs/cell) among cells with non-zero expression
Cell type
rod photoreceptor

cone photoreceptor

rod bipolar cell (BC)

cone BC

microglia

horizontal cell

endothelial cell
pericytes
Müller cells
retinal ganglion cells

Marker genes*

(i)

(ii)

rho

99.5

21.6

gnat1

94.5

5.1

rcvrn

90.2

4.0

nr2e3

68.9

2.2

nrl

79.5

2.5

rbp3

52.4

1.9

arr3

98.0

8.3

gnat2

93.7

4.6

opn1mw

56.8

5.5

opn1sw

82.1

20.0

prkca

93.6

4.1

vstm2b

55.7

1.7

prdm8

26.8

1.2

pcp2

99.5

20.1

trpm1

30.2

1.5

vsx1

16.0

1.6

isl1

32.9

1.7

gsg1

30.0

2.3

sox6

6.6

1.2

aif1

64.9

2.6

tmem119

58.3

3.3

cx3cr1

65.8

4.2

trem2

77.1

5.2

lhx1

91.7

4.1

prox1

94.2

5.4

pax6

93.0

4.0

pecam1

68.9

3.1

cspg4

19.2

1.8

pdgfrb

51.8

3.3

kcnj8

45.2

4.2

glul

99.7

23.0

rlbp1

93.3

5.7

pou4f1

91.6

5.3
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amacrine cells

sncg

98.9

19.2

pou4f2

29.8

1.5

tfap2d

5.1

1.4

gad1

35.9

2.3

gad2

21.1

1.5

slc6a1

40.5

2.4

slc6a9

33.8

2.1

Table 6. Single-cell RNA sequencing identified all the major cell classes in mouse
retina, with proportions comparable with past studies
% composition of cell types

Jeon et al.
1998

Macosko et al.
2015

Current single
cell study

# of
cells

Rod Photoreceptors
Cone Photoreceptors

79.9
2.1

65.6
4.2

40.6
8.1

37474
7473

Müller cells

2.8

3.6

13.6

12597

RGCs

0.5

1.0

0.2

178

Horizontal Cells

0.5

0.6

0.6

516

Amacrine Cells
Bipolar Cells

7.0
7.3

9.9
14.0

7.5
28.3

6941
26153

Endothelial cells
Microglia

–
–

0.6
0.2

0.5
0.3

495
319

Pericytes

–

0.2

0.2

197
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Figure 13. Quality control of scRNAseq data set. This figure shows a summary of the
quality metrics and distribution of retinal cells from the six genetically identical C57BL/6J
mice. We filtered out low-quality cells in which <90% of the reads did not map to the
genome using the Cell Ranger pipeline from 10x genomics, and ultimately obtained
92,343 cells used in our subsequent analyses. (A) Violin plots showing the number of
genes (nGene), UMIs (nUMI), and the percentage of mitochondrial genes (percent.mito)
detected in each batch. The percentage of UMIs mapping to mitochondrial genes is a
common scRNA-seq quality control metric. (B) tSNE plot showing the cell distribution
from nine different batches. Note that cells from each batch contributed to every single
cell cluster. (C) A table displaying the number of cells isolated from each of nine different
retina dissection and scRNA-seq preparations from healthy Black 6 mice. (D)
Unsupervised clustering demonstrates 25 distinct cell clusters shown in a t-distributed
stochastic neighbor embedding (tSNE) map, which we subsequently labeled into 11
major cell classes (N=92,343 cells).

48

Figure 14. scRNAseq of a healthy murine retina reveals complement expression in
different cell types. Distribution of complement expression in normal mouse retina is
delineated by single-cell transcriptomics. Using unsupervised clustering, we detect all
eleven major cell classes in the mouse retina; the distinct cell types that passed quality
control (described in methods) are shown in a t-SNE map (Out of the 92,343 cells total,
91,798 cells passed the filter of having mitochondrial gene expression < 50%, and
200<unique gene counts<3500). Percentages of assigned cell types are summarized in
the right panel of (a). BC: Bipolar cell. Murine retinal cell populations were enriched by
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immunomagnetic cell separation and characterized by qRT-PCR using specific markers:
Glul is a marker for the Müller cell fraction. In (b), cell type-specific expression of
complement genes is shown. Mean expression values of the genes were calculated in
each cluster by randomly subsampling a population of 100 cells for each cell type. Each
row represents a retinal cell type and each column corresponds to a gene. Vascular cell
enrichment was proven by strong expression of pecam. The expression of complement
regulators among the various retinal cell-types is shown by means of a dot plot in (c).
Cell types are arranged roughly by their location in the retina: From inner layer (top) to
outer layer (bottom). The size of each circle (pct.exp) depicts the percentage of cells in
which the gene was detected for a given cell type, and its color depicts the average
transcript count in the expressing cells (avg.exp.scale).

Primarily complement components of the classical pathway were detected. Moreover,
we mapped the expression of both soluble and membrane-bound complement
regulators, and found that the main soluble regulators of complement detected in the
retina were cfh, vtn and clu. Cell types expressing complement regulators at highest
level were Müller cells, pericytes and endothelial cells. Complement receptors, which
detect complement activation (opsonins) are only expressed in microglia cells (Table 7).

Table 7. Cell type-specific expression of complement in the C57/BJ6 mouse retina
Complement

Cell type-specific gene
expression

% of cells within
a given cell type
with non-zero
expression

Mean expression
(based on UMIs) in
cells with non-zero
expression

Microglia

86.2

4.1

Pericytes,
Endothelial cells
not detected
Pericytes,
Endothelial cells
Müller cells,
Microglia

10.7
9.5
–
2.5
2.2
0.8
2.8

2.2
1.0
–
1.9
0.65
1.6
1.4

not detected
not detected
not detected
not detected
not detected
not detected
not detected
not detected

–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–

Classical pathway components
c1q complex
(A, B and C subunit genes)
c1s1
c1s2
c1r
c1rl

Lectin pathway components
mbl-a
mbl-c
fcna
fcnb
colec11
masp1
masp2
masp3
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Classical and lectin pathway components
c2
c4

Cone BCs,
RGCs
Müller cells,
Microglia,
Pericytes,
RGCs,
Endothelial cells

0.3
1.1
1.6
0.6
1.0
1.1
0.4

2.1
1.0
1.6
1.8
2.0
1.0
1.2

not detected
not detected

–
–

–
–

Microglia
not detected
not detected
not detected
not detected
not detected

1.0
–
–
–
–
–

1.4
–
–
–
–
–

Müller cells,
Cone BCs,
Endothelial cells
not detected
not detected
Rod
photoreceptors,
Cone
photoreceptors,
Rod BCs,
Cone BCs,
Amacrine cells,
Müller cells
Microglia,
Endothelial
cells, Pericytes,
Müller cells
Rod BCs
Not detected
Not detected
Not detected
Rod
photoreceptors,
Cone
photoreceptors,
Rod BCs,
Cone BCs,
Horizontal cells,
Amacrine cells,
Microglia,

3.8
0.5
10.7
–
–
0.4
1.6
1.0
1.0
1.3
1.2

1.6
2.1
0.9
–
–
2.5
2.0
2.0
2.1
1.8
1.5

29.8
28.3
15.7
2.2
2.2
–
–
–
63.2
54.5
11.0
11.8
19.2
14.7
15.0
59.9
57.4

1.7
1.3
2.2
1.6
2.0
–
–
–
3.0
2.4
2.1
2.2
1.0
1.9
1.9
3.8
2.4

Alternative pathway components
cfb
cfd

Core complement components
c3
c5
c6
c7
c8
c9

Complement regulators
c1-inh
(serping1)

soluble

c4bp
cpn1
cfp

soluble
soluble
soluble

cfh

soluble

cfi
fhr-a
fhr-b
fhr-c
vtn

soluble
soluble
soluble
soluble
soluble
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clu

soluble

crry

membrane

cd55 (daf-1/ daf2)
cd59a

membrane

cd59b

membrane

membrane

Pericytes,
Endothelial
cells,
Müller cells,
RGCs
Rod
photoreceptors,
Cone
Photoreceptors,
Rod BCs,
Cone BCs,
RGCs,
Müller cells,
Microglia,
Amacrine cells,
Horizontal cells
Rod
photoreceptors,
Cone
photoreceptors,
Cone BCs,
Horizontal cells,
Microglia,
Müller cells,
Amacrine cells,
Endothelial
cells,
RGCs
Microglia

14.5
22.5

1.7
1.0

2.7
16.4
4.4
8.4
28.1
86.8
6.6
10.2
37.6

2.5
2.1
2.0
2.1
1.0
2.8
1.8
1.8
1.1

0.4
2.1
1.1
6.0
7.2
2.2
2.2
27.3
5.1

2.5
2.0
2.0
0.9
1.5
1.5
1.8
1.3
1.0

2.2

2.1

Rod
photoreceptors,
Cone
photoreceptors,
Rod BCs,
RGCs,
Müller cells,
Endothelial
cells,
Amacrine cells,
Cone BCs,
Horizontal cells
Müller cells,
RGCs,
Horizontal cells,
Amacrine cells

6.2
31.3
1.9
19.1
6.2
40.1
5.9
2.9
57.8

2.5
2.7
1.9
1.0
1.6
1.4
1.7
2.1
1.3

1.5
6.2
3.7
0.8

1.6
0.9
1.0
1.6

Not detected
Horizontal cells,
Müller cells
Microglia
Microglia

–
4.7
0.5
33.2
1.0

–
0.8
1.6
1.7
1.2

Complement receptors
cr1
cr2
cr3 (itgam and itgb2)
cr4 (itgax and itgb2)
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c3ar1
c5ar1
c5ar2
c1qr (cd93)
gc1qr (c1qbp)

cc1qr (calr)

vsig4 (CrIg)

Microglia
Microglia
Microglia
Endothelial
cells,
Pericytes
Rod
photoreceptors,
Cone
photoreceptors,
Rod BCs,
Cone BCs,
Horizontal cells,
Amacrine cells,
Microglia,
Pericytes,
Endothelial
cells,
Müller cells,
RGCs
Rod
photoreceptors,
Cone
photoreceptors,
Rod BCs,
Cone BCs,
Horizontal cells,
Amacrine cells,
Microglia,
Pericytes,
Endothelial
cells,
Müller cells,
RGCs
Not detected

27.9
23.5
11.9
50.9
3.6

1.8
1.8
1.7
1.7
1.7

5.6
8.3
9.6
9.6
32.6
15.0
15.0
14.2
22.4
10.1
39.9

2.5
2.0
2.0
2.1
1.0
1.8
1.5
2.0
1.2
1.6
1.1

13.1
18.4
16.6
16.8
48.6
20.9
36.4
15.7
43.8
22.2
37.6

2.5
2.1
2.0
2.1
1.2
1.9
1.8
1.9
1.5
1.7
1.0

–

–

Though our single cell analysis uncovered complement expression in different cell types,
some complement components remained undetectable or were found in relatively rare
cell types. Therefore, we further validated our results on purified Müller cells,
microglia/macrophages (hereafter termed ‘microglia’), vascular cells and retinal neurons
by immunomagnetic cell separation, and RPE by manually scratching eyecups from
albino BALB/c and pigmented C57BL/6 mice (Grosche et al., 2016). All five cell
populations were characterized by the expression of specific marker genes (Fig. 15).
Commonly used housekeeping genes showed high transcriptional and translational
variability across different cell types except pyruvate dehydrogenase E1 component
subunit beta (pdhb) and isocitrate dehydrogenase 3 (NAD+) beta (idh3b), which had
relatively homogeneous expression levels (Data not shown). We used idh3b to
determine how a distinct cell population proportionally contributes to the total retinal
transcriptome, and identified the neuronal fraction (60%) as the cell population
expressing highest levels of transcripts (Fig. 15) followed by Müller cells (25%).
Consistent with our scRNA-Seq data, vascular cells (1%) and microglia (5%) expressed
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lower levels of idh3b, indicating low cell numbers and/or low transcription activity of
these cell types in the mouse retina. Quantifying total RNA by RNA picochip analysis, we
found similar RNA quantity in Müller cells (33%), neurons (26%) and the RPE/choroid
fraction (22%) per mouse. In agreement with previous reports of cell counts in the
mouse, we found neurons make up 85%, RPE cells 13%, Müller cells 2% and microglia
and vascular cells below 1% of all retinal cell types (Jeon et al., 1998). Additionally, we
also found that although Müller cells are a comparatively infrequent cell type (2%), they
contribute up to one-third of the total mRNA content in the retina.

Figure 15. Validation of enrichment of different retinal cell types.
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Schematic view of distinct retinal cell types. Müller cells (blue), the central glia cells
of the retina, are in direct contact with the vitreous and various retinal cell types:
microglia (green), vascular cells (red) and neurons (grey). 80% of the retinal
neurons are light-responsive photoreceptors that are supported by retinal pigment
epithelial cells (RPE, brown).
scRNA-seq data illustrating expression of glutamine sythetase (glul) across retinal
cells (top panels). Murine retinal cell populations were enriched by
immunomagnetic cell separation and characterized by qRT-PCR using specific
markers (bottom panels): Glul is a marker for the Müller cell fraction.
Microglia (and putatively co-enriched macrophages) specifically express cd11b
(itgam).
Vascular cell enrichment was proven by strong expression of pecam.
Retinal neurons were characterized by an enhanced detection of the photoreceptorspecific nrl mRNA compared to the other cell populations.
Rpe65 was exclusively expressed in RPE/choroid. Exemplarily shown mean
values + SEM for cell preparations from BALB/c mice 8, 16 and 24 weeks of age
(n=4 ‒ 6 for each age).

Retinal cell populations express unique complement signatures
Encouraged by the distributed complement expression pattern across 11 cell types, we
hypothesized that specific retinal cell types shape the intraretinal complement
homeostasis through expression of specific complement components. We selected six
disease associated genes (Schäfer et al., 2017; Weber et al., 2014) c1s, c3, cfb, cfp, cfh
and cfi for further validation and found that Müller cells contributed the highest amount of
complement activator transcripts, expressing 34 ‒ 47% of c1s, 53 ‒ 56% of c3 and
28 ‒ 34% of cfb retinal transcripts, depending on the mouse age (8 to 24 weeks) (Fig.
16). Retinal neurons dominated the expression of the complement regulators cfi and cfp,
while 59-74% of the cfh transcripts were detected in the RPE. Despite the relatively low
number of microglia, the resident immune cells of the retina contributed proportionally
more cfh mRNA and a similar amount of cfb transcripts to the retinal complement
population compared to the retinal neurons.
We confirmed expression at the protein level and found that the complement activators
C1s, CFB and CFP were detectable in all enriched murine cell populations. Complement
C3 was detected in RPE, Müller cells and neurons, while the complement inhibitors CFH
and CFI were present in all cell types except vascular cells. There was significant
overlap in the pattern of complement transcript levels determined by qRT-PCR and that
of the complement proteins detected in the various cell populations. For example, strong
c1s mRNA expression found in Müller cells matched the prominent C1s protein levels.
Interestingly, neurons expressed ~ 40 % of the total cfp mRNA, whereas CFP protein
levels were highest in microglia (Fig. 16). This may imply a spatial separation of
complement component transcription and complement component accumulation at the
protein level within the retina.
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Figure 16. Contribution of retinal cell types to the retinal architecture, complement
expression and complosome homeostasis in aging albino mice.
a

mRNA expression of the housekeeping gene idh3b as determined in samples from
retinal cell populations enriched from retinae of 8, 16 and 24 week old albino mice
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without adjusting the RNA input amount per cell type. This enables an estimate of
the contribution of each cell type to the retinal transcriptome. Bars represent mean
values ± SEM (n=4 ‒ 6).
The total RNA amount isolated from retinal cell populations enriched from albino
mice (8-16 weeks old) was investigated using picochip analysis. Bars represent
mean values ± SEM (n=5 ‒ 8). *P<0.05, **P<0.01, Mann-Whitney U-test.
Quantification of PDHB protein expression via Western Blots performed on five
retinal cell types purified from 4 ‒ 6 albino mice.
Published (Jeon et al., 1998) and own retinal cell counts in the healthy mouse
retina.
Scheme of the complement system that can be activated via three different
mechanisms and is enhanced by an amplification loop. Complement components
investigated in the present study are highlighted with respective colors.
Expression levels of C1s, C3, CFB, CFP, CFH and CFI were determined from cells
of albino mice at mRNA level (bars) at indicated ages and at protein level (Western
blot) in samples from 24 week old mice. The overall contribution of each cell
population to the local complement homeostasis was determined by analyzing the
total yield of mRNA or protein derived from the respective cell population.

Table 8. Percentage of murine, albino, aging retinal cell type-specific complement
expression profiles
Complement Müller cells
microglia
vascular cell neuron
RPE
transcript
8 16 24 8
16 24 8
16 24 8
16 24 8
16 24
c1s
9% 5% 11% 2% 3% 2% 4% 14% 11% 8% 7% 2% 9% 4% 4%
c3
12% 8% 16% 3% 3% 4% 1% 3% 6% 6% 5% 7% 3% 1% 1%
cfb
7% 8% 13% 3% 4% 12% 4% 11% 13% 5% 7% 4% 25% 3% 4%
cfp
38% 64% 49% 11% 13% 9% 16% 21% 28% 46% 56% 47% 3% 2% 2%
cfh
32% 14% 10% 71% 73% 72% 72% 49% 38% 14% 7% 9% 60% 91% 89%
cfi
1% 0.8% 2% 9% 5% 2% 3% 3% 4% 22% 17% 31% 0.4% 0.3% 0.3%
*data for 8, 16 and 24 week old mice

Table 9. Percentage of murine, pigmented control and post-ischemic retinal cell
type-specific complement expression profiles
Complement Müller cells
microglia
transcript
C
I/R
C
I/R
c1s
17%
5%
1% 0.3%
c3
26% 38% 0.2% 40%
cfb
12% 47% 52% 38%
cfp
14%
5% 11% 19%
cfh
31%
5% 35%
3%
cfi
0.3% 0.3%
1% 0.3%
*C control, I/R post-ischemic

vascular cell
C
I/R
1%
1%
0.0%
6%
72% 70%
15.1% 14%
10%
7%
2%
2%
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neuron
C
I/R
1%
1%
2%
6%
8% 19%
76% 58%
1%
1%
12% 16%

RPE
C
17%
4%
13%
13%
54%
0.2%

I/R
12%
28%
39%
6%
14%
0.3%

Age-dependent changes in the complement expression of different
retinal cell populations
We detected age-dependent changes in complement expression among the different
retinal cell populations in mice from 8 to 24 weeks old. For example, the c1s, cfb, cfp
and cfi transcripts increased with age among all cell populations. Upregulated c1s
expression in the RPE cells led to doubling of the total retinal c1s mRNA between 8
and 24 weeks (Table 8). Transcripts of the alternative pathway activator cfb, primarily
produced by Müller cells and RPE, also increased at 16 and 24-weeks of age. Though
the largest increase in cfb transcript levels (2.6-fold) was found in the microglial
population between 8- and 24-weeks. The highest proportional contribution of cfp retinal
transcripts came from neurons (55%) and this contribution was also further upregulated
to 73% at 16/24 weeks of age. Meanwhile, cfh expression decreased in 24 week old
mice and c3 expression remained relatively stable (Fig. 16), except for the vascular cell
population wherein c3 levels dropped by 50% between 8 and 24 week-old-mice.
CFH is a CFP antagonist and regarded as the main negative regulator of the
complement system with described intracellular functions (Martin et al., 2016). We found
that cfh expression decreased by 50% in all cells of the 24-week old mice, compared to
the 8-week old mice. Of note, in the 24 week old mice, RPE cells produced the majority
of the retinal cfh (Table 8), although the majority of the cfi transcripts (which acts
together with CFH) were produced by neurons, specifically the rod bipolar cells.
Together with its functional counterpart, cfp, the expression of cfi also increased in
neurons of 24-week-old mice compared to the 8- and 16- week old mice (Fig. 16f).
These divergent changes in the local complement expression pattern in the retina of
aged mice were not accompanied by any detectable retinal cell loss (Fig. 17a-c), but by
increased microglia activation as suggested by alterations in microglial processes was
observed (Fig. 17d,e).
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Figure 17. Retinal phenotype in the investigated aging mice.
a, b, c The quantity of DAPI+ cell nuclei in the (A) ganglion cell layer (GCL), (B) inner
nuclear layer (INL) and (C) outer nuclear layer (ONL) were comparable in 16 - 32
week old albino retinae.
d
Immunolabeling for Iba1 depicts microglia in the inner retina (INR) and in the outer
plexiform layer (OPL). Scale bars, 20 µm.
e
Left, microglia were quantified in the inner retinal layers (INR) such as ganglion
cell and inner plexiform layer and additionally in the outer plexiform layer (OPL) on
basis of Iba1 labeling in mice of the indicated age.
Right, the area occupied by processes of a single microglia was measured as
exemplarily depicted by the dashed circles of different colour for OPL microglia in
D.
a-c,e Bars represent mean values ± SEM. *P<0.05, **P<0.01, Mann-Whitney U-test.
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A characteristic proportion of activating and inhibiting complement
transcripts in distinct retinal cell types
Next, we sought to understand the balance of complement activator and inhibitor
expression in the different cell types by normalizing complement expression levels to
housekeeping genes to allow comparability between cell populations independent of cell
counts. Strikingly, we discovered that certain cell types, such as the RPE and microglia,
mainly express inhibitory complement components (cfh, cfi), whereas other cell
populations, such as neurons and Müller cells mostly express complement activators
(c1s, c3, cfb, cfp); strikingly, neurons expressed mainly the negative regulator cfi and not
cfh (Fig. 18). Since cell types in the neuroretina are organized by layers, this spatial
distribution of complement activators and regulators highlights a unique complement
signature for each retinal cell type that is influenced by anatomical location.
Lastly, we evaluated how tissue damage might change complement expression, and
whether these changes are cell-type specific. To address this question, we used a retinal
ischemia/reperfusion (I/R) injury model to induce acute retinal degeneration (Wagner et
al., 2017). We found a significant increase in the expression of complement activators
24 hours post-ischemia in the different isolated cell populations (Fig. 19). Consistent with
our previous results, cfi was the main complement inhibitor augmented in neurons,
whereas cfh, another major complement inhibitor, was expressed in the remaining cell
populations. Compared to aging retina, the expression of c1s, c3 and cfb transcripts was
more pronounced in post-ischemic retina at both the mRNA and protein levels.
Interestingly, this response was heavily influenced by expression changes in the RPE.
Furthermore, cfh and cfi showed a mutually opposite pattern of expression changes;
while cfh mRNA decreased, cfi increased in I/R retinae (Fig. 19c).
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Figure 18. Comparison of complement component expression between retinal cell
types of aging mice. Expression of complement components was determined by qRTPCR as depicted in (left subpanel). Diagrams represent the relative amount of
transcripts per cell (normalized to the idh3b housekeeper expression) of the different
complement components in the respective cell type enriched from mice at the indicated
age. Note the high expression level of inhibitory complement factors in RPE/choroid
samples as well as in microglial and vascular cells, while complement activating genes
appear to dominate in Müller cells and neurons. Data were collected from 4 ‒ 6 wild type
albino mice (numbers are given in Table 8). The right subpanel shows complement
expression analysis by qRT-PCR on enriched retinal cell types from 8, 16 and 24 week
old mice. Bars represent mean values ± SEM of cells purified from 4 ‒ 6 animals. MannWhitney U-testing was performed on all data. Circle, significant difference compared to
the expression level at 8 weeks of age; diamond, significant difference compared to the
expression level at 16 weeks of age. º/◊P<0.05; º º/◊◊P<0.01.
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Figure 19. Transient ischemic stress results in cell type-specific upregulation of
transcripts from activating complement components and downregulation of cfh.
a The relative amount of complement transcripts per retinal cell type indicated that
complement activating transcripts are more abundant in pigmented mice than in
albino mice in which transcripts of complement inhibitors dominate at the same age.
Note the strong relative upregulation and the resulting shift towards transcripts from
complement activators 24 hours after transient ischemic retinal stress in all retinal
cell types of C57BL/6 mice (numbers are given in Table 9).
b Major changes of local complement expression (normalized to the house keeper)
were detected by qRT-PCR 24 hours after transient ischemia. The most pronounced
upregulation of complement activators was found in Müller cells (c3, cfb), microglia
(c3, cfb, cfp) and RPE (c1s, c3). Cfh was down-regulated in Müller cells, while cfi
was up-regulated in all investigated cell types. Significantly different expression as
compared to that cells from healthy control eyes: *P<0.05, **P<0.01, Mann-Whitney
U-test.
c Complement transcript contribution of the different retinal cell populations (no
normalization to the housekeeper and no adjustment of RNA input) indicated a proinflammatory milieu in the postischemic retina. Mainly Müller cells, microglia and
RPE cells contributed to the changed complement homeostasis in postischemic
retinae.
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Discussion & Relevance of this Study
Since the retina is an immune-privileged tissue, understanding its local complement
system is critical to our understanding of its role in inflammation. To identify the retinal
cell-types expressing complement, we isolated and sequenced 92,000 cells from healthy
mouse retinae. The scRNAseq results were validated for six complement genes by
assays of RNA and protein in enriched cell populations of Müller cells, microglia,
vascular cells, retinal neurons and RPE. Collectively, these results show that
complement components are locally expressed by different retinal cell populations,
challenging the conventional belief that the complement source in the retina is confined
to resident immune cells (Grosche et al., 2016). Given the cell-specific ratios of
activating and inhibiting complement component expression levels, each cell type
appears to have its specific role in maintaining the retinal complement homeostasis.
Moreover, cell populations present in the retina at relatively low numbers, such as
microglia and Müller cells (Jeon et al., 1998), have a major impact on retinal complement
expression levels. We found that these cells contribute substantially to the total retinal
transcriptome. This suggests that quantification of cell numbers alone is insufficient to
draw conclusions about the contribution of cellular activity to the global expression
profile of the retina. Nonetheless, it has been shown that transcription is tightly regulated
according to cellular volume, and cells with larger cell bodies (such as Müller cells) can
provide more mRNA than the more abundant cells with a smaller volume (e.g. neurons,
RPE) (Marguerat and Bähler, 2012; Kempe et al., 2015).
The complement system helps maintain normal ocular functions (Sohn et al., 2003,
2000) and its dysregulation significantly influences retinal disease (Sudharsan et al.,
2017; Radu et al., 2011; Weber et al., 2014; Yang et al., 2016; Scheetz et al., 2013).
Although earlier studies have found low, background expression of complement in retinal
microglia (Luo et al., 2011; Schäfer et al., 2017; Anderson et al., 2010; Rutar et al.,
2012) and RPE/choroid (Schäfer et al., 2017; Luo et al., 2011, 2013), our results
unequivocally show that other cell types are capable of local complement production.
We did observe expression differences between the scRNAseq and the MACS-enriched
cell populations which can be explained by the lower sensitivity of the former method to
detect gene expression compared to RT-PCR. For instance, compared to the single cell
analysis, RT-PCR allowed us to more readily detect the expression of cfp in microglia
and vascular cells, of c1s and c3 in Müller cells, and of cfb in all the major retinal cell
types. Still, both approaches converged in their assessment of cell type-specific
expression for most complement components. Our results adds to previous work on
retinal complement in humans (Tian et al., 2015; Li et al., 2014; Anderson et al., 2010),
mice (Schäfer et al., 2017; Luo et al., 2011) and rats (Rutar et al., 2012) by also
detecting protein expression corresponding to RNA expression for six complement
factors.
The regulation of complement expression in whole cell populations from the aging retina
largely matched the changes we calculated for the normalized cellular expression rates
in the distinct cell types. This implies that expression changes were driven by changes at
the transcriptional level, not by changes in cell numbers in accordance with the data
from our morphometric analyses performed on aging Balb/C mice. Interestingly, the
relative expression of all tested complement components increased in RPE with
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increasing age except for cfh, whose expression decreased. We speculate that cfh alone
is unable to counterbalance the overall age-associated RPE dysfunction (as also
indicated by a reduced rpe65 expression). Accordingly, the RPE-dependent cfh
transcripts decrease at 24-weeks, the putative contribution of cfh in regulating the
complement system in the retinal microenvironment diminishes, and the intraretinal
milieu gets disbalanced.
We also discovered that healthy neurons produce the complement regulators cfp and cfi.
The relevance of these complement components has been shown for AMD (Fritsche et
al., 2016; Weber et al., 2014; Micklisch et al., 2017). In murine models of retinal
degeneration, cfi expression increases after polyethylene glycol induced insult, whereas
cfp expression decreases in the light-damaged retina (Schäfer et al., 2017; Lyzogubov et
al., 2014). Our single cell analysis demonstrated that cfi localizes specifically to rod
bipolar cells in mice. Rods primarily govern scotopic vision and mice have a roddominated retina similar to humans (except for the fovea centralis). CFI is imperative for
the phagocytic activity of the complement pathway and its rod bipolar cell-specific
transcription in the mouse retina further suggests that the retinal complement system is
influenced by functional and anatomical characteristics of the retina.
Age-related anatomical alterations in the retina have been demonstrated in histological
analyses (Grossniklaus et al., 2013). Consistent with previous results (Damani et al.,
2011; Friedman and Ts’o, 1968), we found increased microglial and decreased RPE
marker gene expression as the mice aged. In our study, the expression of complement
transcripts c1s, cfb, cfp and cfi increased while that of cfh decreased in retinal cells
between 8 and 24 weeks of age. This indicates a role for complement in the retinal
adaptation during maturation (Mukai et al., 2018). Although age-dependent upregulation
of complement transcripts, including that of c1q, c3, c4 and cfb, in the retina has been
described (Chen et al., 2010), our findings indicate a prominent role for microglial cells in
this process, as the expression of c3 and cfb increases significantly in this cell type
during aging. Our results also show that Müller cells and neurons provide a substantial
proportion of retinal complement transcripts and, thus, their impact on retinal
complement homeostasis has likely been underestimated by past studies. Cell culture
studies have suggested that Müller glia can produce C1q (Astafurov et al., 2014) and
that complement activation products can regulate Müller cells via C5a-receptor,
contributing to retinal diseases (Cheng et al., 2013). Our study suggests a direct
involvement of Müller cells in the regulation of the retinal complement pathway even with
an intact blood-retinal barrier. It is likely that in the retina, similar to the brain, neurons
and glia cells orchestrate complement-mediated maturation of nervous tissue via
synaptic pruning, progenitor proliferation and neuronal migration (Tenner et al., 2018).
Aging and Alzheimer diseased brains increase expression of c1q, c3 and c4 (Walker and
McGeer, 1992; Cribbs et al., 2012), which might point to a general mechanism of local
complement function in the aging central nervous system.
Retinal I/R injury is a pathological hallmark of diabetic retinopathy and glaucoma, the
former of which is associated with polymorphisms in CFB and CFH (Wang et al., 2013).
We identified Müller cells as the major cell type implicated in this process (evidenced by
downregulation of cfh transcripts and upregulation of cfb) in the analysis of postischemic mouse retina. Gene profiling studies of whole mouse retinas also suggest an
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important role of the complement pathway in I/R associated damage (Andreeva et al.,
2014). Retinal c1q, c1s, c1r, c2, c3, c4a and cfh expression as well as protein deposition
has been reported after transient ischemia in mice (Kuehn et al., 2008; Kim et al., 2013;
Andreeva et al., 2014). However, it remains incompletely understood whether and how
individual retinal cell types modulate the complement activity after retinal I/R injury. Here,
we show that Müller cells, microglia and RPE specifically increase c3 and cfb expression
following ischemia, and cfp is upregulated primarily in microglia. The complement
inhibitor cfi also showed cell type-specific enhanced mRNA levels in microglia, RPE and
retinal neurons, whereas expression of the complement inhibitor cfh was significantly
reduced in Müller cells. These expression changes imply augmentation of the
complement pathway 24 hours post-transient ischemia, and suggest that therapeutic
approaches that reduce complement activity might be beneficial in these subjects.
Genetic variation in several complement genes, such as CFH and CFI, are associated
with AMD, Glaucoma and central serous retinopathy (Fritsche et al., 2016; Weber et al.,
2014; Grassmann et al., 2016). CFI, along with cofactor CFH, regulates complement
activity by degrading complement components C3b and C4b (Davis et al., 1984),
thereby facilitating the cleavage of C3b into inactive fragments (Sim et al., 1993). We
discovered a spatially distinct transcription pattern of cfi and its cofactor cfh. Cfi was
mainly detected in retinal neurons (specifically rod bipolar cells) while cfh was detected
primarily in vascular/endothelium and RPE cells. Further, we found opposing
transcriptional regulation of cfi and cfh during aging and ischemia wherein cfi expression
increased and cfh decreased in both conditions. These findings hint at a CFHindependent function of CFI in the retina, perhaps in conjunction with other cofactors
such as CR1 or CD46 (Sim et al., 1993). To date, there are no known AMD-associated
polymorphisms in the cd46 or cr1 genes, but cd46 knockout induces a retinal
degeneration (Lyzogubov et al., 2016), highlighting its relevant role in maintaining
normal retinal physiology.
Given the considerable expression profile of complement genes in the retina, we infer
that local complement expression helps maintain normal retinal integrity. Moreover, our
data imply that modulations in local complement expression during aging, chronic and
acute stress contribute to retinal cell death and retinal degeneration. A reaction common
to I/R damage and aging appears to be the decrease of intraretinal expression of the
complement inhibitor cfh. Our cell type-specific analyses also provide a novel
perspective on how expression of complement genes, such as those identified by GWAS
for AMD and diabetic retinopathy, in various retinal cell types might explain the disease
mechanisms in question. The tightly orchestrated reaction of all retinal cell types to
distinct conditions of tissue stress suggests that cell type-specific responses must be
considered for successful development of novel therapeutic strategies targeting the
retinal complement activity in the future (Sohn et al., 2003, 2000; Radu et al., 2011;
Scheetz et al., 2013; Sudharsan et al., 2017; Weber et al., 2014; Yang et al., 2016).
Lastly, this study helped decipher the cell type-specific complement expression patterns
in the retina and showed that complement protein deposition also follows cell type
specificity. The local complement transcripts detected by the two methods in the retinal
cells might be insufficient to activate the terminal canonical complement pathway, but it
is plausible that the intracellular complement components may have non-canonical
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functions in the retina (e.g. C3 can mediate synaptic pruning; CFH can govern functions
of phagocytosis and apoptosis) (Martin et al., 2016; Hawksworth et al., 2017). There is a
growing evidence for intracellular functions of early complement components, which
could have an impact on normal physiology (Liszewski et al., 2017). Future work can
build on these results and investigate to the extent to which the different cell types
secrete complement, and how the components produced in different cell types might
interact.

Methods
Animals
scRNAseq was performed on wild type (C57BL/6J) male mice (10 weeks old) purchased
from Jackson Laboratory (Bar Harbor, ME, USA). All experimental procedures were
approved by the University of Pennsylvania Animal Care and Use Committee. Mice were
sacrificed with cervical dislocation under anesthesia. Their eyeballs were quickly
removed and placed in cold phosphate buffered saline (PBS). The mouse retina was
carefully removed under dissecting scope and tissue was dissociated immediately using
the papain dissociation system (Worthington, Lakewood, NJ, USA) following the
manufacturer’s instructions. Briefly, the mouse retina was incubated at 37oC for 30
minutes in Eagle’s Balanced Salt Solution (EBSS) with DNase followed by tissue
trituration with a 10 ml pipette. Cell pellet was collected after centrifugation at 300 × g for
5 minutes and then resuspended in DNase albumin-inhibitor solution. The cell
suspension was carefully layered on top of the albumin-inhibitor solution, then
centrifuged at 70 × g for 6 minutes. The cell pellet was washed and resuspended in 1:1
DMEM/F12 + 10% FBS. All centrifugation steps were performed at room temperature.
The final cell suspension was filtered with 40 μm cell strainer (Falcon, Corning, NY,
USA) to remove large debris. To assess cell viability, cells were stained with 0.4% trypan
blue (Mediatech, Inc., Manassas, VA, USA) and counted using a hemocytometer. Viable
cells (greater than 80%) were submitted to the Center for Applied Genomics at the
Children’s Hospital of Philadelphia (CHOP) for cell separation and lysis on the 10X
Chromium Genomics instrument and sequencing on the Illumina Hi-Seq instrument.
Experiments for immunomagnetic separation were done in accordance with the
European Community Council Directive 2010/63/EU and the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research and were approved by the local
Bavarian authorities (55.2 DMS-2532-2-182, Germany). All mice were housed in a 12hour light/ dark cycle with ~400 lux. Experiments were conducted with 8-, 16- and 24week-old male and female on BALB/c mice. Retinal ischemia was induced in one eye of
8-week old C57BL/6J mice using the high intraocular pressure (HIOP) method (Pannicke
et al., 2014; Wagner et al., 2016). The other eye remained untreated and served as an
internal control. Anesthesia was induced with ketamine (100 mg/kg body weight,
intraperitoneal (ip); Ratiopharm, Ulm, Germany), xylazine (5 mg/kg, ip; Bayer Vital,
Leverkusen, Germany), and atropine sulfate (100 mg/kg, ip; Braun, Melsungen,
Germany). The anterior chamber of the test eye was cannulated from the pars plana
with a 30-gauge infusion needle, connected to a saline bottle. The intraocular pressure
was increased to 160 mmHg for 90 minutes by elevating the bottle. After removing the
needle, the animals survived for 24 hours and subsequently, they were sacrificed with
carbon dioxide for tissue analyses.
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Single Cell RNA Analysis of mouse retina
All analyses were carried out in the statistical software R v 3.5.1. The R package Seurat
was used for data analysis, dataset merging and cell clustering analysis. For clustering,
we used 2000 or more genes that had detectable expression with high variability in the
~92,000 mouse retinal cells. Six genetically identical C57BL/6J mice were sequenced,
our data were consistent across different batches (Supplementary Fig. 1). We filtered
out low-quality cells in which <90% of the reads did not map to the genome using the
Cell Ranger pipeline from 10x genomics, and ultimately obtained 92,343 cells used in
our subsequent analyses. Given the consistent number of genes (nGene), UMIs (nUMI),
and the percentage of mitochondrial genes (percent.mito) detected in each batch, we
merged the sequencing runs and used 30 principal components as an input to tdistributed stochastic neighbor embedding (t-SNE) method for dimension reduction and
data visualization. We found 25 cell clusters within the retina using an unsupervised
analysis that did not rely on known markers of retinal cells. Marker genes were identified
for all clusters with the function markers.all in the R package Seurat; all marker genes
with power less than 0.4 were discarded. Moreover, only cells with mitochondrial gene
percentages < 50%, and those with unique gene counts between 200 and 3,500 were
used, leaving us with 91,798 retinal cells. After filtering, we sought to consolidate the 25
clusters into a total of 11 (for N=91,798 cells), each of which represents a major,
functionally important cell class in the retina. For this, we used the known, established
marker genes for common retinal cell types. Although previous studies of scRNA-seq on
the mouse retina have identified more than 30 different cell types, this difference is
largely explained by their subdivision of bipolar cells (BCs) into numerous subcategories. We decided to classify cell types based on general categories because we
wanted to study complement expression in retinal cells more broadly. Using this
approach, the cell type proportions in the retina proper are comparable between our
study and past studies. Based on mean complement gene expression, we categorized
positive expression for a gene within a cell type only if either ³5% of cells or at least 50
cells within that class had non-zero expression for that gene. The single cell RNA-Seq
data have been deposited in Gene Expression Omnibus (GEO) under accession number
ID GSE116426.

Isolation of retinal cell populations by immunomagnetic enrichment
Retinal cell types were enriched as described previously using magnetic-activated cell
sorting (MACS) (Grosche et al., 2016). Briefly, retinae were treated with papain (0.2
mg/ml; Roche Molecular Biochemicals) for 30 minutes at 37 °C in the dark in Ca2+- and
Mg2+-free extracellular solution (140 mM NaCl, 3 mM KCl, 10 mM HEPES, 11 mM
glucose, pH 7.4). After several washes and 4 minutes of incubation with DNase I (200
U/ml), retinae were triturated in extracellular solution (now with 1 mM MgCl2 and 2 mM
CaCl2). To purify microglial and vascular cells, the retinal cell suspension was
subsequently incubated with CD11b- and CD31 microbeads according to the
manufacturer’s protocol (Miltenyi Biotec, Bergisch Gladbach, Germany). The respective
binding cells were depleted from the retinal suspension using LS-columns, prior to Müller
cell enrichment. To purify Müller glia, the cell suspension was incubated in extracellular
solution containing biotinylated hamster anti-CD29 (clone Ha2/5, 0.1 mg/ml, BD
Biosciences, Heidelberg, Germany) for 15 minutes at 4°C. Cells were washed in an
extracellular solution, spun down, resuspended in the presence of anti-biotin MicroBeads
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(1:5; Miltenyi Biotec,) and incubated for 10 minutes at 4°C. After washing, CD29+ Müller
cells were separated using large cell (LS) columns according to the manufacturer’s
instructions (Miltenyi Biotec). Cells in the flow through of the last sorting step- depleted
of microglia, vascular cells and Müller glia- were considered as the neuronal population.
RPE was collected by scratching the eye cup after the retina had been removed and
thus, scratch samples also contained cells from the underlying choroid. Samples were
digested, and in subsequent steps, macrophages were depleted using anti-CD11bmicrobeads and vascular cells using CD31-microbeads (Miltenyi Biotec).
For qRT-PCR, as described for RNA-seq, total RNA was isolated from the enriched cell
populations using the PureLink® RNA Micro Scale Kit (Thermo Fisher Scientific,
Schwerte, Germany). A DNase digestion step was included to remove genomic DNA
(Roche). We performed RNA integrity validation and quantification using the Agilent
RNA 6000 Pico chip analysis according to the manufactures instructions (Agilent
Technologies, Waldbronn, Germany). First-strand cDNAs from the total RNA purified
from each cell population were synthesized using the RevertAid H Minus First-Strand
cDNA Synthesis Kit (Fermentas by Thermo Fisher Scientific, Schwerte, Germany). We
designed primers using the Universal ProbeLibrary Assay Design Center (Roche) and
measured transcript levels of candidate genes by qRT-PCR using the TaqMan hPSC
Scorecard™ Panel (384 well, ViiA7, Life Technologies, Darmstadt, Germany) according
to the company’s guidelines.

LC-MS/MS mass spectrometry analysis
LC-MS/MS analysis was performed as described previously (Frik et al., 2018; Lepper et
al., 2018)on a Q-Exactive HF mass spectrometer (Thermo Fisher Scientific Inc.,
Waltham, MA, U.S.A.) coupled to an Ultimate 3000 RSLC nano-HPLC (Dionex,
Sunnyvale, CA). Briefly, 0.5 μg sample was automatically loaded onto a nano trap
column (300 μm inner diameter × 5 mm, packed with Acclaim PepMap100 C18. 5 μm,
100 Å; LC Packings, Sunnyvale, CA) before separation by reversed phase
chromatography (HSS-T3 M-class column, 25 cm, Waters) in an 80 minutes non-linear
gradient from 3 to 40% acetonitrile (ACN) in 0.1% formic acid (FA) at a flow rate of 250
nl/min. Eluted peptides were analysed by the Q-Exactive HF mass spectrometer
equipped with a nano-flex ionization source. Full scan MS spectra (from m/z 300 to
1500) and MS/MS fragment spectra were acquired in the Orbitrap with a resolution of
60,000 or 15000 respectively, with maximum injection times of 50 ms each. Up to ten
most intense ions were selected for HCD fragmentation depending on signal intensity
(TOP10 method). Target peptides already selected for MS/MS were dynamically
excluded for 30 seconds. Spectra were analyzed using the Progenesis QI software for
proteomics (Version 3.0, Nonlinear Dynamics, Waters, Newcastle upon Tyne, U.K.) for
label-free quantification, as previously described (Grosche et al., 2016). All features
were exported as a Mascot generic file (mgf) and used for peptide identification with
Mascot (version 2.4) in the UniProtKB/Swiss-Prot taxonomy mouse database (Release
2017.02, 16871 sequences). Search parameters used were: 10 ppm peptide mass
tolerance, 20 mmu fragment mass tolerance, one missed cleavage allowed,
carbamidomethylation set as fixed modification, and methionine oxidation, asparagine or
glutamine deamidation were allowed as variable modifications. A Mascot-integrated
decoy database search calculated an average false discovery rate (FDR) of < 1%.
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For western blot, Cell pellets of enriched cell populations from pooled pair of mouse
eyes were dissolved in reducing Laemmli sample buffer, denatured and sonicated.
Neuronal protein extraction reagent (Thermo Fisher Scientific, Braunschweig, Germany)
was added to the neuron populations. Samples were separated on a 12% SDS-PAGE.
The immunoblot was performed as previously described (Schäfer et al., 2017). Detection
was performed with primary and secondary antibodies diluted in blocking solution. Blots
were developed with WesternSure PREMIUM Chemiluminescent Substrate (LI-COR,
Bad Homburg, Germany).

Immunohistochemistry of the retina and the RPE/choroid flat mounts
To quantify cell nuclei in the retinal layer sections of 4% paraformaldehyde (PFA)-fixated
and paraffin-embedded murine eyes, the sections were deparaffinised and incubated
with Hoechst33342 (1:1000; #H1399, Thermo Fisher Scientific, Braunschweig,
Germany) as previously described (Schäfer et al., 2017). Images were acquired using
confocal microscopy (VisiScope, Visitron Systems, Puchheim, Germany). Retinal
microglia and RPE autofluorescence quantification was performed in the retinal and
RPE/choroid flat mounts, respectively. Anterior segments of mouse eyes were removed,
and the retina and RPE/choroid carefully separated. Flat mounts were fixated in 4% PFA
(RPE/choroid 2 h on ice, retina 1 h room temperature), permeabilized (1% Triton X-100)
and blocked (1% BSA, 5% goat serum, 0.1 M NaPO4, pH 7). RPE/choroid flat mounts
were stained with anti-ZO-1 antibody (overnight at 4° C) and secondary antibody
including Hoechst33342 (1 h, room temperature). Retinal flat mounts were stained with
anti-Iba1 antibody (3% Triton X-100, 1 % DMSO, 5% normal goat serum, overnight at
4° C) and secondary antibody (1% BSA in PBS, overnight at 4° C). Retinal flat mounts
were embedded with photoreceptors facing down, and the ganglion cell layer facing up.
Images were taken with a confocal microscope (VisiScope, Visitron Systems).
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CHAPTER 5: Single Cell Analyses Demarcate Novel Intracellular
Complement Signatures as Key Regulator of Metabolic
Reprogramming in the Human T Cell Life Cycle
Abstract
Spatial separation between the extracellular and intracellular compartments has long
rendered the functions of complement system to be only partially understood. Recent
discoveries have shed light on how the intracellular complement, complosome, can
modulate biosynthetic processes that are fundamental to T cell biology. The
complosome has been postulated as an integral regulator of the metabolic
signatures that are congruous with T cell homeostasis and effector functions.
Nonetheless, the degree to which metabolic processes might be impacted by
intracellular complement activity in T cells remains elusive. Single cell transcriptomics
can provide a snapshot of the mRNA transcripts within a cell, and can help elucidate
how genes of the complement pathway might coordinate their activity with genes from
specific metabolic pathways. Here, we seek to unravel complement–metabolism
crosstalk in purified, human naïve and memory CD4+ and CD8+ T cells at rest, and 12h
and 24h post CD3+CD28 costimulation. Using two novel statistical frameworks for
pathway-level analyses, we mine this single cell data resource for biologically
meaningful patterns. Specifically, first we compare the multivariate distribution of genes
of a given metabolic pathway before and after stimulation, and then assess each
metabolic pathway for transcriptional synergy with the complosome. Using this systems
level strategy, we discovered novel connections between fundamental metabolic
pathways, such as glycolysis and oxidative phosphorylation, and the complosome.
Taken together, through unbiased computational screening we were able to deduce
complosome-mediated T cell metabolic reprogramming based on single cell pathway
analyses.

Background
CD4+ and CD8+ T cell lymphocytes are essential in maintaining immunity against foreign
invaders. Naïve T cells continuously patrol the peripheral circulation for pathogens
(Mahnke et al. 2013) and such encounters, in conjunction with environmental signals,
drive naïve T cells into appropriate “effector” responses that promote pathogen
clearance by producing cytokines and/or cytotoxic mediators. A proportion of these
effector cells persist as memory T cells that become swiftly activated again if the same
pathogen re-infects the host (Golubovskaya and Wu 2016; Lakkis and Sayegh 2003;
Weng, Araki, and Subedi 2012). Successful CD4+ and CD8+ T cell responses require
that cells undergo “metabolic reprogramming”, i.e., move from a relatively quiescent and
metabolically low-level state into an elevated state that allows them to meet the
biosynthetic requirements in accordance with their effector function (Almeida et al. 2016;
Gerriets and Rathmell 2012). For example, circulating naïve T cells mostly rely on
oxidative phosphorylation (OXPHOS) for homeostatic survival, while induction of effector
function by CD4+ and CD8+ T cells depends, at minimum, on increased glycolysis,
OXPHOS and/or glutaminolysis (Gubser et al. 2013; Pearce et al. 2013; van der Windt
et al. 2012; van der Windt et al. 2013; Rathmell 2012). Memory T cells are distinct with
regards to their metabolic profile and tend to utilize long-chain fatty acid oxidation as
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major fuel source upon re-activation (Raud et al. 2018). Furthermore, CD4+ effector T
cell lineages which include T helper (Th) type 1, 2, 9, 17 cells, as well as natural and
induced regulatory T cells, are all characterized by distinct metabolic needs and
signatures for their respective specialized activities (Almeida et al. 2016; Gerriets and
Rathmell 2012). Thus, metabolic regulation of T cell fate is complex and driven by both
extrinsic factors, such as nutrient availability and the microenvironment (MacIver,
Michalek, and Rathmell 2013), as well intrinsic factors, such as intracellular signaling
pathways that affect expression and/or post-translational modifications of nutrient
channels, or metabolic enzymes, thereby impacting the nature of the metabolic
pathways engaged and immunometabolites generated (Buck, O'Sullivan, and Pearce
2015). Nonetheless, the extent to which T cell activation perturbs the metabolic
landscape and, consequently, the mechanisms underlying metabolic remodeling have
remained mostly elusive, limiting our ability to develop cellular therapies that target
immunometabolism.
Recently, a salient innate immune pathway, the complement system, has been identified
as an integral component of human Th1 and CTL biology via regulation of core
metabolic pathways (Arbore et al. 2018; West, Kolev, and Kemper 2018). Importantly,
this noncanonical role of intracellular complement, the complosome, is distinct and
largely independent from the classic activity of the liver-derived and blood-operative
complement components that mediate immunosurveillance and pathogen killing.
Specifically, human CD4+ and CD8+ T cells in circulation express the key complement
components C3 and C5. C3 is cleaved intracellularly continuously by the protease
cathepsin L (CTSL) into C3a and C3b. The intracellular C3a generated via this pathway
engages the C3a receptor (C3aR) expressed on lysosomes and sustains homeostatic T
cell survival via tonic mammalian target of rapamycin (mTOR) activity (Liszewski et al.
2013). T cells also continuously generate intracellular C5a via a yet unknown
mechanism (Arbore et al. 2016). Upon TCR activation and CD28 costimulation,
intracellular C5a engages the intracellular C5aR1 and induces mitochondrial reactive
oxygen species (ROS) which are required for IFN-𝛾 production by CD4+ T cells (Sena et
al. 2013), while C3a and C3b rapidly translocate to the cell surface, where they engage
cell surface C3aR and CD46 (C3b receptor), respectively.
Signaling events downstream of CD46 are critical in driving the high levels of glycolysis
and OXPHOS that are specifically needed for Th1 induction in CD4+ T cells (Hess and
Kemper 2016). Autocrine CD46-mediated signals in TCR and CD28-activated CD8+ T
cells increase lipid metabolism and hence support their optimal IFN-𝛾 secretion,
granzyme B expression and cytotoxic activity (Arbore et al. 2018). Consequently,
patients deficient in CD46 or those that cannot secrete C3 have reduced Th1 and CTL
responses and are prone to recurrent infections (Arbore et al. 2018; Le Friec et al. 2012;
Liszewski et al. 2013). Of note, although CD46 is ubiquitously expressed in humans,
mice lack CD46 expression, and thus the C3-CD46 axis represents a human-specific
pathway (West, Kolev, and Kemper 2018). Although the new noncanonical roles of
complement in cell metabolism have so far been best defined in human T cells, the
notion that the complosome is of broad physiological relevance for normal cell
physiology and homeostasis is now gathering momentum as, for example, intracellular
C3 can regulate autophagy by directly engaging with ATG16L1 in pancreatic 𝛽-cells and
via this, allows for 𝛽-cell survival during diabetogenic stress (King et al. 2019).
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Furthermore, C3a also directly regulates gene expression in B cells after translocation
into the nucleus (Kremlitzka et al. 2019).
Previous approaches to define the average impact of the complosome on T cell
metabolism by assessing the signals downstream of CD46 in bulk T cell populations
have been productive in establishing the complement–metabolism connection (Arbore et
al. 2018; Arbore et al. 2016; Kolev et al. 2015; Liszewski et al. 2013). To gain a deeper
understanding of the complosome-metabolism relationship at a single cell level and to
meaningfully integrate other complosome components into the metabolic network, we
herein employed an unbiased, data-driven systems approach: we generated single cell
transcriptomics data from resting and activated (at two time points) human naïve and
memory CD4+ and CD8+ T cells and developed a method to gauge synergy between the
two biochemical pathways of interest – complement and metabolism – from the
expression of their corresponding genes at the single cell level. To do so, we employed
a novel statistical framework that first entailed a distribution-free, multisample and
multivariate graph-based test assessing metabolic pathways for differential distribution
across the three time points. We subsequently performed canonical correlation analyses
with a stratified permutation testing approach to discover pathways that had high
canonical corrrelations with the complosome.
This framework not only confirmed the functional connection between intracellular C3
and C5 activation products and glycolysis and OXPHOS in CD4+ T cells, but also
identified several novel significant multivariate correlations with additional metabolic
pathways, such as pyruvate and propanoate metabolism. Conversely, our approach
identified new complosome components, including C1QBP, Factor D, clusterin and
CD18 (as part of LFA-1 or the complement receptor CR3) as candidates for novel key
players in T cell metabolism. To corroborate the of our results as resource for
generating mechanistic hypotheses, we validated the instructive role of the complosome
on glycolysis and OXPHOS in vitro for the first time in naïve and memory CD4+ and
CD8+ T cells. Collectively, these results strengthen the case for the complosome as a
critical and broad regulator of T cell metabolism and provide unique multivariate
analytical tools that can be applied for exploring other pathway–pathway interactions.
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Figure 20. Cells were isolated and purified from whole blood from a 39 year old
male Caucasian donor by gradient purification and then using a negative selection
T cell isolation kit. Cells were stained with CD45RA FITC, CD4 PE, CD8 PercpCy5.5,
CD56 APC and CD45RO. Then, they were sorted into naïve and memory CD4+ and
CD8+ T cells as outlined in the schematic. All CD8+ T cells were CD56 negative (not
NKT cells). The cells were then stimulated with anti-CD3 and anti-CD28 antibodies &
collected after 12 hours and 24 hours. Prior to stimulation the plates were coated with
anti-CD3 and anti-CD28 antibodies for 5 hours at 37 degrees C.
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Changes in metabolic pathway usage across individual T cells post
activation
We performed scRNA-seq on purified CD4+ and CD8+ human T cells (Fig. 20), freshly
obtained from a healthy individual at resting state (0h), and 12 and 24 hours (12h and
24h, respectively) after in vitro activation with antibodies to CD3 and CD28 under nonpolarizing conditions (Methods). We chose to activate T cells with CD3+CD28
stimulation to investigate the connections between complement and metabolism driven
by T cell activation during which TCR and CD28 signals engage CD46 in an autocrine
and more physiological fashion via endogenous C3b surface provision. This is opposed
to CD3+CD46 in vitro stimulation that drives a stronger Th1 phenotype under nonskewing conditions due to the increased CD46 engagement by antibodies (Arbore et al.
2018; Kolev et al. 2015; Le Friec et al. 2012; Liszewski and Kemper 2019; Liszewski et
al. 2005; Liszewski et al. 2013). The basic summary statistics for each sequenced
sample are summarized in Table 10.
Table 10. Summary statistics and basic sequencing characteristics for each of the
4 cell types sequenced using Illumina HiSeq2500 at three separate time points: at
rest (0h), and at 12h and 24h for post–CD3+CD8 costimulation.
Number of Cells

Median Genes
per cell

Mean Reads
per cell

Median UMI
Counts per cell

Number of
genes detected

CD4+ Naïve T cells
0h
5219
12h
5054
24h
6496
CD4+ Memory T cells

1451
1667
2038

38221
21993
22638

4778
5537
7475

18839
18387
19137

0h
4301
12h
4968
24h
5747
CD8+ Naïve T cells

1653
2064
3129

33662
31093
36436

5186
6664
12885

18851
19182
19690

0h
2788
12h
3598
24h
5902
CD8+ Memory T cells

1607
1890
2159

40462
50684
37662

5240
7007
7883

17942
19250
19861

1830
2324
2210

73210
45244
21445

5524
7758
7236

18188
18576
18926

0h
12h
24h

2314
3244
5804
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Table 11. List of the KEGG metabolic pathways used as baits in the current study
to assess if any of these pathways might demonstrate a significant association
with the complement pathway
Pathway

KEGG ID

Glycolysis
Citric Acid Cycle
Pentose Phosphate Pathway
Fructose & Mannose Metabolism
Galactose Metabolism
Oxidative Phosphorylation
Purine Metabolism
Pyrimidine Metabolism
Alanine, Aspartate & Glutamine
Metabolism
Glycine, Serine & Threonine Metabolism
Cysteine & Methionine Metabolism
Branch-chain Amino Acid Metabolism
Arginine Metabolism
Inositol Phosphate Metabolism
Arachidonic Acid Metabolism
Pyruvate Metabolism
Propanoate Metabolism
NAD Metabolism
Folate/1-carbon Metabolism
mTOR Pathway

00010
00020
00030
00051
00052
00190
00230
00240
00250

Number of gene
members
65
30
28
36
27
132
162
98
32

00260
00270
00280
00330
00562
00590
00620
00640
00760
00670
04150

32
36
44
54
57
59
40
32
24
20
52

The internal makeup of a T cell comprises of regulatory and signaling pathways that
govern metabolism and impact cellular function. The genes that constitute a particular
pathway undergo changes in transcription/translation as that biochemical pathway
responds to particular cues or stimuli (Nicholson 2019). Prior to assessing metabolic
pathways for transcriptional correlation with the complosome, we wanted to understand
how T cell stimulation alters the metabolic landscape more generally. How the
distribution of gene sets belonging to specific metabolic pathways gets perturbed post
activation remains uncharacterized. Thus, we developed a novel graph-based method
for comparing multivariate distributions across multiple groups or conditions. This
method, MCM, is described in Chapter 3. Briefly, it is distribution-free and based on the
concept of optimal matching (Agarwal et al. 2019). In the context of the dataset under
study, we elucidate the intuition behind our method in Fig 21a and further describe it in
Methods.
Briefly, we pool data from the three time points – 0h, 12h and 24h – and based on the
multivariate distribution for a given pathway’s genes, match pairs of cells that are
“closest” to each other in the high-dimensional space. If the cells from a given condition
(say, 0h) mostly match with cells form within that condition, then the number of intersample matches (0h-12h or 0h-24h) would be inherently small, arguing in favor of the
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pathway being differentially distributed across the time points. On the other hand, if the
number of inter-sample matches are sufficiently large, then the test fails to reject the null
hypothesis, suggesting that based on the data the pathway is likely not differentially
distributed.
We used this method to evaluate whether, for a given cell type, the multivariate
distribution of genes belonging a particular metabolic pathway differs across the three
time points. The metabolic pathways assessed for coordination with the complosome are
listed in Table 11. We observed that upon stimulation, the pathways that demonstrated
the strongest evidence for differential distribution across all cell types were those
fundamental to ATP production, such as glycolysis oxidative phosphorylation and
pyruvate metabolism, or essential for nucleic acid synthesis, viz. pyrimidine and purine
metabolism (Fig. 21b).
To validate that these results indeed detect the genes being up- or down-regulated to
meet the bioenergetic demands of T cell activation, we examined individual genes
comprising these differentially distributed pathways. For example, when we inspected
expression changes in glycolytic genes amid CD4+ Naïve T cells (Fig. 21c), we
observed the gene expression signatures to be in accordance with the literature. For
instance, post stimulation gapdh regulates helper T cell effector functions via a posttranscriptional mechanism (Chang et al. 2013) as ldha expression increases to support
aerobic glycolysis (Peng et al. 2016). Both these molecules ultimately lead to the
production of IFN-γ by T cells. Not only do we find the mRNA levels of these major
genes being upregulated post-activation, we additionally observe changes in genes that
are relatively lowly expressed – but encode key enzymes that promote glycolysis – such
as eno2 and pck2.
The latter point, that genes with relatively low expression or subtle expression changes
post activation are picked up by our multivariate method, is also an important aspect of
why we employed this novel test. Often in differential distribution analyses, genes with
small effect sizes or very low expression go under detected due to the low power of most
univariate tests (Glazko and Emmert-Streib 2009). Moreover, by not relying on individual
gene-level statistics for power and utilizing the joint distribution of a gene-set, our
method allows for an easier interpretation of the results (Fig. 24); for further discussion
on this, please see the corresponding section in Methods.
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Figure 21. Graph-based multivariate test uncovers the biological pathways that
change in distribution between resting and activated states across four T cell
subtypes. (a) Overview of the graph-based test which is based on optimal matching.
For a given pathway X with genes 𝑔§ , the test pools samples from all three time point
conditions in the high-dimensional space ℝ¢¨ and pairs cells based on minimizing the
Euclidean distance between them. The number of edges within-conditions versus those
between conditions are then used to perform hypothesis testing. (b) Application of the
multivariate test to the scRNAseq data generated in this study identifies a subset of the
metabolic pathways as being differentially distributed post activation across all cell types.
(c) Pathway level differences are reflective of the gene-level differences as explicated in
this example of CD4+ Naïve T cells and glycolysis. Our test suggests that genes that
constitute the glycolysis pathway are differentially distributed between 0h, 12h and 24h,
and this can be verified by examining individual genes.

A statistical framework for detecting pathway-pathway synergy
unravels several metabolic hubs that potentially interact with the
complosome across different T cell subtypes
Having a better cognizance of the metabolic pathways whose genes undergo a temporal
change in their multivariate distribution, we sought to understand whether a subset of the
metabolic pathways might show transcriptional coordination with the complosome. To
that end, we developed a statistical procedure wherein first, based on KEGG
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annotations (Kanehisa et al. 2017), we created subsets of the original scRNAseq data;
each subset having the same number of cells but differing in the number of genes in
accordance with the specific metabolic pathway. For example, submatrix X might have c
number of cells and 𝑔§ number of genes that belong to pathway X, and another
submatrix Y might have 𝑔© genes corresponding to pathway Y. Then, we compute the
largest canonical correlation between X and Y, and define that as the multivariate or
canonical correlation between the two pathways (see Methods).
To determine whether the estimated canonical correlation is statistically meaningful, we
devise a stratified permutation test in which the cells are stratified based on technical
covariates, and the permutation is performed within these strata (Fig. 22a). The
stratification step is important for single cell data, which are inherently noisy, sparse and
confounded with several technical factors, such as library size and the number of genes
detected per cell. A completely random permutation breaks the inherent biological and
technical covariate structure in the data, and results in increased false positive
associations (Fig. 27). On the other hand, matching the cells based on technical
covariates allows for better control of type 1 error. We observe that in accordance with
past reports, our method is able to detect a significant association between complement
and the mTOR pathway in CD4+ T cells, specifically at 24h post-stimulation (Fig. 22b),
thereby recapitulating aspects of known biology. At rest, the multivariate correlation is
low and expectedly, the resulting p-value is high (Fig. 22c).

78

a

b

Genes (g)
Pi : i th
pathway

Cells (c)

N=

P1

…

P2

Pk

Pathway Annotations (e.g., based on KEGG)

Cells (c)

Step 1

mTOR Pathway
Folate/1-C metab
NAD metabolism
Propanoate metab
Pyruvate metab
Arachidonic acid metab
Inositol Phosphate metab
Arginine metab
Branch-chain AA metab
Cysteine & methionine metab
Glycine, serine & threonine metab
Ala/Asp/Glut metab
Pyrimidine metab
Purine metab
Oxidative Phosphorylation
Galactose metab
Fructose metab
Pentose Phosphate Pathway
Citric acid cycle
Glycolysis

t0

t12

t24

t0

t12 t24

Naive

t0

t12

Memory

t24

g2

g1

c

Y

Largest canonical correlation between X and Y

A null distribution to determine if |rXY | is meaningful
Keep Y fixed and consider X

A

…

Bipartite
Matching

B

Swap cells in set A matched with those in set B.
Recompute canonical correlation ("#% )
*)

t12 t24

Naive

t12

t24

Memory

t0

Naive

t12

t24

Memory
CD8+

CD4+

q-val

Y

Repeat (i) and (ii) m times to obtain #"$ = ("#% , #"' ,…, #"( ), and
determine if rXY > 95% quantile for the distribution of #"$

“true” biological signal

80

d

50

#"(

Reject +, if rXY > 95%
quantile for the
distribution of #"$ ?

110 140

0.005 0.15 0.3 0.7 1

≅ #"%
.
.
.

t0

mTOR Pathway
Folate/1-C metab
NAD metabolism
Propanoate metab
Pyruvate metab
Arachidonic acid metab
Inositol Phosphate metab
Arginine metab
Branch-chain AA metab
Cysteine & methionine metab
Glycine, serine & threonine metab
Ala/Asp/Glut metab
Pyrimidine metab
Purine metab
Oxidative Phosphorylation
Galactose metab
Fructose metab
Pentose Phosphate Pathway
Citric acid cycle
Glycolysis

-#./0.123

(ii)

…

Randomly
divide cells
into two sets

t0

0.35 0.5 0.7

20

(i)

t12 t24

0.2

0

Step 3

≅ rXY

t0

Memory
CD8+

Multivariate
correlation

X

t12 t24

Naive

CD4+

Step 2

t0

0.0

0.2

0.4

0.6

0.8

1.0

4 − 6780.

Figure 22. A statistical framework to assess metabolic pathways for correlation
with the complosome authenticates a complement-metabolism axis. (a) Outline of
the strategy used to determine associations between the complement pathway and a set
of target/candidate metabolic pathways. (b) Heatmap depicting the largest canonical
correlation between complement and various metabolic pathways across each T cell
subtype, profiled at 0h, 12h and 24h post activation. The corresponding p-values
obtained by stratified permutation testing are displayed in (c). (d) Distribution of the pvalues suggests that the model is not over-sensitive or biased as the of p-values are
uniformly distributed with a left peak.
A priori, one would not surmise that the expression of every metabolic pathway is
relevantly associated with complosome expression. Thus, the distribution of p-values
resulting from the stratified permutation procedure might be expected to be uniformly
distributed with a left peak indicating the presence of true and meaningful significant
correlations. Examining the distribution of p-values obtained by our proposed method
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suggests that this is indeed the case (Fig. 22d), further lending support to this approach
being unbiased. Additionally, and as expected, the higher the magnitude of the canonical
correlation between a given metabolic pathway and the complosome, the lower the
estimated p-value (Fig. 23a). To further ensure that any detected effects are not due to
in technical differences in sequencing between the different cell types, we randomly
selected 2,000 cells for every cell type and at each time point, and down-sampled this
dataset to a mean UMI count of 4,500/cell. When we applied our method on this
downsampled dataset, we were still able to detect majority of the pathway-pathway
associations (Fig. 23b) that were conspicuous in the original dataset.
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Figure 23. Stratified permutation testing helps control the false discovery
proportion while assessing pathway-pathway synergy, and associations between
the complosome and basic cell metabolic processes hold true even in data
downsampled to match for sequencing statistics. (a) The magnitude of the largest
canonical correlation is linear with the estimated p-value, intuitively suggesting that
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increased strength of correlation between two pathways associates with its statistical
significance. (b) A subtle but important step of our statistical framework to determine the
significance of the CCA analysis is to match cells based on technical confounders, and
compute an empirical null by permuting the matched cells. Were a regular permutation
strategy employed instead of the stratified permutation, the distribution of p-values is
highly left skewed and detects excessive false positives. (c) We downsampled the entire
dataset to have 2,000 cells at a mean library size of 4,500 UMIs/cell across every cell
type and at each time point. This setup was designed to address the possibility that
increased canonical correlation could be a direct result of increased library size and/or
the number of cells. Despite adjusting for these technical differences, associations
between the complosome, and glycolysis and oxidative phosphorylation, remained
significant.

Exploring the molecular basis of the interactions that underlie a
complement-metabolism axis through gene-level features
Among all four cell types, most metabolic pathways demonstrated evidence for
differential distribution post activation as well as for synergy with the complosome, with
increasing multivariate correlations at 12h and 24h post activation. These signatures
insinuate at possibly an unanticipated and broad regulation of cell metabolism by the
complosome. To evaluate their biological relevance, we focused specifically on two
pathways fundamental to basic cell metabolism, viz. glycolysis and OXPHOS. First, we
examined the Pearson correlation between genes of the complement pathway and those
belonging to glycolysis. We observed that in general, the correlations between most
complement and glycolytic genes increase temporally between 0h and 24h. For
instance, previous work has shown that in human CD8+ T cells, autocrine CD46
signaling augments nutrient influx and fatty acid synthesis (Arbore et al. 2018). Our
analysis suggests that complosome expression also influences the expression of genes
belonging to glycolysis in these cells (Fig 24a). In addition to the known regulator cd46,
several other complement genes showed a similar temporal increase, with the strongest
contributions from c1qbp, cd55, itgb2, calr, cd46 and cd59. These genes were
consistently strongly correlated with glycolytic genes across the other three cell types
examined as well (Fig. 25).
In canonical correlation analysis, the weights or loadings on each variable are analogous
to beta weights in regression (Uurtio et al. 2017), and examining the loading on each
complement gene provides another window into identifying target molecules that might
mediate a given metabolic pathway. When we examined the weights on complement
genes across CD8+ Naïve T cells, we found that the same aforementioned six
complement genes had the highest weights (Fig 24b). This pattern in CCA loadings
could be observed across all cell types (Fig. 26), motivating the hypothesis that one or
more of these complosome components could be directly involved in moderating
glycolysis. To further explore this, we compared the dispersion in gene expression
across using measures such as the Gini index and coefficient of variation (CV). Gini
index ranges between 0 and 1 wherein 0 indicates that the gene expression is unfiromly
distributed across cells, and a value closer to 1 indicates an unequal and skewed
distribution of that gene’s expression. Gini index can unravel properties hidden by mean
expression, and can help contextualize rare cell states (Barroso, Puzovic, and Dutheil
81

2018; O'Hagan et al. 2018). Recent work has suggested that measures of variation are
important in T cell biology, where gene expression variance can help cells rapidly adapt
rapidly to an environmetal stimulus (Martinez-Jimenez et al. 2017; Hebenstreit et al.
2012). Thus, we recovered the Gini index and CV using a deconvolution model (Wang et
al. 2018), and for the six genes with the largest canonical loadings – c1qbp, cd55, itgb2,
calr, cd46 and cd59 – scrutinized changes in gene expression distribution over time.
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Figure 24. Probing gene–gene correlations, canonical loadings and changes in
transcriptional noise to extrapolate the specific complement components that
might be involved in regulating glycolysis, in CD8+ T cells as an example. (a)
Gene–gene correlations between members of the complement pathway and glycolytic
genes suggest a temporal increase in the Pearson correlations between 0h and 24h. (b)
Examining the weights on complement genes during canonical correlation analysis
allows us to scrutinize which genes had the high contributions in the pathway-level
association with glycolysis. (c) Gini-index provides a robust measure of dispersion for a
gene expression distribution. Here, a polynomial slope-graph highlights that different
members of the complossome likely become active at different time points poststimulation.
The CV and Gini coefficient values for each gene among each cell type and across each
time point are summarized in Table 12. The temporal trend of these measures enables a
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more detailed characterization of complosome activity during T cell activation. For
instance, amidst CD8+ Naïve T cells, the expression of the membrane-bound
complement regulators, cd46, cd55 and cd59, changes gradually in the first 12 hours as
the Gini coefficients remain relatively steady, but then, between 12h and 24h, there is a
rapid rise in their Gini index. On the other hand, the Gini coefficients for itgb2, c1qbp and
calr rise rapidly between 0 and 12h. While the exact mechanism of these molecules in
the regulation of glycolysis is unknown, changes in their Gini indices suggest that some
of these complosome molecules might be early drivers of metabolic changes while
others, especially the membrane-bound regulators, could be more late-acting. This
notion is in accordance with (Arbore et al. 2018), which shows that first T cells utilize the
itgb2 encoded LFA-1 to migrate across the body, and then engage CD46 in an autocrine
fashion to allow the cells to meet their bioenergetic needs. Altogether, our pathway
analyses support a complement–metabolism axis across both naïve and memory T
cells, and point to specific complosome members that likely regulate the basic metabolic
processes in T cells.
Table 12. Coefficient of Variation (CV) and the Gini index (gini) computed for six
complement genes that were suspected to be the most prime candidates for being
regulators of glycolysis and/or oxidative phosphorylation. The corresponding
standard errors for the CV and gini estimates are provided adjacent to each statistic (±).
Abbreviations:4N – CD4+ Naïve T cells; 8N – CD8+ Naïve T cells; 4M – CD4+ Memory
T cells; 8M – CD8+ Memory T cells; t0 – resting state; t12 – 12h post stimulation; t24 – 24h
post stimulation with CD3+CD28

4N t0
4N t12
4N t24
4M t0
4M t12
4M t24
8N t0
8N t12
8N t24
8M t0
8M t12

c1qbp
CV
gini
0.14± 0.076±
0.03
0.02
0.44± 0.23±
0.03
0.02
0.36± 0.19±
0.02
0.01
0.29± 0.12±
0.08
0.04
0.39± 0.21±
0.03
0.02
0.33± 0.19±
0.01
0.01
0.33± 0.17±
0.12
0.06
0.68± 0.37±
0.03
0.02
0.35± 0.19±
0.01
0.01
0.70± 0.31±
0.07
0.05
0.43± 0.24±
0.02
0.02

cd55
CV
gini
0.62± 0.31±
0.09
0.04
1.03± 0.48±
0.11
0.05
1.02± 0.46±
0.09
0.03
0.77± 0.38±
0.12
0.05
1.23± 0.50±
0.22
0.05
1.24± 0.57±
0.17
0.06
0.55± 0.29±
0.08
0.04
0.60± 0.30±
0.10
0.03
0.79± 0.39±
0.06
0.02
0.77± 0.39±
0.14
0.05
0.92± 0.44±
0.14
0.04

itgb2
CV
gini
0.55± 0.29±
0.09
0.04
0.79± 0.38±
0.11
0.04
0.52± 0.26±
0.07
0.03
0.67± 0.33±
0.11
0.04
0.76± 0.39±
0.11
0.04
0.53± 0.26±
0.07
0.03
0.81± 0.41±
0.13
0.03
1.3± 0.56±
0.11
0.05
0.69± 0.34±
0.07
0.02
1.05± 0.48±
0.10
0.04
0.83± 0.42±
0.10
0.04
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calr
CV
0.47±
0.06
0.59±
0.02
0.46±
0.02
0.51±
0.06
0.51±
0.03
0.46±
0.02
0.48±
0.08
0.79±
0.02
0.44±
0.02
0.54±
0.04
0.48±
0.02

gini
0.24±
0.03
0.32±
0.01
0.25±
0.01
0.24±
0.04
0.26±
0.01
0.24±
0.01
0.24±
0.04
0.41±
0.01
0.23±
0.01
0.26±
0.03
0.27±
0.01

cd46
CV
gini
0.38± 0.20±
0.08
0.04
0.87± 0.44±
0.12
0.03
0.83± 0.43±
0.11
0.03
0.69± 0.35±
0.12
0.04
0.95± 0.45±
0.14
0.03
0.80± 0.41±
0.12
0.03
0.76± 0.40±
0.11
0.03
0.63± 0.34±
0.11
0.04
0.96± 0.45±
0.14
0.02
0.68± 0.35±
0.11
0.04
0.75± 0.38±
0.13
0.04

cd59
CV
gini
0.95± 0.46±
0.11
0.02
0.78± 0.40±
0.13
0.04
0.93± 0.45±
0.14
0.03
0.86± 0.43±
0.15
0.04
0.71± 0.37±
0.12
0.04
1.11± 0.49±
0.12
0.04
1.09± 0.43±
0.27
0.03
1.02± 0.47±
0.17
0.03
1.2±
0.52±
0.21
0.12
1.24± 0.49±
0.29
0.05
0.91± 0.44±
0.16
0.04

8M t24

0.32±
0.02

0.17±
0.01

1.09± 0.48± 0.44± 0.24± 0.43± 0.23± 0.83±
0.15
0.03
0.08
0.04
0.02
0.01
0.11
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0.47

0.61±
0.12
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Figure 25. Pearson correlation between genes of the complement pathway and
those involved in glycolysis. (a), (b) and (c) demonstrate gene-gene correlations in
CD4+ Naïve, CD4+ Memory and D8+ Memory T cells, respectively. Similar to our
findings in CD8+ Naïve T cells (Fig. 3), gene-gene correlations increase over time post
activation, and this increase is also reflected in the increase in the multivariate canonical
correlation between the complosome and glycolysis across all the T cell subtypes
profiled.

Discussion
Along with the pathogen- and danger-associated molecular patterns (PAMPs and
DAMPs, respectively) and certain cell surface receptors, the complement pathway plays
a fundamental role in immunosurveillance and protection of the human body against
harmful pathogens. Recent work has demonstrated that in addition to being “guardians
of the extracellular space” (Kolev, Le Friec, and Kemper 2014), members of the
complement system form a key component of intracellular regulatory mechanisms that
govern lymphocytic activation and function. In particular, resting CD4+ T cells express
CD46, which sustains IL-7R expression and restrains Notch signaling (Le Friec et al.
2012; Liszewski et al. 2013). Further, intracellular C3 levels have been shown to drive
mTOR activation and support homeostatic survival, while intracellular C5 mediates
production of reactive oxygen species (ROS), further supporting Th1 activity (Kolev and
Kemper 2017; West and Kemper 2019). In cytotoxic T lymphocytes (CTLs), autocrine
CD46 engagement has been shown to induce nutrient influx, glycolysis and fatty acid
synthesis (Arbore et al. 2018). A common theme amongst these studies, as well as
others in the literature regarding the role of complosome activity in T cell function
(Arbore et al. 2016; Kolev, Le Friec, and Kemper 2014; West, Kolev, and Kemper 2018),
implicates the importance of the complement–metabolism axis specifically via activity of
the complosome and/or the production of metabolites that subsequently modulate
lymphocytic function.
As the connections between complosome and basic cell metabolic processes have
sparked a renewed interest in complement biology over the last decade, it is becoming
increasingly clear that the diverse mechanistic routes by which complement activity
influences immunometabolism are yet to be discovered. Correlative studies in human
subjects often form the bedrock of hypothesis generation. These data-driven hypotheses
can then be phenocopied at the wet bench in order to explicate mechanistic
relationships. With this notion in mind, our goal was to assess pathway-pathway
associations between the complosome and a set of core metabolic pathways at the
single cell level in order to better understand the previously reported connections
between complement activity and regulation of T cell metabolism.
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Figure 26. Canonical weights on the complement genes for each cell type and time
point profiled for the two pathways that we subsequently validated in vitro.
Glycolysis and oxidative phosphorylation demonstrated a significant association with the
complosome and examining the CCA loadings on the complement genes suggests that
complement components have similar weights for both metabolic pathways [(a) and (b)],
indicating that the underlying mechanism by which the two pathways are modulated by
the complosome might also be shared among cell types.
Breakthroughs in single cell RNA profiling have added to our understanding of complex,
nonlinear relationships between genes, providing a unique opportunity to study how
biochemical pathways, and by proxy cellular functions, might be associated with each
other. However, few, if any, statistical procedures for multivariate analysis among
biochemical pathways exist for scRNAseq data. Here, we developed novel frameworks
for pathway-level explorations in single cell data, and demonstrated that these
frameworks are useful in unearthing new biological patterns. Specifically, in this study
we harness scRNAseq data generated from resting and activated purified human T cell
populations to determine which metabolic pathways experience a distribution shift upon
stimulation, and whether specific metabolic pathways show evidence for transcriptional
association with the complosome. Our approach not only detected known relationships
– such as between complement and the mTOR pathway in CD4+ T cells, or between
glycolysis and complement in CD8+ T cells – but also disinterred new associations.
Furthermore, we disentangled the relationship between complement and
glycolysis/oxidative phosphorylation in vitro, evincing how complement activity regulates
these metabolic process in both CD4+ and CD8+ T cells. Additional connections
discovered by our analysis, such as those between the complosome and
purine/pyrimidine synthesis, can motivate future work on complement’s noncanonical
functions.
In the long term, targeting the complement–metabolism axis can potentially create new
treatment avenues to successfully deploy T cells against autoimmune diseases. Further
still, enhanced ability to modulate T cell function is important for cancer immunotherapy
as well as for inducing immunologic tolerance in settings such as transplantation. In
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order for these prospects to be successful, however, understanding how the intracellular
complement interacts with other drivers of metabolism is crucial. Thus, an understanding
of which metabolic processes are governed by the complosome is important in designing
the next generation of cell-based therapies (Kemper and Kohl 2018). The pathway-level
approach presented in this work provides a systematic way of studying the relationships
between intracellular complement activity and the generation of specific
immunometabolites. Additionally, as tools to map the metabolic configuration of cells
within complex microenvironments become available using single cell metabolomics, it
will also become clear how the subcellular location of the complosome and the various
metabolites impacts their interaction (de Goede, Harber, and Van den Bossche 2019;
MacIver, Michalek, and Rathmell 2013).
Lastly, despite having detected significant associations between complement and
specific metabolic pathways, as with any transcriptomic screening study, there are
limitations to this approach. In general, single cell data are sparse and provide a patchy
picture of gene expression in a cell. Therefore, it is possible that with greater sequencing
depth, signals undetected in our current dataset might become more clear. Additionally,
our data was generated from a young, healthy Caucasian male, and additional humanbased studies might be needed to appreciate the generalizability of our findings.
Nonetheless, this work lays the foundation for future work in pathway-level analyses at
the single cell level, and unveils specific metabolic pathways that can be focus of
subsequent research on complosome and T cell biology.

Methods
Library sequencing and preprocessing steps for the single cell transcriptomics data
We prepared single cell transcriptome libraries using the 10xGenomics Chromium Single
Cell v3 kit, in accordance with the company’s manual. Subsequently, the single cell
libraries were sequenced by the NovaSeq 6000 sequencing system (Illumina, Inc., San
Diego, CA, USA) with reads per cell targeted to be at a mean of 50,000 reads for each
sample sequenced. Initial quality control was performed on the resulting scRNAseq data
from each sample using Cell Ranger (Version 2.1.0). The number of cells sequenced,
genes detected and the mean reads and UMIs per cell are listed in Table S1. To prepare
the data for the multivariate analyses described in this study, we normalized the original
gene count matrix obtained from CellRanger using Seurat v3.1.0 (Stuart et al. 2019).
Briefly, we divided the UMI count for each gene in every cell by the total number of UMIs
in that cell. The normalized data were then multiplied by 10,000 and transformed to a
natural log scale. Next, if a cell had less than 200 genes detected, or if the proportion of
the transcript counts from mitochondrial genes was greater than 50%, that cell was filtered
out from any downstream analysis. To obtain pathway-specific matrices, the function
scPath(), from our package multicross, was used. These pathway-specific (cells x genes)
matrices were used as the input for both the multivariate graph-based test as well as the
canonical correlation analysis.
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A graph-based test based on optimal matching to detect differentially distributed
pathways across multiple samples
Given K multivariate probability distributions F1, F2, ... , FK, the K-sample problem is to
test the hypotheses
H0 : F1 = ··· = FK

versus

H1 : Fs ≠ Ft ,

for some 1 ≤ s < t ≤ K

based on collections of observations – 𝜒= , 𝜒6 , … , 𝜒? – coming from F1,F2,...,FK
respectively. In the single cell setting, F’s correspond to the tissue samples, and 𝜒’s
denote the number of cells sequenced for a given condition K. For example, in this work
we are interesting in comparing the multivariate distribution of a gene set (corresponding
to a particular pathway) across conditions F1 (0h), F2 (12h) and F3 (24h) for a given cell
type.
Several tests exist for nonparametric testing in the 2-sample framework that are based
on the idea of constructing graphs on the pooled sample 𝜒= ∪ 𝜒6 ∪ … ∪ 𝜒? , such as
nearest neighbor graphs (Henze 1988; Schilling 1986), minimal spanning trees
(Friedman and Rafsky 1979) or graphs based on optimal non-bipartite matching
(Rosenbaum 2005). Inspired by the latter method and ideas developed in another recent
paper (Chen and Friedman 2017), we developed a universally consistent and
distribution-free multisample test, i.e. the null distribution of the test statistic does not
depend on the distribution of the data (Agarwal et al. 2019). Briefly, our novel
multisample crossmatch test, based on the Mahalanobis disparity, begins by pooling the
samples 𝜒= , 𝜒6 , … , 𝜒? corresponding to the distributions F1,F2,...,FK (respectively)
together. We then construct a minimum non-bipartite matching on the pooled sample, i.e.
a matching on {𝜒= ∪ 𝜒6 ∪ … ∪ 𝜒? }, which minimizes the sum of lengths of all the edges.
For each 1 ≤ s < t ≤ K, the (s,t)-cross count ast is then defined as the number of matched
edges in the pooled sample {𝜒= ∪ 𝜒6 ∪ … ∪ 𝜒? with one endpoint in 𝜒s and the other
endpoint in 𝜒t. The test statistic is then defined as:
•
𝑆 ≔ n𝐴 − 𝔼•€ 𝐴o 𝐶𝑜𝑣•…=
n𝐴on𝐴 − 𝔼•€ 𝐴o,
€
‡

where 𝐴: = (𝑎BD ) =|B†D|? ∈ ℝn x o denotes the vector of cross-counts.
𝑆 is distribution free under H0, and exact expressions for the entries of 𝔼•€ 𝐴 and
𝐶𝑜𝑣•€ (𝐴) can be computed from a given dataset. Instead of using the exact null
distribution of 𝑆 its weak limit, the chi-squared distribution with n?6o degrees of freedom
can be used for computing the test cut-off. Since 𝑆 is a measure of distance between
𝔼•€ 𝐴 and 𝐴, the null hypothesis is rejected when 𝑆 is “sufficiently large”, i.e. exceeds
the cut-off. Additional theoretical details are described and proved in an associated
statistical work: (Agarwal et al. 2019), and the method is publicly available through the R
package multicross.
Although results from a gene-level differential expression (DE) analysis are commonly
used to subsequently assess them for enrichment in a gene set corresponding to
biochemical pathways, this approach is biased by the gene-level statistics and
potentially neglects many genes of importance to a particular biological function. This
becomes apparent when we compare metabolic gene expression differences between
naïve and memory T cells at each time point (Fig. 24a). Our method allows us to
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discover that at each time point several pathways, e.g., glycolysis, oxidative
phosphorylation, pyruvate metabolism, the mTOR pathway, and purine and pyrimidine
metabolism, appear to be consistently differentially distributed between naïve and
memory cells. In comparison, a DE analysis using Seurat (Stuart et al. 2019) identified
very few DE metabolic genes between naïve and memory cells (Fig. 24b), which were
not insufficient to run a gene set enrichment analysis and recover the pathways being
affected. This observation is supported by previous work that described how changes in
gene expression of metabolic genes can be moderate and hard to detect for individual
genes, but can be better understood through pathway-level analysis (Mootha et al.
2003).
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Figure 27. Application of MCM to identify metabolic genes that are differentially
expressed (DE) between naïve and memory T cells within CD4+ and CD8+
subtypes at each of the three time points. (a) Heatmap showing which metabolic
pathways were detected as DE between naïve and memory cells by our method. (b)
When gene-level analysis for differential expression was done using the Wilcoxon ranksum test, only a handful of genes, with moderate log2-fold changes, were detected. The
latter approach is underpowered in making pathway-level inferences which are afforded
by the former graph-based statistical test.

Canonical Correlation Analysis (CCA) to examine multivariate correlation between two
gene sets, each corresponding to a given pathway
Suppose we have two matrices, 𝑋¡×¢s and 𝑌¡×¢x , each representing the normalized gene
expression values for a given pair of pathways, (𝑃= , 𝑃6 ), respectively, in a single cell
transcriptomics experiment. The rows in the matrix represent c cells, and the columns, g
genes. Note that both 𝑋 and 𝑌 have the same number of cells, but different number of
genes, depending on how many genes constitute a given pathway. We perform CCA on
𝑋 and 𝑌 (Tabachnick and Fidell 1989), defined using the singular value decomposition of
a matrix C :
𝐶 = 𝑅©© …= 𝑅©§ 𝑅§§ …= 𝑅§© ,
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where RXX is the correlation among the genes g1, RYX is the correlation among the
genes g2 and g1, RYY is the correlation among the genes g2 and RXY is the correlation
among g1 and g2. CCA strives to maximize the product moment correlation between
features (Hotelling 1936); here all correlation measures are calculated using Pearson’s
correlation.
We compute the singular value decomposition of C as:
𝐶 = 𝑈 ¯ Λ 𝐵² ,
Where Λ is the diagonal matrix of the singular values of C, and 𝐵² refers to the canonical
coefficients. The 𝑖 DK eigenvalue 𝜆t of the matrix C is equal to the square of the
𝑖 DK canonical correlation which is called 𝑟 6 (§©)´ . Hence, the largest canonical correlation
is the square root of the first eigenvalue, 𝜆= , of C (∴ 𝑟§© = √𝜆= ).

Stratified permutation testing to determine the significance of the largest canonical
correlation
To determine whether 𝑟§© computed using CCA is “large enough”, we perform stratified
permutation testing. The stratification step is important for single cell data, which are
inherently noisy, sparse and confounded with several technical factors, such as library
size and the number of genes detected per cell. A completely random permutation would
break the inherent biological and technical covariate structure in the data; for example,
cells with a significantly high mitochondrial percentage might indicate cell lysis or
trauma, and that could, in turn, affect the expression of other genes. Moreover, a
random permutation (without any stratification) results in substantially increased false
positive associations. In our pipeline, we create default strata based on: (i) number of
non-zero genes detected, (ii) library size, and (iii) percentage of mitochondrial gene
expression.
We then split the cells randomly into two sets and perform complete nearest neighbor
matching between the two sets to pair two cells while minimizing the Euclidean distance
between them based on their covariates. The paired cells are swapped producing a
random stratified permutation; this permutation strategy preserves, to a large degree, the
biological and technical structure unique to each set of cells. Appropriately controlling for
this structure allows us to produce a more realistic permutation null for 𝑟§© . Our
algorithm, described in pseudocode below, takes as input two matrices X and Y, and the
covariate matrix m:
1. The user can choose to provide m, capturing the cell-specific characteristics that must
be accounted for while matching. By default, we can generate m by taking as input the
raw single cell counts matrix, and producing a 𝑚: = 𝑐 × 3 matrix whose rows represent
the c cells and whose columns represent the three covariates described above.
2. Keep Y fixed.
loop:
for iterations j:1 → 10,000 do
(i) Randomly split 𝑋¡×¢s into two sets 𝑋¹º×¢s and 𝑋̇º×¢s .
x
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x

(ii) Match every cell c´ in 𝑋¹ to its nearest neighbor cell 𝑐⃛ in 𝑋̇ while minimizing
the Euclidean distance between c´ and 𝑐⃛ based on their covariates in m (bipartite
perfect matching):
∑À´Ás(¾´´ … ¾
⃛ ´ )x

dist <c´, 𝑐⃛> = ½

Â

,

where m´ and 𝑚
⃛ represent the covariate vectors for cells c´ and 𝑐⃛, respectively; v
represents the number of covariates, which in our default model would be 3.
At most one cell in either 𝑋¹ and 𝑋̇ remains unmatched if the number of cells is odd.
(iii) Swap the cells in 𝑋¹ with their matched cell in 𝑋̇. This amounts to a stratified
permutation of the rows of X, to obtain 𝑋Ã. Compute and store 𝑟§Ã© for the jth
iteration.
3. The set of 𝑟§Ã© s across j iterations allows us to obtain an empirical null distribution, 𝔇,
for 𝑟§© . We determine the p-value for the significance of 𝑟§© based on where it falls on
𝔇.
Since we compute the p-value for z simultaneous hypothesis tests (z pair-wise
comparisons for pathway–pathway interactions) with the procedure outlined above, we
control the FDR and compute q-values as described next.

Estimating the false discovery rate (FDR)
(a) Suppose we have p-values 𝑃 Å = (𝑃= , … , 𝑃Å ), each for the test examining the synergy
between z pairs of pathways.
(b) Let 𝑃(:) ≡ 0, and order the p-values 𝑃(:) = 0 < 𝑃(=) < ⋯ < 𝑃(Å) .
(c) Define hypothesis indicators 𝐻 Å = (𝐻= , … , 𝐻Å ), where 𝐻t = 0 when the ith null
hypothesis (no transcriptional synergy between the pathways) is true and 𝐻t = 1 when
the ith alternative hypothesis is true.
(d) A multiple testing threshold T is a map [0,1]Å → [0,1], where we reject each null
hypothesis with 𝑃t ≤ 𝑇(𝑃 Å ). As a function of T, we define the false discovery proportion
(FDP) as:
𝐹𝐷𝑃(𝑇) = ∑

∑´ ={Ê´ | •} (=…•´ )
´ ={Ê´

| •} Ë={bÌÌ Ê´ Í •}

(e) We determine T using the Benjamini-Hochberg procedure (𝑇Î• ):
t

𝑇Î• = max {𝑃(t) : 𝑃(t) ≤ 𝛼 Å , 0 ≤ 𝑖 ≤ 𝑧}, and where 𝛼 = 0.2.
(f) Lastly, the FDR for the threshold 𝑇Î• is defined as the expected FDP:
𝐹𝐷𝑅 = 𝔼[𝐹𝐷𝑃(𝑇Î• )]

92

BIBLIOGRAPHY
Agarwal, Divyansh, Somabha Mukherjee, Bhaswar Bikram Bhattacharya, and Nancy
Ruonan Zhang. 2019. 'Distribution-Free Multisample Test Based on Optimal
Matching with Applications to Single Cell Genomics', eprint arXiv:1906.04776.
Almeida, L., M. Lochner, L. Berod, and T. Sparwasser. 2016. 'Metabolic pathways in T
cell activation and lineage differentiation', Semin Immunol, 28: 514-24.
Andrews, TS, and M Hemberg. 2018. 'False signals induced by single-cell imputation
[version 1; referees: 4 approved with reservations]', F1000Research, 7.
Arbore, G., E. E. West, J. Rahman, G. Le Friec, N. Niyonzima, M. Pirooznia, I. Tunc, P.
Pavlidis, N. Powell, Y. Li, P. Liu, A. Servais, L. Couzi, V. Fremeaux-Bacchi, L.
Placais, A. Ferraro, P. R. Walsh, D. Kavanagh, B. Afzali, P. Lavender, H. J.
Lachmann, and C. Kemper. 2018. 'Complement receptor CD46 co-stimulates
optimal human CD8(+) T cell effector function via fatty acid metabolism', Nat
Commun, 9: 4186.
Arbore, G., E. E. West, R. Spolski, A. A. B. Robertson, A. Klos, C. Rheinheimer, P.
Dutow, T. M. Woodruff, Z. X. Yu, L. A. O'Neill, R. C. Coll, A. Sher, W. J.
Leonard, J. Kohl, P. Monk, M. A. Cooper, M. Arno, B. Afzali, H. J. Lachmann,
A. P. Cope, K. D. Mayer-Barber, and C. Kemper. 2016. 'T helper 1 immunity
requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells',
Science, 352: aad1210.
Badsha, Md. Bahadur, Rui Li, Boxiang Liu, Yang I. Li, Min Xian, Nicholas E. Banovich,
and Audrey Qiuyan Fu. 2018. 'Imputation of single-cell gene expression with an
autoencoder neural network', bioRxiv: 504977.
Bantug, G. R., L. Galluzzi, G. Kroemer, and C. Hess. 2018. 'The spectrum of T cell
metabolism in health and disease', Nat Rev Immunol, 18: 19-34.
Barroso, G. V., N. Puzovic, and J. Y. Dutheil. 2018. 'The Evolution of Gene-Specific
Transcriptional Noise Is Driven by Selection at the Pathway Level', Genetics,
208: 173-89.
Bendall, S. C., K. L. Davis, A. D. Amir el, M. D. Tadmor, E. F. Simonds, T. J. Chen, D.
K. Shenfeld, G. P. Nolan, and D. Pe'er. 2014. 'Single-cell trajectory detection
uncovers progression and regulatory coordination in human B cell development',
Cell, 157: 714-25.
Benjamini, Yoav, and Yosef Hochberg. 1995. 'Controlling the False Discovery Rate: A
Practical and Powerful Approach to Multiple Testing', Journal of the Royal
Statistical Society. Series B (Methodological), 57: 289-300.
Bickel, P. J. 1969. 'A Distribution Free Version of the Smirnov Two Sample Test in the
$p$-Variate Case', Ann. Math. Statist., 40: 1-23.
Boije, H., S. Shirazi Fard, P. H. Edqvist, and F. Hallbook. 2016. 'Horizontal Cells, the
Odd Ones Out in the Retina, Give Insights into Development and Disease', Front
Neuroanat, 10: 77.
Buck, M. D., D. O'Sullivan, and E. L. Pearce. 2015. 'T cell metabolism drives immunity',
J Exp Med, 212: 1345-60.
93

Buettner, F., K. N. Natarajan, F. P. Casale, V. Proserpio, A. Scialdone, F. J. Theis, S. A.
Teichmann, J. C. Marioni, and O. Stegle. 2015. 'Computational analysis of cellto-cell heterogeneity in single-cell RNA-sequencing data reveals hidden
subpopulations of cells', Nat Biotechnol, 33: 155-60.
Buettner, F., N. Pratanwanich, D. J. McCarthy, J. C. Marioni, and O. Stegle. 2017. 'fscLVM: scalable and versatile factor analysis for single-cell RNA-seq', Genome
Biol, 18: 212.
Cao, L. J., and F. H. Tay. 2003. 'Support vector machine with adaptive parameters in
financial time series forecasting', IEEE Trans Neural Netw, 14: 1506-18.
Chang, C. H., J. D. Curtis, L. B. Maggi, Jr., B. Faubert, A. V. Villarino, D. O'Sullivan, S.
C. Huang, G. J. van der Windt, J. Blagih, J. Qiu, J. D. Weber, E. J. Pearce, R. G.
Jones, and E. L. Pearce. 2013. 'Posttranscriptional control of T cell effector
function by aerobic glycolysis', Cell, 153: 1239-51.
Chen, Hao, and Jerome H. Friedman. 2017. 'A New Graph-Based Two-Sample Test for
Multivariate and Object Data', Journal of the American Statistical Association,
112: 397-409.
Cios, Krzysztof J., Roman W. Swiniarski, Witold Pedrycz, and Lukasz A. Kurgan. 2007.
'Feature Extraction and Selection Methods.' in, Data Mining: A Knowledge
Discovery Approach (Springer US: Boston, MA).
Crow, M., and J. Gillis. 2018. 'Co-expression in Single-Cell Analysis: Saving Grace or
Original Sin?', Trends Genet, 34: 823-31.
de Goede, K. E., K. J. Harber, and J. Van den Bossche. 2019. 'Let's Enter the Wonderful
World of Immunometabolites', Trends Endocrinol Metab, 30: 329-31.
Delmans, M., and M. Hemberg. 2016. 'Discrete distributional differential expression
(D3E)--a tool for gene expression analysis of single-cell RNA-seq data', BMC
Bioinformatics, 17: 110.
Di Carlo, Dino, Henry Tat Kwong Tse, and Daniel R. Gossett. 2012. 'Introduction: Why
Analyze Single Cells?' in Sara Lindström and Helene Andersson-Svahn (eds.),
Single-Cell Analysis: Methods and Protocols (Humana Press: Totowa, NJ).
Dolatabadi, S., J. Candia, N. Akrap, C. Vannas, T. Tesan Tomic, W. Losert, G. Landberg,
P. Aman, and A. Stahlberg. 2017. 'Cell Cycle and Cell Size Dependent Gene
Expression Reveals Distinct Subpopulations at Single-Cell Level', Front Genet, 8:
1.
Edqvist, P. H., M. Lek, H. Boije, S. M. Lindback, and F. Hallbook. 2008. 'Axon-bearing
and axon-less horizontal cell subtypes are generated consecutively during chick
retinal development from progenitors that are sensitive to follistatin', BMC Dev
Biol, 8: 46.
Fan, A., and M. Palaniswami. 2000. 'Selecting bankruptcy predictors using a support
vector machine approach', Proceedings of the IEEE-INNS-ENNS International
Joint Conference on Neural Networks. IJCNN 2000. Neural Computing: New
Challenges and Perspectives for the New Millennium, 6: 354-59.
Fey, D., M. Halasz, D. Dreidax, S. P. Kennedy, J. F. Hastings, N. Rauch, A. G. Munoz,
R. Pilkington, M. Fischer, F. Westermann, W. Kolch, B. N. Kholodenko, and D.
R. Croucher. 2015. 'Signaling pathway models as biomarkers: Patient-specific
94

simulations of JNK activity predict the survival of neuroblastoma patients', Sci
Signal, 8: ra130.
Finak, G., A. McDavid, M. Yajima, J. Deng, V. Gersuk, A. K. Shalek, C. K. Slichter, H.
W. Miller, M. J. McElrath, M. Prlic, P. S. Linsley, and R. Gottardo. 2015.
'MAST: a flexible statistical framework for assessing transcriptional changes and
characterizing heterogeneity in single-cell RNA sequencing data', Genome Biol,
16: 278.
Friedman, Jerome H., and Lawrence C. Rafsky. 1979. 'Multivariate Generalizations of
the Wald-Wolfowitz and Smirnov Two-Sample Tests', Ann. Statist., 7: 697-717.
Gavilan, Jose M., and Francisco Velasco Morente. 2014. 'Three Similarity Measures
between One-Dimensional Data Sets', Revista Colombiana de Estadística, 37.
Genton, Marc G. 2002. 'Classes of kernels for machine learning: a statistics perspective',
J. Mach. Learn. Res., 2: 299-312.
Gerriets, V. A., and J. C. Rathmell. 2012. 'Metabolic pathways in T cell fate and
function', Trends Immunol, 33: 168-73.
Gisbrecht, Andrej, Alexander Schulz, and Barbara Hammer. 2015. 'Parametric nonlinear
dimensionality reduction using kernel t-SNE', Neurocomputing, 147: 71-82.
Glazko, G. V., and F. Emmert-Streib. 2009. 'Unite and conquer: univariate and
multivariate approaches for finding differentially expressed gene sets',
Bioinformatics, 25: 2348-54.
Golubovskaya, V., and L. Wu. 2016. 'Different Subsets of T Cells, Memory, Effector
Functions, and CAR-T Immunotherapy', Cancers (Basel), 8.
Gubser, P. M., G. R. Bantug, L. Razik, M. Fischer, S. Dimeloe, G. Hoenger, B. Durovic,
A. Jauch, and C. Hess. 2013. 'Rapid effector function of memory CD8+ T cells
requires an immediate-early glycolytic switch', Nat Immunol, 14: 1064-72.
Guo, X., Y. Zhang, L. Zheng, C. Zheng, J. Song, Q. Zhang, B. Kang, Z. Liu, L. Jin, R.
Xing, R. Gao, L. Zhang, M. Dong, X. Hu, X. Ren, D. Kirchhoff, H. G. Roider, T.
Yan, and Z. Zhang. 2018. 'Global characterization of T cells in non-small-cell
lung cancer by single-cell sequencing', Nat Med, 24: 978-85.
Han, X., R. Wang, Y. Zhou, L. Fei, H. Sun, S. Lai, A. Saadatpour, Z. Zhou, H. Chen, F.
Ye, D. Huang, Y. Xu, W. Huang, M. Jiang, X. Jiang, J. Mao, Y. Chen, C. Lu, J.
Xie, Q. Fang, Y. Wang, R. Yue, T. Li, H. Huang, S. H. Orkin, G. C. Yuan, M.
Chen, and G. Guo. 2018. 'Mapping the Mouse Cell Atlas by Microwell-Seq', Cell,
172: 1091-107 e17.
Hebenstreit, D., A. Deonarine, M. M. Babu, and S. A. Teichmann. 2012. 'Duel of the
fates: the role of transcriptional circuits and noise in CD4+ cells', Curr Opin Cell
Biol, 24: 350-8.
Heller, Ruth, Shane T. Jensen, Paul R. Rosenbaum, and Dylan S. Small. 2010.
'Sensitivity Analysis for the Cross-Match Test, With Applications in Genomics',
Journal of the American Statistical Association, 105: 1005-13.
Heller, Ruth, Paul R. Rosenbaum, and Dylan S. Small. 2010. 'Using the Cross-Match
Test to Appraise Covariate Balance in Matched Pairs', The American Statistician,
64: 299-309.
Henze, Norbert. 1988. 'A Multivariate Two-Sample Test Based on the Number of Nearest
Neighbor Type Coincidences', Ann. Statist., 16: 772-83.
95

Hess, C., and C. Kemper. 2016. 'Complement-Mediated Regulation of Metabolism and
Basic Cellular Processes', Immunity, 45: 240-54.
Hofmann, Thomas, Bernhard Schölkopf, and Alexander J. Smola. 2008. 'Kernel methods
in machine learning', The Annals of Statistics, 36: 1171-220.
Hotelling, H. 1936. 'Relations between Two Sets of Variates', Biometrika, 28: 321-77.
Hu, Z., J. Zhu, and K. Tse. 2013. 'Stocks market prediction using Support Vector
Machine', 6th International Conference on Information Management, Innovation
Management and Industrial Engineering, 2: 115-18.
Huang, M., J. Wang, E. Torre, H. Dueck, S. Shaffer, R. Bonasio, J. I. Murray, A. Raj, M.
Li, and N. R. Zhang. 2018. 'SAVER: gene expression recovery for single-cell
RNA sequencing', Nat Methods, 15: 539-42.
Ji, Z., and H. Ji. 2016. 'TSCAN: Pseudo-time reconstruction and evaluation in single-cell
RNA-seq analysis', Nucleic Acids Res, 44: e117.
Kanehisa, M., M. Furumichi, M. Tanabe, Y. Sato, and K. Morishima. 2017. 'KEGG: new
perspectives on genomes, pathways, diseases and drugs', Nucleic Acids Res, 45:
D353-D61.
Karatzoglou, Alexandros, Alexandros Smola, Kurt Hornik, and Achim Zeileis. 2004.
'kernlab - An S4 Package for Kernel Methods in R', 2004, 11: 20.
Kemper, C., and J. Kohl. 2018. 'Back to the future - non-canonical functions of
complement', Semin Immunol, 37: 1-3.
Kharchenko, P. V., L. Silberstein, and D. T. Scadden. 2014. 'Bayesian approach to singlecell differential expression analysis', Nat Methods, 11: 740-2.
Kim, T., I. R. Chen, Y. Lin, A. Y. Wang, J. Y. H. Yang, and P. Yang. 2018. 'Impact of
similarity metrics on single-cell RNA-seq data clustering', Brief Bioinform.
King, B. C., K. Kulak, U. Krus, R. Rosberg, E. Golec, K. Wozniak, M. F. Gomez, E.
Zhang, D. J. O'Connell, E. Renstrom, and A. M. Blom. 2019. 'Complement
Component C3 Is Highly Expressed in Human Pancreatic Islets and Prevents beta
Cell Death via ATG16L1 Interaction and Autophagy Regulation', Cell Metab, 29:
202-10 e6.
Kolev, M., S. Dimeloe, G. Le Friec, A. Navarini, G. Arbore, G. A. Povoleri, M. Fischer,
R. Belle, J. Loeliger, L. Develioglu, G. R. Bantug, J. Watson, L. Couzi, B. Afzali,
P. Lavender, C. Hess, and C. Kemper. 2015. 'Complement Regulates Nutrient
Influx and Metabolic Reprogramming during Th1 Cell Responses', Immunity, 42:
1033-47.
Kolev, M., and C. Kemper. 2017. 'Keeping It All Going-Complement Meets
Metabolism', Front Immunol, 8: 1.
Kolev, M., G. Le Friec, and C. Kemper. 2014. 'Complement--tapping into new sites and
effector systems', Nat Rev Immunol, 14: 811-20.
Korthauer, K. D., L. F. Chu, M. A. Newton, Y. Li, J. Thomson, R. Stewart, and C.
Kendziorski. 2016. 'A statistical approach for identifying differential distributions
in single-cell RNA-seq experiments', Genome Biol, 17: 222.
Kremlitzka, M., A. A. Nowacka, F. C. Mohlin, P. Bompada, Y. De Marinis, and A. M.
Blom. 2019. 'Interaction of Serum-Derived and Internalized C3 With DNA in
Human B Cells-A Potential Involvement in Regulation of Gene Transcription',
Front Immunol, 10: 493.
96

Kruskal, William H. 1952. 'A Nonparametric test for the Several Sample Problem', The
Annals of Mathematical Statistics, 23: 525-40.
Kung, S. Y. 2014. 'Dimension-reduction: PCA/KPCA and feature selection.' in S. Y.
Kung (ed.), Kernel Methods and Machine Learning (Cambridge University Press:
Cambridge).
La Manno, G., R. Soldatov, A. Zeisel, E. Braun, H. Hochgerner, V. Petukhov, K.
Lidschreiber, M. E. Kastriti, P. Lonnerberg, A. Furlan, J. Fan, L. E. Borm, Z. Liu,
D. van Bruggen, J. Guo, X. He, R. Barker, E. Sundstrom, G. Castelo-Branco, P.
Cramer, I. Adameyko, S. Linnarsson, and P. V. Kharchenko. 2018. 'RNA velocity
of single cells', Nature, 560: 494-98.
Lakkis, F. G., and M. H. Sayegh. 2003. 'Memory T cells: a hurdle to immunologic
tolerance', J Am Soc Nephrol, 14: 2402-10.
Lalanne, J. B., J. C. Taggart, M. S. Guo, L. Herzel, A. Schieler, and G. W. Li. 2018.
'Evolutionary Convergence of Pathway-Specific Enzyme Expression
Stoichiometry', Cell, 173: 749-61 e38.
Le Friec, G., D. Sheppard, P. Whiteman, C. M. Karsten, S. A. Shamoun, A. Laing, L.
Bugeon, M. J. Dallman, T. Melchionna, C. Chillakuri, R. A. Smith, C. Drouet, L.
Couzi, V. Fremeaux-Bacchi, J. Kohl, S. N. Waddington, J. M. McDonnell, A.
Baker, P. A. Handford, S. M. Lea, and C. Kemper. 2012. 'The CD46-Jagged1
interaction is critical for human TH1 immunity', Nat Immunol, 13: 1213-21.
Liszewski, M. K., and C. Kemper. 2019. 'Complement in Motion: The Evolution of
CD46 from a Complement Regulator to an Orchestrator of Normal Cell
Physiology', J Immunol, 203: 3-5.
Liszewski, M. K., C. Kemper, J. D. Price, and J. P. Atkinson. 2005. 'Emerging roles and
new functions of CD46', Springer Semin Immunopathol, 27: 345-58.
Liszewski, M. K., M. Kolev, G. Le Friec, M. Leung, P. G. Bertram, A. F. Fara, M.
Subias, M. C. Pickering, C. Drouet, S. Meri, T. P. Arstila, P. T. Pekkarinen, M.
Ma, A. Cope, T. Reinheckel, S. Rodriguez de Cordoba, B. Afzali, J. P. Atkinson,
and C. Kemper. 2013. 'Intracellular complement activation sustains T cell
homeostasis and mediates effector differentiation', Immunity, 39: 1143-57.
Liu, Jianzhou, and Rong Huang. 2010. 'Generalized Schur complements of matrices and
compound matrices', Electronic Journal of Linear Algebra, 21.
Lu, Huchuan, and Fan Yang. 2014. 'Active Shape Model and Its Application to Face
Alignment.' in Yen-Wei Chen and Lakhmi C. Jain (eds.), Subspace Methods for
Pattern Recognition in Intelligent Environment (Springer Berlin Heidelberg:
Berlin, Heidelberg).
Lynch, M., and G. K. Marinov. 2015. 'The bioenergetic costs of a gene', Proc Natl Acad
Sci U S A, 112: 15690-5.
MacIver, N. J., R. D. Michalek, and J. C. Rathmell. 2013. 'Metabolic regulation of T
lymphocytes', Annu Rev Immunol, 31: 259-83.
Macosko, E. Z., A. Basu, R. Satija, J. Nemesh, K. Shekhar, M. Goldman, I. Tirosh, A. R.
Bialas, N. Kamitaki, E. M. Martersteck, J. J. Trombetta, D. A. Weitz, J. R. Sanes,
A. K. Shalek, A. Regev, and S. A. McCarroll. 2015. 'Highly Parallel Genomewide Expression Profiling of Individual Cells Using Nanoliter Droplets', Cell,
161: 1202-14.
97

Mahnke, Y. D., T. M. Brodie, F. Sallusto, M. Roederer, and E. Lugli. 2013. 'The who's
who of T-cell differentiation: human memory T-cell subsets', Eur J Immunol, 43:
2797-809.
Mann, H. B., and D. R. Whitney. 1947. 'On a Test of Whether one of Two Random
Variables is Stochastically Larger than the Other', Ann. Math. Statist., 18: 50-60.
Martinez-Jimenez, C. P., N. Eling, H. C. Chen, C. A. Vallejos, A. A. Kolodziejczyk, F.
Connor, L. Stojic, T. F. Rayner, M. J. T. Stubbington, S. A. Teichmann, M. de la
Roche, J. C. Marioni, and D. T. Odom. 2017. 'Aging increases cell-to-cell
transcriptional variability upon immune stimulation', Science, 355: 1433-36.
Matthews, D. E. 2007. 'An overview of phenylalanine and tyrosine kinetics in humans', J
Nutr, 137: 1549S-55S; discussion 73S-75S.
McHugh, M. D., J. Berez, and D. S. Small. 2013. 'Hospitals with higher nurse staffing
had lower odds of readmissions penalties than hospitals with lower staffing',
Health Aff (Millwood), 32: 1740-7.
Mika, Sebastian, Bernhard Scholkopf, Alex Smola, Klaus-Robert Muller, Matthias
Scholz, and Gunnar Ratsch. 1999. "Kernel PCA and de-noising in feature spaces."
In Proceedings of the 1998 conference on Advances in neural information
processing systems II, 536-42. MIT Press.
Minh, Ha Quang, Partha Niyogi, and Yuan Yao. 2006. "Mercer’s Theorem, Feature
Maps, and Smoothing." In, 154-68. Berlin, Heidelberg: Springer Berlin
Heidelberg.
Mood, A. M. 1940. 'The Distribution Theory of Runs', Ann. Math. Statist., 11: 367-92.
Mootha, V. K., C. M. Lindgren, K. F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P.
Puigserver, E. Carlsson, M. Ridderstrale, E. Laurila, N. Houstis, M. J. Daly, N.
Patterson, J. P. Mesirov, T. R. Golub, P. Tamayo, B. Spiegelman, E. S. Lander, J.
N. Hirschhorn, D. Altshuler, and L. C. Groop. 2003. 'PGC-1alpha-responsive
genes involved in oxidative phosphorylation are coordinately downregulated in
human diabetes', Nat Genet, 34: 267-73.
Moskowitz, C. S., V. E. Seshan, E. R. Riedel, and C. B. Begg. 2008. 'Estimating the
empirical Lorenz curve and Gini coefficient in the presence of error with nested
data', Stat Med, 27: 3191-208.
Nettleton, Dan, and T Banerjee. 2001. 'Testing the equality of distributions of random
vectors with categorical components %J Comput. Stat. Data Anal', 37: 195-208.
Nicholson, D. J. 2019. 'Is the cell really a machine?', J Theor Biol, 477: 108-26.
O'Hagan, S., M. Wright Muelas, P. J. Day, E. Lundberg, and D. B. Kell. 2018. 'GeneGini:
Assessment via the Gini Coefficient of Reference "Housekeeping" Genes and
Diverse Human Transporter Expression Profiles', Cell Syst, 6: 230-44 e1.
Ogretmen, B. 2018. 'Sphingolipid metabolism in cancer signalling and therapy', Nat Rev
Cancer, 18: 33-50.
Padovan-Merhar, O., G. P. Nair, A. G. Biaesch, A. Mayer, S. Scarfone, S. W. Foley, A.
R. Wu, L. S. Churchman, A. Singh, and A. Raj. 2015. 'Single mammalian cells
compensate for differences in cellular volume and DNA copy number through
independent global transcriptional mechanisms', Mol Cell, 58: 339-52.
98

Pau, G., F. Fuchs, O. Sklyar, M. Boutros, and W. Huber. 2010. 'EBImage--an R package
for image processing with applications to cellular phenotypes', Bioinformatics, 26:
979-81.
Pearce, E. L., M. C. Poffenberger, C. H. Chang, and R. G. Jones. 2013. 'Fueling
immunity: insights into metabolism and lymphocyte function', Science, 342:
1242454.
Pearson, Karl. 1892. The Grammar of Science.
Peng, M., N. Yin, S. Chhangawala, K. Xu, C. S. Leslie, and M. O. Li. 2016. 'Aerobic
glycolysis promotes T helper 1 cell differentiation through an epigenetic
mechanism', Science, 354: 481-84.
Peregrin-Alvarez, J. M., C. Sanford, and J. Parkinson. 2009. 'The conservation and
evolutionary modularity of metabolism', Genome Biol, 10: R63.
Petrie, Adam. 2016. 'Graph-theoretic multisample tests of equality in distribution for high
dimensional data %J Comput. Stat. Data Anal', 96: 145-58.
Poche, R. A., and B. E. Reese. 2009. 'Retinal horizontal cells: challenging paradigms of
neural development and cancer biology', Development, 136: 2141-51.
Qiu, X., Q. Mao, Y. Tang, L. Wang, R. Chawla, H. A. Pliner, and C. Trapnell. 2017.
'Reversed graph embedding resolves complex single-cell trajectories', Nat
Methods, 14: 979-82.
Rathmell, J. C. 2012. 'Metabolism and autophagy in the immune system:
immunometabolism comes of age', Immunol Rev, 249: 5-13.
Raud, B., P. J. McGuire, R. G. Jones, T. Sparwasser, and L. Berod. 2018. 'Fatty acid
metabolism in CD8(+) T cell memory: Challenging current concepts', Immunol
Rev, 283: 213-31.
Regev, A., S. A. Teichmann, E. S. Lander, I. Amit, C. Benoist, E. Birney, B.
Bodenmiller, P. Campbell, P. Carninci, M. Clatworthy, H. Clevers, B. Deplancke,
I. Dunham, J. Eberwine, R. Eils, W. Enard, A. Farmer, L. Fugger, B. Gottgens, N.
Hacohen, M. Haniffa, M. Hemberg, S. Kim, P. Klenerman, A. Kriegstein, E.
Lein, S. Linnarsson, E. Lundberg, J. Lundeberg, P. Majumder, J. C. Marioni, M.
Merad, M. Mhlanga, M. Nawijn, M. Netea, G. Nolan, D. Pe'er, A. Phillipakis, C.
P. Ponting, S. Quake, W. Reik, O. Rozenblatt-Rosen, J. Sanes, R. Satija, T. N.
Schumacher, A. Shalek, E. Shapiro, P. Sharma, J. W. Shin, O. Stegle, M. Stratton,
M. J. T. Stubbington, F. J. Theis, M. Uhlen, A. van Oudenaarden, A. Wagner, F.
Watt, J. Weissman, B. Wold, R. Xavier, N. Yosef, and Participants Human Cell
Atlas Meeting. 2017. 'The Human Cell Atlas', Elife, 6.
Rizzetto, S., A. A. Eltahla, P. Lin, R. Bull, A. R. Lloyd, J. W. K. Ho, V. Venturi, and F.
Luciani. 2017. 'Impact of sequencing depth and read length on single cell RNA
sequencing data of T cells', Sci Rep, 7: 12781.
Romney, A. K., C. C. Moore, W. H. Batchelder, and T. L. Hsia. 2000. 'Statistical
methods for characterizing similarities and differences between semantic
structures', Proc Natl Acad Sci U S A, 97: 518-23.
Rosenbaum, Paul R. 2005. 'An exact distribution-free test comparing two multivariate
distributions based on adjacency', Journal of the Royal Statistical Society: Series
B (Statistical Methodology), 67: 515-30.
99

Rozenblatt-Rosen, O., M. J. T. Stubbington, A. Regev, and S. A. Teichmann. 2017. 'The
Human Cell Atlas: from vision to reality', Nature, 550: 451-53.
Saelens, W., R. Cannoodt, H. Todorov, and Y. Saeys. 2019. 'A comparison of single-cell
trajectory inference methods', Nat Biotechnol, 37: 547-54.
Saitoh, Saburou. 1988. Theory of reproducing kernels and its applications (Longman
Scientific & Technical; Wiley: Harlow, Essex, England; New York).
Salavert, F., M. R. Hidago, A. Amadoz, C. Cubuk, I. Medina, D. Crespo, J. CarbonellCaballero, and J. Dopazo. 2016. 'Actionable pathways: interactive discovery of
therapeutic targets using signaling pathway models', Nucleic Acids Res, 44:
W212-6.
Schaid, D. J. 2010. 'Genomic similarity and kernel methods I: advancements by building
on mathematical and statistical foundations', Hum Hered, 70: 109-31.
Schenk, U., M. Frascoli, M. Proietti, R. Geffers, E. Traggiai, J. Buer, C. Ricordi, A. M.
Westendorf, and F. Grassi. 2011. 'ATP inhibits the generation and function of
regulatory T cells through the activation of purinergic P2X receptors', Sci Signal,
4: ra12.
Schilling, Mark F. 1986. 'Multivariate Two-Sample Tests Based on Nearest Neighbors',
Journal of the American Statistical Association, 81: 799-806.
Schmidt, J. F., C. Santelli, and S. Kozerke. 2016. 'MR Image Reconstruction Using Block
Matching and Adaptive Kernel Methods', PLoS One, 11: e0153736.
Schölkopf, Bernhard, Christopher J. C. Burges, and Alexander J. Smola. 1999. Advances
in kernel methods : support vector learning (MIT Press: Cambridge, Mass.).
Scholkopf, Bernhard, Alexander J. Smola, and Klaus-Robert Muller. 1999. 'Kernel
principal component analysis.' in Scholkopf Bernhard, J. C. Burges Christopher
and J. Smola Alexander (eds.), Advances in kernel methods (MIT Press).
Schweizer, B., and A. Sklar. 1960. 'Statistical metric spaces', Pacific J. Math., 10: 31334.
Sena, L. A., S. Li, A. Jairaman, M. Prakriya, T. Ezponda, D. A. Hildeman, C. R. Wang,
P. T. Schumacker, J. D. Licht, H. Perlman, P. J. Bryce, and N. S. Chandel. 2013.
'Mitochondria are required for antigen-specific T cell activation through reactive
oxygen species signaling', Immunity, 38: 225-36.
Shawe-Taylor, John, and Nello Cristianini. 2004. Kernel methods for pattern analysis
(Cambridge University Press: Cambridge, UK ; New York).
Skinnider, M. A., J. W. Squair, and L. J. Foster. 2019. 'Evaluating measures of
association for single-cell transcriptomics', Nat Methods, 16: 381-86.
Stepanov, S. Ya. 2002. 'Symmetrization of the sign-definiteness criteria of symmetrical
quadratic forms', Journal of Applied Mathematics and Mechanics, 66: 933-41.
Stephens, M. A. 1992. 'Introduction to Kolmogorov (1933) On the Empirical
Determination of a Distribution.' in Samuel Kotz and Norman L. Johnson (eds.),
Breakthroughs in Statistics: Methodology and Distribution (Springer New York:
New York, NY).
Stuart, T., A. Butler, P. Hoffman, C. Hafemeister, E. Papalexi, W. M. Mauck, 3rd, Y.
Hao, M. Stoeckius, P. Smibert, and R. Satija. 2019. 'Comprehensive Integration of
Single-Cell Data', Cell, 177: 1888-902 e21.
100

Supek, F., M. Bosnjak, N. Skunca, and T. Smuc. 2011. 'REVIGO summarizes and
visualizes long lists of gene ontology terms', PLoS One, 6: e21800.
Svensson, V., and L. Pachter. 2018. 'RNA Velocity: Molecular Kinetics from Single-Cell
RNA-Seq', Mol Cell, 72: 7-9.
Tabachnick, Barbara G., and Linda S. Fidell. 1989. Using multivariate statistics (Harper
& Row: New York).
Tabula Muris, Consortium, coordination Overall, coordination Logistical, collection
Organ, processing, preparation Library, sequencing, analysis Computational data,
annotation Cell type, group Writing, group Supplemental text writing, and
investigators Principal. 2018. 'Single-cell transcriptomics of 20 mouse organs
creates a Tabula Muris', Nature, 562: 367-72.
Tian, Luyi, Xueyi Dong, Saskia Freytag, Kim-Anh Le Cao, Shian Su, Daniela AmannZalcenstein, Tom S Weber, Azadeh Seidi, Shalin Naik, and Matthew E Ritchie.
2018. 'scRNA-seq mixology: towards better benchmarking of single cell RNAseq protocols and analysis methods', bioRxiv: 433102.
Todorov, H., and Y. Saeys. 2018. 'Computational approaches for high-throughput singlecell data analysis', FEBS J.
Trapnell, C., D. Cacchiarelli, J. Grimsby, P. Pokharel, S. Li, M. Morse, N. J. Lennon, K.
J. Livak, T. S. Mikkelsen, and J. L. Rinn. 2014. 'The dynamics and regulators of
cell fate decisions are revealed by pseudotemporal ordering of single cells', Nat
Biotechnol, 32: 381-86.
Uhlig, S., and E. Gulbins. 2008. 'Sphingolipids in the lungs', Am J Respir Crit Care Med,
178: 1100-14.
Upadhyay, Ved Prakash, Subhash Panwar, Ramchander Merugu, and Ravindra
Panchariya. 2016. "Forecasting Stock Market Movements Using Various Kernel
Functions in Support Vector Machine." In Proceedings of the International
Conference on Advances in Information Communication Technology &
Computing, 1-5. Bikaner, India: ACM.
Uurtio, Viivi, Joao M. Monteiro, Jaz Kandola, John Shawe-Taylor, Delmiro FernandezReyes, and Juho Rousu. 2017. 'A Tutorial on Canonical Correlation Methods',
ACM Comput. Surv., 50: 1-33.
van der Windt, G. J., B. Everts, C. H. Chang, J. D. Curtis, T. C. Freitas, E. Amiel, E. J.
Pearce, and E. L. Pearce. 2012. 'Mitochondrial respiratory capacity is a critical
regulator of CD8+ T cell memory development', Immunity, 36: 68-78.
van der Windt, G. J., D. O'Sullivan, B. Everts, S. C. Huang, M. D. Buck, J. D. Curtis, C.
H. Chang, A. M. Smith, T. Ai, B. Faubert, R. G. Jones, E. J. Pearce, and E. L.
Pearce. 2013. 'CD8 memory T cells have a bioenergetic advantage that underlies
their rapid recall ability', Proc Natl Acad Sci U S A, 110: 14336-41.
van Dijk, D., R. Sharma, J. Nainys, K. Yim, P. Kathail, A. J. Carr, C. Burdziak, K. R.
Moon, C. L. Chaffer, D. Pattabiraman, B. Bierie, L. Mazutis, G. Wolf, S.
Krishnaswamy, and D. Pe'er. 2018. 'Recovering Gene Interactions from SingleCell Data Using Data Diffusion', Cell, 174: 716-29 e27.
Wald, A., and J. Wolfowitz. 1940. 'On a Test Whether Two Samples are from the Same
Population', Ann. Math. Statist., 11: 147-62.
101

Wang, B., J. Zhu, E. Pierson, D. Ramazzotti, and S. Batzoglou. 2017. 'Visualization and
analysis of single-cell RNA-seq data by kernel-based similarity learning', Nat
Methods, 14: 414-16.
Wang, J., D. Agarwal, M. Huang, G. Hu, Z. Zhou, C. Ye, and N. R. Zhang. 2019. 'Data
denoising with transfer learning in single-cell transcriptomics', Nat Methods, 16:
875-78.
Wang, J., M. Huang, E. Torre, H. Dueck, S. Shaffer, J. Murray, A. Raj, M. Li, and N. R.
Zhang. 2018. 'Gene expression distribution deconvolution in single-cell RNA
sequencing', Proc Natl Acad Sci U S A, 115: E6437-E46.
Wang, T., and S. Nabavi. 2018. 'SigEMD: A powerful method for differential gene
expression analysis in single-cell RNA sequencing data', Methods, 145: 25-32.
Wang, X., E. P. Xing, and D. J. Schaid. 2015. 'Kernel methods for large-scale genomic
data analysis', Brief Bioinform, 16: 183-92.
Weinberger, Kilian Q., Fei Sha, and Lawrence K. Saul. 2004. "Learning a kernel matrix
for nonlinear dimensionality reduction." In Proceedings of the twenty-first
international conference on Machine learning, 106. Banff, Alberta, Canada:
ACM.
Weiss, Lionel. 1960. 'Two-Sample Tests for Multivariate Distributions', Ann. Math.
Statist., 31: 159-64.
Weng, N. P., Y. Araki, and K. Subedi. 2012. 'The molecular basis of the memory T cell
response: differential gene expression and its epigenetic regulation', Nat Rev
Immunol, 12: 306-15.
West, E. E., and C. Kemper. 2019. 'Complement and T Cell Metabolism: Food for
Thought', Immunometabolism, 1: e190006.
West, E. E., M. Kolev, and C. Kemper. 2018. 'Complement and the Regulation of T Cell
Responses', Annu Rev Immunol, 36: 309-38.
'What Is Your Conceptual Definition of "Cell Type" in the Context of a Mature
Organism?'. 2017. Cell Syst, 4: 255-59.
Whitfield, M. L., L. K. George, G. D. Grant, and C. M. Perou. 2006. 'Common markers
of proliferation', Nat Rev Cancer, 6: 99-106.
Wong, S. K. M., and Y. Y. Yao. 1987. "A statistical similarity measure." In Proceedings
of the 10th annual international ACM SIGIR conference on Research and
development in information retrieval, 3-12. New Orleans, Louisiana, USA: ACM.
Zhang, L., and S. Zhang. 2018. 'Comparison of computational methods for imputing
single-cell RNA-sequencing data', IEEE/ACM Trans Comput Biol Bioinform.
Zheng, C., L. Zheng, J. K. Yoo, H. Guo, Y. Zhang, X. Guo, B. Kang, R. Hu, J. Y. Huang,
Q. Zhang, Z. Liu, M. Dong, X. Hu, W. Ouyang, J. Peng, and Z. Zhang. 2017.
'Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell
Sequencing', Cell, 169: 1342-56 e16.

102

